Form990
Click to see attachment
Department of the TreasuryInternal Revenue Service
Return of Organization Exempt From Income Tax
Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code (except private foundations)
MediumBullet Do not enter social security numbers on this form as it may be made public.
MediumBullet Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2019
Open to Public Inspection
A For the 2019 calendar year, or tax year beginning 10-01-2017 , and ending 09-30-2018
BCheck if applicable:
CName of organization
THE FOUNDATION FOR AIDS RESEARCH
 
% BRADLEY JENSEN
Doing business as
Aids Research Foundation or amfAR
 
Number and street (or P.O. box if mail is not delivered to street address)
120 WALL STREET 13TH FLOOR
 
Room/suite
City or town, state or province, country, and ZIP or foreign postal code
NEW YORK, NY100053908
D Employer identification number

13-3163817
E Telephone number

G Gross receipts $ 65,167,864
F Name and address of principal officer:
KEVIN FROST
120 WALL STREET 13TH FLOOR
NEW YORK,NY10005
I
Tax-exempt status: (   ) LeftBullet (insert no.) or
J
Website:MediumBullet
WWW.AMFAR.ORG
H(a)
Is this a group return for
subordinates?
H(b)
Are all subordinates
included?
If "No," attach a list. (see instructions)
H(c)
Group exemption number MediumBullet  
K Form of organization:  
L Year of formation: 1983
M State of legal domicile: NY
Part I
Summary
Activities & Governance 1 Briefly describe the organization’s mission or most significant activities: AMFAR IS DEDICATED TO ENDING THE GLOBAL AIDS EPIDEMIC THROUGH INNOVATIVE RESEARCH.
2 Check this box MediumBullet
3 Number of voting members of the governing body (Part VI, line 1a) ........ 3 12
4 Number of independent voting members of the governing body (Part VI, line 1b) ..... 4 12
5 Total number of individuals employed in calendar year 2019 (Part V, line 2a) ...... 5 88
6 Total number of volunteers (estimate if necessary) ............. 6 0
7a Total unrelated business revenue from Part VIII, column (C), line 12 ........ 7a 0
b Net unrelated business taxable income from Form 990-T, line 39 ......... 7b 60,801
Revenues Prior Year Current Year
8 Contributions and grants (Part VIII, line 1h) ......... 50,842,378 42,784,390
9 Program service revenue (Part VIII, line 2g) ......... 0 0
10 Investment income (Part VIII, column (A), lines 3, 4, and 7d ) .... 1,434,528 1,668,073
11 Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e) -11,850,334 -12,144,387
12 Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12) 40,426,572 32,308,076
Expenses; 13 Grants and similar amounts paid (Part IX, column (A), lines 1–3 )... 12,204,275 12,574,033
14 Benefits paid to or for members (Part IX, column (A), line 4)..... 0 0
15 Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10) 11,102,574 11,259,330
16a Professional fundraising fees (Part IX, column (A), line 11e) ..... 746,863 735,053
b Total fundraising expenses (Part IX, column (D), line 25) MediumBullet5,935,707    
17 Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e).... 19,193,671 14,468,481
18 Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25) 43,247,383 39,036,897
19 Revenue less expenses. Subtract line 18 from line 12....... -2,820,811 -6,728,821
Net Assets or Fund Balances; Beginning of Current Year End of Year
20 Total assets (Part X, line 16)............. 80,221,720 69,536,136
21 Total liabilities (Part X, line 26)............. 20,491,474 16,985,457
22 Net assets or fund balances. Subtract line 21 from line 20..... 59,730,246 52,550,679
Part II
Signature Block
Under penalties of perjury, I declare that I have examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true, correct, and complete. Declaration of preparer (other than officer) is based on all information of which preparer has any knowledge.
Sign Here
JumboBullet
Signature of officer Date
JumboBullet
Type or print name and title
Paid Preparer Use Only
Print/Type preparer's name
Preparer's signature
Date
PTIN
Firm's name MediumBullet

Firm's EIN MediumBullet
Firm's address MediumBullet



Phone no.
May the IRS discuss this return with the preparer shown above? (see instructions) ..........
For Paperwork Reduction Act Notice, see the separate instructions.
Cat. No. 11282Y Form 990 (2019)
Form 990 (2019)
Page 2
Part III
Statement of Program Service Accomplishments
Check if Schedule O contains a response or note to any line in this Part III..............
1
Briefly describe the organization’s mission: THE FOUNDATION FOR AIDS RESEARCH IS AN INTERNATIONAL NOT-FOR-PROFIT ORGANIZATION INCORPORATED IN NEW YORK IN 1989. AMFAR WAS FORMED THROUGH THE UNIFICATION IN 1985 OF TWO NOT-FOR-PROFIT ORGANIZATIONS, THE AIDS MEDICAL FOUNDATION ("AMF"), INCORPORATED IN NEW YORK IN APRIL 1983, AND THE NATIONAL AIDS RESEARCH FOUNDATION, INCORPORATED IN CALIFORNIA IN AUGUST 1985. FIRST BASED IN CALIFORNIA, AMFAR TRANSFERRED ITS LEGAL DOMICILE TO NEW YORK IN 1989, USING THE INITIAL INCORPORATION DOCUMENTS OF AMF, MAKING IT AMFS LEGAL SUCCESSOR. AMFAR HAS OFFICES IN NEW YORK, NY, WASHINGTON, D.C., AND BANGKOK, THAILAND. ON MARCH 7, 2005, THE BOARD OF TRUSTEES OF THE AMERICAN FOUNDATION FOR AIDS RESEARCH APPROVED A CHANGE IN LEGAL NAME TO "THE FOUNDATION FOR AIDS RESEARCH." ON OCTOBER 18, 2005, THE NEW YORK STATE DEPARTMENT OF STATE APPROVED THIS CHANGE. IN ADDITION, THE FOUNDATION HAS SECURED APPROVAL FOR DOING BUSINESS AS (DBA) THE FOLLOWING: - AMERICAN FOUNDATION FOR AIDS RESEARCH - AMFAR - AIDS RESEARCH
2
Did the organization undertake any significant program services during the year which were not listed on
the prior Form 990 or 990-EZ? .....................
If "Yes," describe these new services on Schedule O.
3
Did the organization cease conducting, or make significant changes in how it conducts, any program
services? ...........................
If "Yes," describe these changes on Schedule O.
4
Describe the organization’s program service accomplishments for each of its three largest program services, as measured by expenses. Section 501(c)(3) and 501(c)(4) organizations are required to report the amount of grants and allocations to others, the total expenses, and revenue, if any, for each program service reported.
4a (Code:   ) (Expenses $ 18,260,220 including grants of $ 10,029,065 ) (Revenue $ 0 )
RESEARCH: AMFAR SUPPORTS RESEARCH PROJECTS THAT EXPLORE NOVEL APPROACHES TO SCIENTIFICALLY SOUND BUT UNTESTED HYPOTHESES IN ALL AREAS OF RESEARCH ON HIV/AIDS, FUNDING GOAL-ORIENTED STUDIES THAT OFTEN LACK THE PRELIMINARY DATA REQUIRED FOR SUPPORT FROM TRADITIONAL GRANT MAKERS. THE FOUNDATION PLAYS A VITAL ROLE IN HIV/AIDS RESEARCH, IDENTIFYING CRITICAL GAPS IN KNOWLEDGE AND PROVIDING ESSENTIAL SEED MONEY THAT ENABLES GRANTEES AND FELLOWS TO TEST THE MERITS OF NEW CONCEPTS OR TECHNOLOGIES THAT SUBSEQUENTLY CAN BE VALIDATED THROUGH LARGE-SCALE STUDIES, SUCH AS THOSE FUNDED BY THE U.S. NATIONAL INSTITUTES OF HEALTH. FOR FURTHER DETAILS, SEE SCHEDULE O.
4b (Code:   ) (Expenses $ 5,051,313 including grants of $ 2,072,635 ) (Revenue $ 0 )
TREAT ASIA: AMFARS TREAT ASIA (THERAPEUTICS RESEARCH, EDUCATION, AND AIDS TRAINING IN ASIA) PROGRAM IS A NETWORK OF HOSPITALS, CLINICS, AND RESEARCH INSTITUTIONS WORKING WITH CIVIL SOCIETY TO ENSURE THE SAFE AND EFFECTIVE DELIVERY OF TREATMENTS FOR HIV AND ITS CO-INFECTIONS TO ADULTS AND CHILDREN ACROSS THE ASIA-PACIFIC THROUGH RESEARCH, EDUCATION, AND ADVOCACY OF EVIDENCE-BASED HIV-RELATED POLICIES. THE TREAT ASIA NETWORK ENCOMPASSES 21 ADULT AND 20 PEDIATRIC SITES THROUGHOUT THE REGION, WHICH COLLABORATE ON A VARIETY OF PROJECTS. FOR FURTHER DETAILS, SEE SCHEDULE O.
4c (Code:   ) (Expenses $ 4,139,558 including grants of $ 0 ) (Revenue $ 0 )
PUBLIC INFORMATION: AMFAR SEEKS TO TRANSLATE AND DISSEMINATE INFORMATION ON IMPORTANT HIV-RELATED RESEARCH, TREATMENT, PREVENTION, AND POLICY ISSUES FOR DIVERSE AUDIENCES AND TO INCREASE AWARENESS AND KNOWLEDGE OF THE PANDEMIC. AMFAR PUBLISHES A WIDE RANGE OF EDUCATIONAL MATERIALS, MAINTAINS AN INFORMATIVE WEBSITE, AND ENGAGES RESPECTED PUBLIC FIGURES, HIV/AIDS SCIENTISTS, AND POLICYMAKERS IN COMMUNICATING THE NEED FOR CONTINUED RESEARCH TO DEVELOP NEW METHODS OF PREVENTION, TREATMENT, AND, ULTIMATELY, A CURE FOR HIV. FOR FURTHER DETAILS, SEE SCHEDULE O.
(Code:   ) (Expenses $ 2,141,014 including grants of $ 21,655 ) (Revenue $ 0 )
public policy
(Code:   ) (Expenses $ 921,926 including grants of $ 450,677 ) (Revenue $ 0 )
GMT Initiative
4d Other program services (Describe in Schedule O.)
(Expenses $ 3,062,940 including grants of $ 472,332 ) (Revenue $ 0 )
4e Total program service expensesMediumBullet30,514,031
Form 990 (2019)
Form 990 (2019)
Page 3
Part IV
Checklist of Required Schedules
Yes
No
1
Is the organization described in section 501(c)(3) or 4947(a)(1) (other than a private foundation)? If "Yes," complete Schedule AClick to see attachment.....................
1
Yes
 
2
Is the organization required to complete Schedule B, Schedule of Contributors (see instructions)? Click to see attachment...
2
Yes
 
3
Did the organization engage in direct or indirect political campaign activities on behalf of or in opposition to candidates for public office? If "Yes," complete Schedule C, Part IClick to see attachment.............
3
 
No
4
Section 501(c)(3) organizations. Did the organization engage in lobbying activities, or have a section 501(h) election in effect during the tax year? If "Yes," complete Schedule C, Part IIClick to see attachment.........
4
Yes
 
5
Is the organization a section 501(c)(4), 501(c)(5), or 501(c)(6) organization that receives membership dues, assessments, or similar amounts as defined in Revenue Procedure 98-19? If "Yes," complete Schedule C, Part IIIClick to see attachment..
5
 
No
6
Did the organization maintain any donor advised funds or any similar funds or accounts for which donors have the right to provide advice on the distribution or investment of amounts in such funds or accounts? If "Yes," complete Schedule D, Part IClick to see attachment.........................
6
 
No
7
Did the organization receive or hold a conservation easement, including easements to preserve open space,
the environment, historic land areas, or historic structures? If "Yes," complete Schedule D, Part IIClick to see attachment....
7
 
No
8
Did the organization maintain collections of works of art, historical treasures, or other similar assets? If "Yes,"
complete Schedule D, Part IIIClick to see attachment..............
8
Yes
 
9
Did the organization report an amount in Part X, line 21 for escrow or custodial account liability; serve as a custodian for amounts not listed in Part X; or provide credit counseling, debt management, credit repair, or debt negotiation services? If "Yes," complete Schedule D, Part IVClick to see attachment..............
9
 
No
10
Did the organization, directly or through a related organization, hold assets in temporarily restricted endowments, permanent endowments, or quasi endowments? If "Yes," complete Schedule D, Part V......
10
 
 
11
If the organization’s answer to any of the following questions is "Yes," then complete Schedule D, Parts VI, VII, VIII, IX, or X as applicable.
a
Did the organization report an amount for land, buildings, and equipment in Part X, line 10? If "Yes," complete
Schedule D, Part VI. Click to see attachment...................
11a
Yes
 
b
Did the organization report an amount for investments—other securities in Part X, line 12 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VIIClick to see attachment.......
11b
 
No
c
Did the organization report an amount for investments—program related in Part X, line 13 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VIIIClick to see attachment.......
11c
 
No
d
Did the organization report an amount for other assets in Part X, line 15 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part IXClick to see attachment............
11d
 
No
e
Did the organization report an amount for other liabilities in Part X, line 25? If "Yes," complete Schedule D, Part XClick to see attachment
11e
Yes
 
f
Did the organization’s separate or consolidated financial statements for the tax year include a footnote that addresses the organization’s liability for uncertain tax positions under FIN 48 (ASC 740)? If "Yes," complete Schedule D, Part XClick to see attachment
11f
Yes
 
12a
Did the organization obtain separate, independent audited financial statements for the tax year? If "Yes," complete
Schedule D, Parts XI and XIIClick to see attachment......................
12a
Yes
 
b
Was the organization included in consolidated, independent audited financial statements for the tax year? If "Yes," and if the organization answered "No" to line 12a, then completing Schedule D, Parts XI and XII is optional Click to see attachment
12b
 
No
13
Is the organization a school described in section 170(b)(1)(A)(ii)? If "Yes," complete Schedule E
13
 
No
14a
Did the organization maintain an office, employees, or agents outside of the United States? .....
14a
Yes
 
b
Did the organization have aggregate revenues or expenses of more than $10,000 from grantmaking, fundraising, business, investment, and program service activities outside the United States, or aggregate foreign investments valued at $100,000 or more? If "Yes," complete Schedule F, Parts I and IV.........Click to see attachment
14b
Yes
 
15
Did the organization report on Part IX, column (A), line 3, more than $5,000 of grants or other assistance to or for any foreign organization? If “Yes,” complete Schedule F, Parts II and IV.....Click to see attachment
15
Yes
 
16
Did the organization report on Part IX, column (A), line 3, more than $5,000 of aggregate grants or other assistance to or for foreign individuals? If “Yes,” complete Schedule F, Parts III and IV...Click to see attachment
16
 
No
17
Did the organization report a total of more than $15,000 of expenses for professional fundraising services on Part IX, column (A), lines 6 and 11e? If "Yes," complete Schedule G, Part I(see instructions) ....Click to see attachment
17
Yes
 
18
Did the organization report more than $15,000 total of fundraising event gross income and contributions on Part VIII, lines 1c and 8a? If "Yes," complete Schedule G, Part II............ Click to see attachment
18
Yes
 
19
Did the organization report more than $15,000 of gross income from gaming activities on Part VIII, line 9a? If "Yes," complete Schedule G, Part III...................Click to see attachment
19
 
No
20a
Did the organization operate one or more hospital facilities? If "Yes," complete Schedule H....
20a
 
No
b
If "Yes" to line 20a, did the organization attach a copy of its audited financial statements to this return?
20b
 
 
21
Did the organization report more than $5,000 of grants or other assistance to any domestic organization or domestic government on Part IX, column (A), line 1? If “Yes,” complete Schedule I, Parts I and II.....Click to see attachment
21
Yes
 
Form 990 (2019)
Form 990 (2019)
Page 4
Part IV
Checklist of Required Schedules (continued)
Yes
No
22
Did the organization report more than $5,000 of grants or other assistance to or for domestic individuals on Part IX, column (A), line 2? If “Yes,” complete Schedule I, Parts I and III........Click to see attachment
22
 
No
23
Did the organization answer "Yes" to Part VII, Section A, line 3, 4, or 5 about compensation of the organization’s current and former officers, directors, trustees, key employees, and highest compensated employees? If "Yes," complete Schedule J....................... Click to see attachment
23
Yes
 
24a
Did the organization have a tax-exempt bond issue with an outstanding principal amount of more than $100,000 as of the last day of the year, that was issued after December 31, 2002? If “Yes,” answer lines 24b through 24d and complete Schedule K. If “No,” go to line 25a...............
24a
 
No
b
Did the organization invest any proceeds of tax-exempt bonds beyond a temporary period exception?...
24b
 
 
c
Did the organization maintain an escrow account other than a refunding escrow at any time during the year
to defease any tax-exempt bonds? ...............
24c
 
 
d
Did the organization act as an "on behalf of" issuer for bonds outstanding at any time during the year?...
24d
 
 
25a
Section 501(c)(3), 501(c)(4), and 501(c)(29) organizations. Did the organization engage in an excess benefit transaction with a disqualified person during the year? If "Yes," complete Schedule L, Part I ....
25a
 
No
b
Is the organization aware that it engaged in an excess benefit transaction with a disqualified person in a prior year, and that the transaction has not been reported on any of the organization’s prior Forms 990 or 990-EZ? If "Yes," complete Schedule L, Part I.......................
25b
 
No
26
Did the organization report any amount on Part X, line 5 or 22 for receivables from or payables to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons? If "Yes," complete Schedule L, Part II...........
26
 
No
27
Did the organization provide a grant or other assistance to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or employee thereof, a grant selection committee member, or to a 35% controlled entity (including an employee thereof) or family member of any of these persons?
If "Yes," complete
Schedule L, Part III.........................
27
 
No
28
Was the organization a party to a business transaction with one of the following parties (see Schedule L, Part IV instructions for applicable filing thresholds, conditions, and exceptions):
a
A current or former officer, director, trustee, key employee, creator or founder, or substantial contributor? If "Yes," complete Schedule L, Part IV......................
28a
 
No
b
A family member of any individual described in line 28a? If "Yes," complete Schedule L, Part IV.....
28b
 
No
c
A 35% controlled entity of one or more individuals and/or organizations described in lines 28a or 28b? If "Yes," complete Schedule L, Part IV.....................
28c
 
 
29
Did the organization receive more than $25,000 in non-cash contributions? If "Yes," complete Schedule M..Click to see attachment
29
Yes
 
30
Did the organization receive contributions of art, historical treasures, or other similar assets, or qualified conservation contributions? If "Yes," complete Schedule M .................Click to see attachment
30
 
No
31
Did the organization liquidate, terminate, or dissolve and cease operations? If "Yes," complete Schedule N, Part I
31
 
No
32
Did the organization sell, exchange, dispose of, or transfer more than 25% of its net assets? If "Yes," complete Schedule N, Part II........................
32
 
No
33
Did the organization own 100% of an entity disregarded as separate from the organization under Regulations sections 301.7701-2 and 301.7701-3? If "Yes," complete Schedule R, Part I............
33
 
No
34
Was the organization related to any tax-exempt or taxable entity? If "Yes," complete Schedule R, Part II, III, or IV, and Part V, line 1.........................
34
 
No
35a
Did the organization have a controlled entity within the meaning of section 512(b)(13)?
35a
 
No
b
If ‘Yes’ to line 35a, did the organization receive any payment from or engage in any transaction with a controlled entity within the meaning of section 512(b)(13)? If "Yes," complete Schedule R, Part V, line 2 ...
35b
 
 
36
Section 501(c)(3) organizations. Did the organization make any transfers to an exempt non-charitable related organization? If "Yes," complete Schedule R, Part V, line 2.............
36
 
No
37
Did the organization conduct more than 5% of its activities through an entity that is not a related organization and that is treated as a partnership for federal income tax purposes? If "Yes," complete Schedule R, Part VI
37
 
No
38
Did the organization complete Schedule O and provide explanations in Schedule O for Part VI, lines 11b and 19? Note. All Form 990 filers are required to complete Schedule O. ............
38
Yes
 
Part V
Statements Regarding Other IRS Filings and Tax Compliance
Check if Schedule O contains a response or note to any line in this Part V...........
Yes
No
1a
Enter the number reported in Box 3 of Form 1096. Enter -0- if not applicable ..
1a
135
b
Enter the number of Forms W-2G included in line 1a. Enter -0- if not applicable .
1b
0
c
Did the organization comply with backup withholding rules for reportable payments to vendors and reportable gaming (gambling) winnings to prize winners? ..................
1c
Yes
 
Form 990 (2019)
Form 990 (2019)
Page 5
Part V
Statements Regarding Other IRS Filings and Tax Compliance (continued)
2a
Enter the number of employees reported on Form W-3, Transmittal of Wage and
Tax Statements, filed for the calendar year ending with or within the year covered by this return ..................
2a
88
b
If at least one is reported on line 2a, did the organization file all required federal employment tax returns?
Note. If the sum of lines 1a and 2a is greater than 250, you may be required to e-file (see instructions)
2b
Yes
 
3a
Did the organization have unrelated business gross income of $1,000 or more during the year?...
3a
Yes
 
b
If “Yes,” has it filed a Form 990-T for this year? If “No” to line 3b, provide an explanation in Schedule O...
3b
Yes
 
4a
At any time during the calendar year, did the organization have an interest in, or a signature or other authority over, a financial account in a foreign country (such as a bank account, securities account, or other financial account)? ..
4a
Yes
 
b
If "Yes," enter the name of the foreign country: MediumBulletTH
See instructions for filing requirements for FinCEN Form 114, Report of Foreign Bank and Financial Accounts (FBAR).
5a
Was the organization a party to a prohibited tax shelter transaction at any time during the tax year? ..
5a
 
No
b
Did any taxable party notify the organization that it was or is a party to a prohibited tax shelter transaction?
5b
 
No
c
If "Yes," to line 5a or 5b, did the organization file Form 8886-T? ............
5c
 
 
6a
Does the organization have annual gross receipts that are normally greater than $100,000, and did the organization solicit any contributions that were not tax deductible as charitable contributions? ...
6a
 
No
b
If "Yes," did the organization include with every solicitation an express statement that such contributions or gifts were not tax deductible? ......................
6b
 
 
7
Organizations that may receive deductible contributions under section 170(c).
a
Did the organization receive a payment in excess of $75 made partly as a contribution and partly for goods and services provided to the payor? ....................
7a
Yes
 
b
If "Yes," did the organization notify the donor of the value of the goods or services provided? .....
7b
Yes
 
c
Did the organization sell, exchange, or otherwise dispose of tangible personal property for which it was required to file Form 8282? .........................
7c
 
No
d
If "Yes," indicate the number of Forms 8282 filed during the year ....
7d
 
e
Did the organization receive any funds, directly or indirectly, to pay premiums on a personal benefit contract?
7e
 
No
f
Did the organization, during the year, pay premiums, directly or indirectly, on a personal benefit contract? ..
7f
 
No
g
If the organization received a contribution of qualified intellectual property, did the organization file Form 8899 as required? ......................
7g
 
 
h
If the organization received a contribution of cars, boats, airplanes, or other vehicles, did the organization file a Form 1098-C? ..........................
7h
 
 
8
Sponsoring organizations maintaining donor advised funds. Did a donor advised fund maintained by the sponsoring organization have excess business holdings at any time during the year? ........
8
 
 
9
Sponsoring organizations maintaining donor advised funds.
a
Did the sponsoring organization make any taxable distributions under section 4966?........
9a
 
 
b
Did the sponsoring organization make a distribution to a donor, donor advisor, or related person?...
9b
 
 
10
Section 501(c)(7) organizations. Enter:
a
Initiation fees and capital contributions included on Part VIII, line 12 ...
10a
 
b
Gross receipts, included on Form 990, Part VIII, line 12, for public use of club facilities
10b
 
11
Section 501(c)(12) organizations. Enter:
a
Gross income from members or shareholders .........
11a
 
b
Gross income from other sources (Do not net amounts due or paid to other sources against amounts due or received from them.) ..........
11b
 
12a
Section 4947(a)(1) non-exempt charitable trusts. Is the organization filing Form 990 in lieu of Form 1041?
12a
 
 
b
If "Yes," enter the amount of tax-exempt interest received or accrued during the year.
12b
 
13
Section 501(c)(29) qualified nonprofit health insurance issuers.
a
Is the organization licensed to issue qualified health plans in more than one state? .........
Note. See the instructions for additional information the organization must report on Schedule O.
13a
 
 
b
Enter the amount of reserves the organization is required to maintain by the states in which the organization is licensed to issue qualified health plans ....
13b
 
c
Enter the amount of reserves on hand ............
13c
 
14a
Did the organization receive any payments for indoor tanning services during the tax year?.....
14a
 
No
b
If "Yes," has it filed a Form 720 to report these payments? If "No," provide an explanation in Schedule O..
14b
 
 
15
Is the organization subject to the section 4960 tax on payment(s) of more than $1,000,000 in remuneration or excess parachute payment(s) during the year? ....................
If "Yes," see instructions and file Form 4720, Schedule N.
15
 
 
16
Is the organization an educational institution subject to the section 4968 excise tax on net investment income? ..
If "Yes," complete Form 4720, Schedule O.
16
 
 
Form 990 (2019)
Form 990 (2019)
Page 6
Part VI
Governance, Management, and Disclosure For each "Yes" response to lines 2 through 7b below, and for a "No" response to lines 8a, 8b, or 10b below, describe the circumstances, processes, or changes in Schedule O. See instructions.
Check if Schedule O contains a response or note to any line in this Part VI..............
Section A. Governing Body and Management
Yes
No
1a
Enter the number of voting members of the governing body at the end of the tax year
1a
12
If there are material differences in voting rights among members of the governing body, or if the governing body delegated broad authority to an executive committee or similar committee, explain in Schedule O.
b
Enter the number of voting members included in line 1a, above, who are independent
1b
12
2
Did any officer, director, trustee, or key employee have a family relationship or a business relationship with any other officer, director, trustee, or key employee? .................
2
 
No
3
Did the organization delegate control over management duties customarily performed by or under the direct supervision of officers, directors or trustees, or key employees to a management company or other person? .
3
 
No
4
Did the organization make any significant changes to its governing documents since the prior Form 990 was filed? .
4
 
No
5
Did the organization become aware during the year of a significant diversion of the organization’s assets? .
5
 
No
6
Did the organization have members or stockholders? ................
6
 
No
7a
Did the organization have members, stockholders, or other persons who had the power to elect or appoint one or more members of the governing body? ....................
7a
 
No
b
Are any governance decisions of the organization reserved to (or subject to approval by) members, stockholders, or persons other than the governing body? ...................
7b
 
No
8
Did the organization contemporaneously document the meetings held or written actions undertaken during the year by the following:
a
The governing body? .......................
8a
Yes
 
b
Each committee with authority to act on behalf of the governing body? ............
8b
Yes
 
9
Is there any officer, director, trustee, or key employee listed in Part VII, Section A, who cannot be reached at the organization’s mailing address? If "Yes," provide the names and addresses in Schedule O.......
9
 
No
Section B. Policies (This Section B requests information about policies not required by the Internal Revenue Code.)
Yes
No
10a
Did the organization have local chapters, branches, or affiliates? ............
10a
 
No
b
If "Yes," did the organization have written policies and procedures governing the activities of such chapters, affiliates, and branches to ensure their operations are consistent with the organization's exempt purposes?
10b
 
 
11a
Has the organization provided a complete copy of this Form 990 to all members of its governing body before filing the form? ............................
11a
Yes
 
b
Describe in Schedule O the process, if any, used by the organization to review this Form 990. .....
12a
Did the organization have a written conflict of interest policy? If "No," go to line 13.......
12a
Yes
 
b
Were officers, directors, or trustees, and key employees required to disclose annually interests that could give rise to conflicts? ..........................
12b
Yes
 
c
Did the organization regularly and consistently monitor and enforce compliance with the policy? If "Yes," describe in Schedule O how this was done...................
12c
Yes
 
13
Did the organization have a written whistleblower policy? ...............
13
Yes
 
14
Did the organization have a written document retention and destruction policy? .........
14
Yes
 
15
Did the process for determining compensation of the following persons include a review and approval by independent persons, comparability data, and contemporaneous substantiation of the deliberation and decision?
a
The organization’s CEO, Executive Director, or top management official ...........
15a
Yes
 
b
Other officers or key employees of the organization ................
15b
Yes
 
If "Yes" to line 15a or 15b, describe the process in Schedule O (see instructions).
16a
Did the organization invest in, contribute assets to, or participate in a joint venture or similar arrangement with a taxable entity during the year? ......................
16a
 
No
b
If "Yes," did the organization follow a written policy or procedure requiring the organization to evaluate its participation in joint venture arrangements under applicable federal tax law, and take steps to safeguard the organization’s exempt status with respect to such arrangements? ............
16b
 
 
Section C. Disclosure
17
List the states with which a copy of this Form 990 is required to be filedMediumBullet
AL , AR , CA , FL , GA , HI , IL , KS , KY , MD , MA , MI , MN , MS , NH , NJ , NM , NY , NC , OK , OR , PA , RI , SC , TN , UT , VA , WV , WI
18
Section 6104 requires an organization to make its Form 1023 (or 1024-A if applicable), 990, and 990-T (501(c)(3)s only) available for public inspection. Indicate how you made these available. Check all that apply.
19
Describe in Schedule O whether (and if so, how) the organization made its governing documents, conflict of interest policy, and financial statements available to the public during the tax year.
20
State the name, address, and telephone number of the person who possesses the organization's books and records:
MediumBulletBRADLEY JENSEN120 WALL STREET 13TH FLOOR   NEW YORK,NY100053908 (212) 806-1703
Form 990 (2019)
Form 990 (2019)
Page 7
Part VII
Compensation of Officers, Directors,Trustees, Key Employees, Highest Compensated Employees, and Independent Contractors
Check if Schedule O contains a response or note to any line in this Part VII..............
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees
1a Complete this table for all persons required to be listed. Report compensation for the calendar year ending with or within the organization’s tax year.
RoundBullet List all of the organization’s current officers, directors, trustees (whether individuals or organizations), regardless of amount
of compensation. Enter -0- in columns (D), (E), and (F) if no compensation was paid.

RoundBullet List all of the organization’s current key employees, if any. See instructions for definition of "key employee."
RoundBullet List the organization’s five current highest compensated employees (other than an officer, director, trustee or key employee)
who received reportable compensation (Box 5 of Form W-2 and/or Box 7 of Form 1099-MISC) of more than $100,000 from the
organization and any related organizations.

RoundBullet List all of the organization’s former officers, key employees, or highest compensated employees who received more than $100,000
of reportable compensation from the organization and any related organizations.

RoundBullet List all of the organization’s former directors or trustees that received, in the capacity as a former director or trustee of the
organization, more than $10,000 of reportable compensation from the organization and any related organizations.

See instructions for the order in which to list the persons above.
Check this box if neither the organization nor any related organization compensated any current officer, director, or trustee.
(A)
Name and title 		(B)
Average hours per week (list any hours for related organizations below dotted line) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W-2/1099-MISC) 		(E)
Reportable compensation from related organizations (W-2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; OfficerInd; Key Employee; Highest compensated employee; FormerOfcrDirectorTrusteeInd;
(1) Mathilde Krim PhD......................................................................
Founding Chairman(Thru 1/18)
 1.0
.................
0.0 		X   X       0 0 0
(2) Bill Roedy......................................................................
Chairman of the Board
 1.0
.................
0.0 		X   X       0 0 0
(3) Kenneth Cole Thru 218......................................................................
Chairman of the Board
 1.0
.................
0.0 		X   X       0 0 0
(4) Patricia J Matson......................................................................
Vice Chairman (Thru 6/18)
 1.0
.................
0.0 		X   X       0 0 0
(5) Donald Capoccia......................................................................
Vice Chairman (AS OF 2/18)
 1.0
.................
0.0 		X   X       0 0 0
(6) Cindy Rachofsky......................................................................
Vice Chairman
 1.0
.................
0.0 		X   X       0 0 0
(7) John C Simons Thru 218......................................................................
Vice Chairman AND TREASURER
 1.0
.................
0.0 		X   X       0 0 0
(8) Mervyn F Silverman MDMPH......................................................................
Secretary (Thru 2/18)
 1.0
.................
0.0 		X   X       0 0 0
(9) Arlen H Andelson......................................................................
Secretary
 1.0
.................
0.0 		X   X       0 0 0
(10) Michael J Klingensmith......................................................................
Treasurer
 1.0
.................
0.0 		X   X       0 0 0
(11) Harry Belafonte......................................................................
Trustee (Thru 8/18)
 1.0
.................
0.0 		X           0 0 0
(12) David Bohnett......................................................................
Trustee (thru of 9/18)
 1.0
.................
0.0 		X           0 0 0
(13) Zev Braun......................................................................
Trustee (NON-VOTING)
 1.0
.................
0.0 		X           0 0 0
(14) Jonathan S Canno......................................................................
Trustee
 1.0
.................
0.0 		X           0 0 0
(15) Jane B Eisner NON-VOTing......................................................................
Trustee (Thru 2/18)
 1.0
.................
0.0 		X           0 0 0
(16) Jay Ellis......................................................................
Trustee (As of 9/18)
 1.0
.................
0.0 		X           0 0 0
(17) Aileen Getty......................................................................
Trustee (as of 2/18)
 1.0
.................
0.0 		X           0 0 0
Form 990 (2019)
Form 990 (2019)
Page 8
Part VII
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (continued)
(A)
Name and title 		(B)
Average hours per week (list any hours for related organizations below dotted line) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W-2/1099-MISC) 		(E)
Reportable compensation from related organizations (W-2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; OfficerInd; Key Employee; Highest compensated employee; FormerOfcrDirectorTrusteeInd;
(18) Regan Hofmann........................................................................
Secretary (Thru 12/17)
 1.0
.......................0.0 		X           0 0 0
(19) Michele V McNeill PharmD........................................................................
Trustee (NON-VOTING)
 1.0
.......................0.0 		X           0 0 0
(20) Edward Milstein........................................................................
Trustee
 1.0
.......................0.0 		X           0 0 0
(21) Peter Piot........................................................................
Trustee (Thru 10/17)
 1.0
.......................0.0 		X           0 0 0
(22) Vincent A Roberti........................................................................
Trustee (Thru 2/18)
 1.0
.......................0.0 		X           0 0 0
(23) Raymond F Schinazi PhD........................................................................
Trustee
 1.0
.......................0.0 		X           0 0 0
(24) Alan D Schwartz........................................................................
Trustee (as of 2/18)
 1.0
.......................0.0 		X           0 0 0
(25) Mario Stevenson........................................................................
Trustee (as of 2/18)
 1.0
.......................0.0 		X           0 0 0
(26) Diana L Taylor NON-VOTing........................................................................
Trustee (Thru 12/17)
 1.0
.......................0.0 		X           0 0 0
(27) Kevin Frost........................................................................
Chief Executive Officer
 40.0
.......................0.0 		    X       458,595 0 104,028
(28) Bradley Jensen........................................................................
Assistant Treasurer, CFO
 40.0
.......................0.0 		    X       276,038 0 70,093
(29) Rowena Johnston........................................................................
ASST SEC, VP, RESEARCH
 40.0
.......................0.0 		    X       203,095 0 31,119
(30) Edward Donnelly........................................................................
Asst Treasurer, Controller
 40.0
.......................0.0 		    X       163,157 0 27,291
(31) Eric Muscatell........................................................................
Vice President of Development
 40.0
.......................0.0 		      X     218,403 0 32,827
(32) Annette Sohn........................................................................
Vice President, TREAT Asia PGM
 40.0
.......................0.0 		      X     235,334 0 24,141
(33) AnnMarie Shannahan........................................................................
Vice President, Public Info.
 40.0
.......................0.0 		      X     234,029 0 33,314
(34) Gregorio Millet........................................................................
Vice President, Public Policy
 40.0
.......................0.0 		      X     188,800 0 45,291
(35) Andrew McInness........................................................................
Director, Publications
 40.0
.......................0.0 		        X   166,993 0 63,731
(36) Anthony Ancona........................................................................
Vice President, Human Resource
 40.0
.......................0.0 		        X   189,243 0 47,564
(37) Susan Doster........................................................................
Chief Technology Officer
 40.0
.......................0.0 		        X   149,646 0 50,915
(38) Bennah Serfaty........................................................................
Sr Director of Communications
 40.0
.......................0.0 		        X   132,347 0 61,266
(39) JONATHAN KEY........................................................................
DIRECTOR, PHILANTHROPY
 40.0
.......................0.0 		        X   190,220 0 53,712
(40) John F Logan JD PhD........................................................................
AssT. Sec., Vp & GEN COUNSEL
 40.0
.......................0.0 		          X 109,139 0 14,508
1b Sub-Total................MediumBullet
c Total from continuation sheets to Part VII, Section A....MediumBullet
d Total (add lines 1b and 1c)...........MediumBullet 2,915,039 0 659,800
2
Total number of individuals (including but not limited to those listed above) who received more than $100,000 of reportable compensation from the organization MediumBullet28
Yes
No
3
Did the organization list any former officer, director or trustee, key employee, or highest compensated employee on line 1a? If "Yes," complete Schedule J for such individual ..............
3
Yes
 
4
For any individual listed on line 1a, is the sum of reportable compensation and other compensation from the organization and related organizations greater than $150,000? If "Yes," complete Schedule J for such
individual...........................
4
Yes
 
5
Did any person listed on line 1a receive or accrue compensation from any unrelated organization or individual for services rendered to the organization? If "Yes," complete Schedule J for such person ........
5
 
No
Section B. Independent Contractors
1
Complete this table for your five highest compensated independent contractors that received more than $100,000 of compensation from the organization. Report compensation for the calendar year ending with or within the organization’s tax year.
(A)
Name and business address 		(B)
Description of services 		(C)
Compensation
INCA INTERNATIONAL PRODUCTIONS INC,
40 WORTH STREET SUITE 827
NEW YORK,NY10013 		events production 1,041,412
AAB PRODUCTION INC,
64 ALLEN ROAD 5TH FLOOR
NEW YORK,NY10002 		Events Production 648,220
GIBSON DUNN CRUTCHER LLP,
200 PARK AVENUE
NEW YORK,NY10166 		LEGAL SERVICES 466,724
JOSH WOODS PRODUCTION,
39 WEST 14TH STREET SUITE 504
NEW YORK,NY10011 		Events Production 420,350
EIDOLON COMMUNICATIONS INC,
15 MAIDEN LANE SUITE 1401
NEW YORK,NY10038 		DIRECT MAIL/CONSULT. 256,910
2
Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization MediumBullet13
Form 990 (2019)
Form 990 (2019)
Page 9
Part VIII
Statement of Revenue
Check if Schedule O contains a response or note to any line in this Part VIII.............
(A)
Total revenue 		(B)
Related or
exempt
function
revenue 		(C)
Unrelated
business
revenue 		(D)
Revenue
excluded from
tax under sections
512 - 514
Contributions, Gifts, GrantAmt and OtherAmt Similar Amounts 1a Federated campaigns..1a 135,853
b Membership dues..1b  
c Fundraising events..1c 31,268,021
d Related organizations1d  
e Government grants (contributions)1e 5,761,067
f All other contributions, gifts, grants, and similar amounts not included above1f 5,619,449
g Noncash contributions included in lines 1a - 1f:$ 1g 47,725
h Total. Add lines 1a-1f.......MediumBullet 42,784,390
Program Service RevenueAmt Business Code
2a
b
c
d
e
f All other program service revenue.        
g Total. Add lines 2a–2f .....MediumBullet 0
OtherAmtRevenueAmt 3 Investment income (including dividends, interest, and othersimilar amounts) ......MediumBullet 1,490,107     1,490,107
4 Income from investment of tax-exempt bond proceedsMediumBullet 0      
5 Royalties...........MediumBullet 100,565     100,565
(ii) Personal (i) Real
6a Gross rents     6a
b Less: rental expenses     6b
c Rental income or (loss) 0 0 6c
d Net rental income or (loss).......MediumBullet 0      
(ii) Other (i) Securities
7a Gross amount from sales of assets other than inventory -1,504 18,693,800 7a
b Less: cost or other basis and sales expenses   18,517,338 7b
c Gain or (loss) -1,504 176,462 7c
d Net gain or (loss).........MediumBullet 177,966     177,966
8a Gross income from fundraising events (not including $ 31,268,021of contributions reported on line 1c). See Part IV, line 18 ....
8a 2,043,540
b Less: direct expenses ... 8b 14,341,010
c Net income or (loss) from fundraising events..MediumBullet -12,297,470   -12,297,470
9a Gross income from gaming activities.
See Part IV, line 19 ...
9a 0
b Less: direct expenses ... 9b 0
c Net income or (loss) from gaming activities..MediumBullet 0      
10a Gross sales of inventory, less
returns and allowances ..
10a 48,094
b Less: cost of goods sold .. 10b 1,440
c Net income or (loss) from sales of inventory..MediumBullet 46,654     46,654
Business Code Miscellaneous Revenue
11a LIST RENTALS 900099 2,793     2,793
b STORE SALES 900099 2,675     2,675
c MISCELLANEOUS INCOME 900099 396     396
d All other revenue ....        
e Total. Add lines 11a–11d ...... MediumBullet 5,864
12 Total revenue. See instructions.....MediumBullet 32,308,076     -10,476,314
Form 990 (2019)
Form 990 (2019)
Page 10
Part IX
Statement of Functional Expenses
Section 501(c)(3) and 501(c)(4) organizations must complete all columns. All other organizations must complete column (A).Check if Schedule O contains a response or note to any line in this Part IX..............
Do not include amounts reported on lines 6b,
7b, 8b, 9b, and 10b of Part VIII. 		(A)
Total expenses 		(B)
Program service expenses 		(C)
Management and general expenses 		(D)
Fundraising
expenses
1 Grants and other assistance to domestic organizations and domestic governments. See Part IV, line 21 .... 7,978,506 7,978,506
2 Grants and other assistance to domestic individuals. See Part IV, line 22 ........... 0  
3 Grants and other assistance to foreign organizations, foreign governments, and foreign individuals. See Part IV, lines 15 and 16. ............. 4,595,527 4,595,527
4 Benefits paid to or for members ....... 0  
5 Compensation of current officers, directors, trustees, and key employees ........... 2,445,008 1,771,295 317,839 355,874
6 Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) ......... 0      
7 Other salaries and wages........ 6,217,335 4,222,760 662,299 1,332,276
8 Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) .... 379,569 254,512 42,153 82,904
9 Other employee benefits ....... 1,688,768 1,120,358 229,985 338,425
10 Payroll taxes ........... 528,650 351,702 63,485 113,463
11 Fees for services (non-employees):        
a Management ...... 0      
b Legal ......... 1,422,075 1,418,720 2,586 769
c Accounting ........... 198,759   198,759  
d Lobbying ........... 104,808 104,808    
e Professional fundraising services. See Part IV, line 17 735,053 735,053
f Investment management fees ...... 307,636   307,636  
g Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O) 1,599,736 887,177 50,513 662,046
12 Advertising and promotion .... 256,584 223,512 3,763 29,309
13 Office expenses ....... 72,365 46,181 6,201 19,983
14 Information technology ...... 239,711 181,387 25,172 33,152
15 Royalties .. 0      
16 Occupancy ........... 1,419,478 1,041,693 148,154 229,631
17 Travel ............ 1,181,209 505,252 2,092 673,865
18 Payments of travel or entertainment expenses for any federal, state, or local public officials . 0      
19 Conferences, conventions, and meetings .... 661,761 649,394 5,115 7,252
20 Interest ........... 11   11  
21 Payments to affiliates ....... 0      
22 Depreciation, depletion, and amortization .. 512,694 383,231 54,526 74,937
23 Insurance ... 328,941 245,879 34,983 48,079
24 Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a PROGRAM MATERIALS 1,978,880 1,978,880    
b PROGRAM TECHNICAL SUPPORT 808,415 808,415    
c BAD DEBT EXPENSE 726,368 542,949 77,250 106,169
d POSTAGE & SHIPPING 559,630 322,873 2,820 233,937
e All other expenses 2,089,420 879,020 351,817 858,583
25 Total functional expenses. Add lines 1 through 24e 39,036,897 30,514,031 2,587,159 5,935,707
26 Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here MediumBullet if following SOP 98-2 (ASC 958-720). 506,115 166,754   339,361
Form 990 (2019)
Form 990 (2019)
Page 11
Part X
Balance Sheet
Check if Schedule O contains a response or note to any line in this Part IX..............
(A)
Beginning of year 		(B)
End of year
Assets 1 Cash–non-interest-bearing ........ 9,608,338 1 5,477,346
2 Savings and temporary cash investments ......... 822,496 2 691,606
3 Pledges and grants receivable, net ...... 1,054,693 3 699,100
4 Accounts receivable, net ............. 7,565,297 4 6,388,976
5 Loans and other payables to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons .......
0 5 0
6 Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), and persons described in section 4958(c)(3)(B) ...
0 6 0
7 Notes and loans receivable, net ........... 0 7 0
8 Inventories for sale or use ............ 444,076 8 425,761
9 Prepaid expenses and deferred charges ...... 2,895,192 9 1,960,938
10a Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D 10a 7,842,486
b Less: accumulated depreciation 10b 4,920,952 3,074,500 10c 2,921,534
11 Investments—publicly traded securities . 53,263,236 11 48,872,134
12 Investments—other securities. See Part IV, line 11 ..... 0 12 0
13 Investments—program-related. See Part IV, line 11 .. 0 13 0
14 Intangible assets ............... 0 14 0
15 Other assets. See Part IV, line 11 ........... 1,493,892 15 2,098,741
16 Total assets. Add lines 1 through 15 (must equal line 33)... 80,221,720 16 69,536,136
Liabilities 17 Accounts payable and accrued expenses ..... 3,028,826 17 3,655,122
18 Grants payable ... 3,445,162 18 2,768,840
19 Deferred revenue ......... 11,985,013 19 8,596,427
20 Tax-exempt bond liabilities ......... 0 20 0
21 Escrow or custodial account liability. Complete Part IV of Schedule D 0 21 0
22 Loans and other payables to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons .........
0 22 0
23 Secured mortgages and notes payable to unrelated third parties .. 0 23 0
24 Unsecured notes and loans payable to unrelated third parties .. 0 24 0
25 Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17 - 24). Complete Part X of Schedule D 2,032,473 25 1,965,068
26 Total liabilities. Add lines 17 through 25.. 20,491,474 26 16,985,457
Net Assets or Fund Balance Organizations that follow FASB ASC 958, check here MediumBullet and complete lines 27, 28, 32, and 33.
27 Net assets without donor restrictions ..........   27  
28 Net assets with donor restrictions ...........   28  
Organizations that do not follow FASB ASC 958, check here MediumBullet and complete lines 29 through 33.
29 Capital stock or trust principal, or current funds .....   29  
30 Paid-in or capital surplus, or land, building or equipment fund ...   30  
31 Retained earnings, endowment, accumulated income, or other funds   31  
32 Total net assets or fund balances ........... 59,730,246 32 52,550,679
33 Total liabilities and net assets/fund balances ........ 80,221,720 33 69,536,136
Form 990 (2019)
Form 990 (2019)
Page 12
Part XI
Reconcilliation of Net Assets
Check if Schedule O contains a response or note to any line in this Part XI..............
1
Total revenue (must equal Part VIII, column (A), line 12) ............
1
32,308,076
2
Total expenses (must equal Part IX, column (A), line 25) ............
2
39,036,897
3
Revenue less expenses. Subtract line 2 from line 1 ..............
3
-6,728,821
4
Net assets or fund balances at beginning of year (must equal Part X, line 32, column (A)) ..
4
59,730,246
5
Net unrealized gains (losses) on investments ...............
5
-450,746
6
Donated services and use of facilities .................
6
 
7
Investment expenses .....................
7
 
8
Prior period adjustments .....................
8
 
9
Other changes in net assets or fund balances (explain in Schedule O) ........
9
 
10
Net assets or fund balances at end of year. Combine lines 3 through 9 (must equal Part X, line 32, column (B))
10
52,550,679
Part XII
Financial Statements and Reporting
Check if Schedule O contains a response or note to any line in this Part XII.............
Yes
No
1
Accounting method used to prepare the Form 990:  
If the organization changed its method of accounting from a prior year or checked "Other," explain in
Schedule O.
2a
Were the organization’s financial statements compiled or reviewed by an independent accountant?
2a
 
No
If ‘Yes,’ check a box below to indicate whether the financial statements for the year were compiled or reviewed on a separate basis, consolidated basis, or both:
b
Were the organization’s financial statements audited by an independent accountant?
2b
Yes
 
If ‘Yes,’ check a box below to indicate whether the financial statements for the year were audited on a separate basis, consolidated basis, or both:
c
If "Yes," to line 2a or 2b, does the organization have a committee that assumes responsibility for oversight of the audit, review, or compilation of its financial statements and selection of an independent accountant?
2c
Yes
 
If the organization changed either its oversight process or selection process during the tax year, explain in Schedule O.
3a
As a result of a federal award, was the organization required to undergo an audit or audits as set forth in the Single Audit Act and OMB Circular A-133?
3a
Yes
 
b
If "Yes," did the organization undergo the required audit or audits? If the organization did not undergo the required audit or audits, explain why in Schedule O and describe any steps taken to undergo such audits.
3b
Yes
 
Form 990 (2019)
Form 990 (2019)
Additional Data


Software ID:  
Software Version:  
Form 990, Special Condition Description:
Special Condition Description
SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service
Public Charity Status and Public Support
Complete if the organization is a section 501(c)(3) organization or a section 4947(a)(1) nonexempt charitable trust.
right arrow Attach to Form 990 or Form 990-EZ.
right arrow Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2019
Open to Public
Inspection
Name of the organization
THE FOUNDATION FOR AIDS RESEARCH
 
Employer identification number

13-3163817
Part I
Reason for Public Charity Status (All organizations must complete this part.) See instructions.
The organization is not a private foundation because it is: (For lines 1 through 12, check only one box.)
1
2
3
4
5
6
7
8
9
10
11
12
a
b
c
d
e
f
Enter the number of supported organizations ...............................  
g
Provide the following information about the supported organization(s).
(i) Name of supported organization (ii) EIN (iii) Type of organization (described on lines 1- 10 above (see instructions)) (iv) Is the organization listed in your governing document? (v) Amount of monetary support (see instructions) (vi) Amount of other support (see instructions)
Yes No
Total
 
   
For Paperwork Reduction Act Notice, see the Instructions for
Form 990 or 990-EZ.
Cat. No. 11285F
Schedule A (Form 990 or 990-EZ) 2019

Schedule A (Form 990 or 990-EZ) 2019
Page 2
Part II
Support Schedule for Organizations Described in Sections 170(b)(1)(A)(iv) and 170(b)(1)(A)(vi)
(Complete only if you checked the box on line 5, 7, or 8 of Part I or if the organization failed to qualify under Part III. If the organization failed to qualify under the tests listed below, please complete Part III.)
Section A. Public Support
Calendar year (or fiscal year beginning in) right arrow (a) 2015 (b) 2016 (c) 2017 (d) 2018 (e) 2019 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. 57,556,516 56,251,128 58,810,206 50,842,378 42,784,390 266,244,618
2 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....           0
3 The value of services or facilities furnished by a governmental unit to the organization without charge..           0
4 Total. Add lines 1 through 3 57,556,516 56,251,128 58,810,206 50,842,378 42,784,390 266,244,618
5 The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. 2,177,368
6 Public support. Subtract line 5 from line 4. 264,067,250
Section B. Total Support
Calendar year (or fiscal year beginning in) right arrow (a) 2015 (b) 2016 (c) 2017 (d) 2018 (e) 2019 (f) Total
7 Amounts from line 4.. 57,556,516 56,251,128 58,810,206 50,842,378 42,784,390 266,244,618
8 Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... 804,366 1,652,775 1,316,372 1,354,513 1,590,672 6,718,698
9 Net income from unrelated business activities, whether or not the business is regularly carried on..           0
10 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. 1,693,833 2,103,589 2,246,081 1,819,001 2,097,498 9,960,002
11 Total support. Add lines 7 through 10 282,923,318
12
12
 
13
First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a section 501(c)(3) organization, check this box and stop here........................................right arrow
Section C. Computation of Public Support Percentage
14
14
93.335 %
15
15
93.697 %
16a
b
17a
b
18
Private foundation. If the organization did not check a box on line 13, 16a, 16b, 17a, or 17b, check this box and see
instructions ..................................................... right arrow
Schedule A (Form 990 or 990-EZ) 2019

Schedule A (Form 990 or 990-EZ) 2019
Page 3
Part III
Support Schedule for Organizations Described in Section 509(a)(2)
(Complete only if you checked the box on line 10 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)
Section A. Public Support
Calendar year (or fiscal year beginning in) right arrow (a) 2015 (b) 2016 (c) 2017 (d) 2018 (e) 2019 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .            
2 Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose            
3 Gross receipts from activities that are not an unrelated trade or business under section 513 .....            
4 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...            
5 The value of services or facilities furnished by a governmental unit to the organization without charge            
6 Total. Add lines 1 through 5            
7a Amounts included on lines 1, 2, and 3 received from disqualified persons            
b Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.            
c Add lines 7a and 7b..            
8 Public support. (Subtract line 7c from line 6.)  
Section B. Total Support
Calendar year (or fiscal year beginning in) right arrow (a) 2015 (b) 2016 (c) 2017 (d) 2018 (e) 2019 (f) Total
9 Amounts from line 6...            
10a Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..            
b Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.            
c Add lines 10a and 10b.            
11 Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.            
12 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) ..            
13 Total support. (Add lines 9, 10c, 11, and 12.)..            
14
Section C. Computation of Public Support Percentage
15
15
 
16
16
 
Section D. Computation of Investment Income Percentage
17
17
 
18
18
 
19a
b
20
Schedule A (Form 990 or 990-EZ) 2019

Schedule A (Form 990 or 990-EZ) 2019
Page 4
Part IV
Supporting Organizations
(Complete only if you checked a box on line 12 of Part I. If you checked 12a of Part I, complete Sections A and B. If you checked 12b of Part I, complete Sections A and C. If you checked 12c of Part I, complete Sections A, D, and E. If you checked 12d of Part I, complete Sections A and D, and complete Part V.)
Section A. All Supporting Organizations
Yes
No
1
Are all of the organization’s supported organizations listed by name in the organization’s governing documents?
If "No," describe in Part VI how the supported organizations are designated. If designated by class or purpose,
describe the designation. If historic and continuing relationship, explain.
1
 
 
2
Did the organization have any supported organization that does not have an IRS determination of status under section 509(a)(1) or (2)? If "Yes," explain in Part VI how the organization determined that the supported organization was described in section 509(a)(1) or (2).
2
 
 
3a
Did the organization have a supported organization described in section 501(c)(4), (5), or (6)? If "Yes," answer (b) and (c) below.
3a
 
 
b
Did the organization confirm that each supported organization qualified under section 501(c)(4), (5), or (6) and satisfied the public support tests under section 509(a)(2)? If "Yes," describe in Part VI when and how the organization made the determination.
3b
 
 
c
Did the organization ensure that all support to such organizations was used exclusively for section 170(c)(2)(B) purposes? If "Yes," explain in Part VI what controls the organization put in place to ensure such use.
3c
 
 
4a
Was any supported organization not organized in the United States ("foreign supported organization")? If “Yes” and if you checked 12a or 12b in Part I, answer (b) and (c) below.
4a
 
 
b
Did the organization have ultimate control and discretion in deciding whether to make grants to the foreign supported organization? If “Yes,” describe in Part VI how the organization had such control and discretion despite being controlled or supervised by or in connection with its supported organizations.
4b
 
 
c
Did the organization support any foreign supported organization that does not have an IRS determination under sections 501(c)(3) and 509(a)(1) or (2)? If “Yes,” explain in Part VI what controls the organization used to ensure that all support to the foreign supported organization was used exclusively for section 170(c)(2)(B) purposes.
4c
 
 
5a
Did the organization add, substitute, or remove any supported organizations during the tax year? If “Yes,” answer (b) and (c) below (if applicable). Also, provide detail in Part VI, including (i) the names and EIN numbers of the supported organizations added, substituted, or removed; (ii) the reasons for each such action; (iii) the authority under the organization's organizing document authorizing such action; and (iv) how the action was accomplished (such as by amendment to the organizing document).
5a
 
 
b
Type I or Type II only. Was any added or substituted supported organization part of a class already designated in the organization's organizing document?
5b
 
 
c
Substitutions only. Was the substitution the result of an event beyond the organization's control?
5c
 
 
6
Did the organization provide support (whether in the form of grants or the provision of services or facilities) to anyone other than (i) its supported organizations, (ii) individuals that are part of the charitable class benefited by one or more of its supported organizations, or (iii) other supporting organizations that also support or benefit one or more of the filing organization’s supported organizations? If “Yes,” provide detail in Part VI.
6
 
 
7
Did the organization provide a grant, loan, compensation, or other similar payment to a substantial contributor (defined in section 4958(c)(3)(C)), a family member of a substantial contributor, or a 35% controlled entity with regard to a substantial contributor? If “Yes,” complete Part I of Schedule L (Form 990 or 990-EZ) .
7
 
 
8
Did the organization make a loan to a disqualified person (as defined in section 4958) not described in line 7? If “Yes,” complete Part I of Schedule L (Form 990 or 990-EZ).
8
 
 
9a
Was the organization controlled directly or indirectly at any time during the tax year by one or more disqualified persons as defined in section 4946 (other than foundation managers and organizations described in section 509(a)(1) or (2))? If “Yes,” provide detail in Part VI.
9a
 
 
b
Did one or more disqualified persons (as defined in line 9a) hold a controlling interest in any entity in which the supporting organization had an interest? If “Yes,” provide detail in Part VI.
9b
 
 
c
Did a disqualified person (as defined in line 9a) have an ownership interest in, or derive any personal benefit from, assets in which the supporting organization also had an interest? If “Yes,” provide detail in Part VI.
9c
 
 
10a
Was the organization subject to the excess business holdings rules of section 4943 because of section 4943(f) (regarding certain Type II supporting organizations, and all Type III non-functionally integrated supporting organizations)? If “Yes,” answer line 10b below.
10a
 
 
b
Did the organization have any excess business holdings in the tax year? (Use Schedule C, Form 4720, to determine whether the organization had excess business holdings).
10b
 
 
Schedule A (Form 990 or 990-EZ) 2019

Schedule A (Form 990 or 990-EZ) 2019
Page 5
Part IV
Supporting Organizations (continued)
Yes
No
11
Has the organization accepted a gift or contribution from any of the following persons?
a
A person who directly or indirectly controls, either alone or together with persons described in (b) and (c) below, the governing body of a supported organization?
11a
 
 
b
A family member of a person described in (a) above?
11b
 
 
c
A 35% controlled entity of a person described in (a) or (b) above? If “Yes” to a, b, or c, provide detail in Part VI.
11c
 
 
Section B. Type I Supporting Organizations
Yes
No
1
Did the directors, trustees, or membership of one or more supported organizations have the power to regularly appoint or elect at least a majority of the organization’s directors or trustees at all times during the tax year? If “No,” describe in Part VI how the supported organization(s) effectively operated, supervised, or controlled the organization’s activities. If the organization had more than one supported organization, describe how the powers to appoint and/or remove directors or trustees were allocated among the supported organizations and what conditions or restrictions, if any, applied to such powers during the tax year.
1
 
 
2
Did the organization operate for the benefit of any supported organization other than the supported organization(s) that operated, supervised, or controlled the supporting organization? If “Yes,” explain in Part VI how providing such benefit carried out the purposes of the supported organization(s) that operated, supervised or controlled the supporting organization.
2
 
 
Section C. Type II Supporting Organizations
Yes
No
1
Were a majority of the organization’s directors or trustees during the tax year also a majority of the directors or trustees of each of the organization’s supported organization(s)? If “No,” describe in Part VI how control or management of the supporting organization was vested in the same persons that controlled or managed the supported organization(s).
1
 
 
Section D. All Type III Supporting Organizations
Yes
No
1
Did the organization provide to each of its supported organizations, by the last day of the fifth month of the organization’s tax year, (i) a written notice describing the type and amount of support provided during the prior tax year, (ii) a copy of the Form 990 that was most recently filed as of the date of notification, and (iii) copies of the organization’s governing documents in effect on the date of notification, to the extent not previously provided?
1
 
 
2
Were any of the organization’s officers, directors, or trustees either (i) appointed or elected by the supported organization(s) or (ii) serving on the governing body of a supported organization? If "No," explain in Part VI how the organization maintained a close and continuous working relationship with the supported organization(s).
2
 
 
3
By reason of the relationship described in (2), did the organization’s supported organizations have a significant voice in the organization’s investment policies and in directing the use of the organization’s income or assets at all times during the tax year? If "Yes," describe in Part VI the role the organization’s supported organizations played in this regard.
3
 
 
Section E. Type III Functionally-Integrated Supporting Organizations
1
Check the box next to the method that the organization used to satisfy the Integral Part Test during the year (see instructions):
a
b
c
2
Activities Test. Answer (a) and (b) below.
Yes
No
a
Did substantially all of the organization’s activities during the tax year directly further the exempt purposes of the supported organization(s) to which the organization was responsive? If "Yes," then in Part VI identify those supported organizations and explain how these activities directly furthered their exempt purposes, how the organization was responsive to those supported organizations, and how the organization determined that these activities constituted substantially all of its activities.
2a
 
 
b
Did the activities described in (a) constitute activities that, but for the organization’s involvement, one or more of the organization’s supported organization(s) would have been engaged in? If "Yes," explain in Part VI the reasons for the organization’s position that its supported organization(s) would have engaged in these activities but for the organization’s involvement.
2b
 
 
3
Parent of Supported Organizations. Answer (a) and (b) below.
a
Did the organization have the power to regularly appoint or elect a majority of the officers, directors, or trustees of each of the supported organizations? Provide details in Part VI.
3a
 
 
b
Did the organization exercise a substantial degree of direction over the policies, programs and activities of each of its supported organizations? If "Yes," describe in Part VI. the role played by the organization in this regard.
3b
 
 
Schedule A (Form 990 or 990-EZ) 2019

Schedule A (Form 990 or 990-EZ) 2019
Page 6
Part V
Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations
1
Section A - Adjusted Net Income (A) Prior Year (B) Current Year
(optional)
1 Net short-term capital gain 1    
2 Recoveries of prior-year distributions 2    
3 Other gross income (see instructions) 3    
4 Add lines 1 through 3 4    
5 Depreciation and depletion 5    
6 Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) 6    
7 Other expenses (see instructions) 7    
8 Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) 8    
Section B - Minimum Asset Amount (A) Prior Year (B) Current Year
(optional)
1 Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): 1
a Average monthly value of securities 1a    
b Average monthly cash balances 1b    
c Fair market value of other non-exempt-use assets 1c    
d Total (add lines 1a, 1b, and 1c) 1d    
e Discount claimed for blockage or other factors
(explain in detail in Part VI):  
2 Acquisition indebtedness applicable to non-exempt use assets 2    
3 Subtract line 2 from line 1d 3    
4 Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). 4    
5 Net value of non-exempt-use assets (subtract line 4 from line 3) 5    
6 Multiply line 5 by .035 6    
7 Recoveries of prior-year distributions 7    
8 Minimum Asset Amount (add line 7 to line 6) 8    
Section C - Distributable Amount Current Year
1 Adjusted net income for prior year (from Section A, line 8, Column A) 1  
2 Enter 85% of line 1 2  
3 Minimum asset amount for prior year (from Section B, line 8, Column A) 3  
4 Enter greater of line 2 or line 3 4  
5 Income tax imposed in prior year 5  
6 Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) 6  
7
Schedule A (Form 990 or 990-EZ) 2019

Schedule A (Form 990 or 990-EZ) 2019
Page 7
Part V
Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations(continued)
Section D - Distributions Current Year
1 Amounts paid to supported organizations to accomplish exempt purposes  
2 Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in
excess of income from activity		  
3 Administrative expenses paid to accomplish exempt purposes of supported organizations  
4 Amounts paid to acquire exempt-use assets  
5 Qualified set-aside amounts (prior IRS approval required)  
6 Other distributions (describe in Part VI). See instructions  
7Total annual distributions. Add lines 1 through 6.  
8 Distributions to attentive supported organizations to which the organization is responsive (provide
details in Part VI). See instructions		  
9 Distributable amount for 2019 from Section C, line 6  
10 Line 8 amount divided by Line 9 amount  
Section E - Distribution Allocations (see instructions) (i)
Excess Distributions 		(ii)
Underdistributions
Pre-2019 		(iii)
Distributable
Amount for 2019
1 Distributable amount for 2019 from Section C, line 6  
2 Underdistributions, if any, for years prior to 2019 (reasonable cause required-- explain in Part VI).
See instructions.		  
3 Excess distributions carryover, if any, to 2019:
a From 2014.......  
b From 2015.......  
c From 2016.......  
d From 2017.......  
e From 2018.......  
fTotal of lines 3a through e  
g Applied to underdistributions of prior years  
h Applied to 2019 distributable amount  
i Carryover from 2014 not applied (see
instructions) 		 
j Remainder. Subtract lines 3g, 3h, and 3i from 3f.  
4Distributions for 2019 from Section D, line 7:
$  
a Applied to underdistributions of prior years  
b Applied to 2019 distributable amount  
c Remainder. Subtract lines 4a and 4b from 4.  
5 Remaining underdistributions for years prior to
2019, if any. Subtract lines 3g and 4a from line 2.
If the amount is greater than zero, explain in Part VI.
See instructions.		  
6 Remaining underdistributions for 2019. Subtract
lines 3h and 4b from line 1. If the amount is greater
than zero, explain in Part VI. See instructions.		  
7 Excess distributions carryover to 2020. Add lines
3j and 4c.		  
8 Breakdown of line 7:
a Excess from 2015.....  
b Excess from 2016.....  
c Excess from 2017.....  
d Excess from 2018.....  
e Excess from 2019.....  
Schedule A (Form 990 or 990-EZ) (2019)

Schedule A (Form 990 or 990-EZ) 2019
Page 8
Part VI
Supplemental Information. Provide the explanations required by Part II, line 10; Part II, line 17a or 17b; Part III, line 12; Part IV, Section A, lines 1, 2, 3b, 3c, 4b, 4c, 5a, 6, 9a, 9b, 9c, 11a, 11b, and 11c; Part IV, Section B, lines 1 and 2; Part IV, Section C, line 1; Part IV, Section D, lines 2 and 3; Part IV, Section E, lines 1c, 2a, 2b, 3a and 3b; Part V, line 1; Part V, Section B, line 1e; Part V Section D, lines 5, 6, and 8; and Part V, Section E, lines 2, 5, and 6. Also complete this part for any additional information. (See instructions).
Facts And Circumstances Test
 
Return Reference Explanation
Schedule A (Form 990 or 990-EZ) 2019


Additional Data


Software ID:  
Software Version:  
Schedule B
(Form 990, 990-EZ,
or 990-PF)
Department of the Treasury
Internal Revenue Service
Schedule of Contributors

Arrow Bullet Attach to Form 990, 990-EZ, or 990-PF.
Arrow Bullet Go to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2019
Name of the organization
THE FOUNDATION FOR AIDS RESEARCH
 
Employer identification number

13-3163817
Organization type (check one):
Filers of:
Section:
Form 990 or 990-EZ






Form 990-PF




Check if your organization is covered by the General Rule or a Special Rule.  
Note: Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.
General Rule
Special Rules
......... Arrow Bullet $  
Caution: An organization that isn't covered by the General Rule and/or the Special Rules doesn't file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2, of its Form 990; or check the box on line H of its Form 990-EZ
or on its Form 990PF, Part I, line 2, to certify that it doesn't meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).
For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.
Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2019)
Schedule B (Form 990, 990-EZ, or 990-PF) (2019) Page 2
Name of organization
THE FOUNDATION FOR AIDS RESEARCH
  		Employer identification number
13-3163817
Part I
Contributors
Contributors (see instructions). Use duplicate copies of Part I if additional space is needed.
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2019)
Schedule B (Form 990, 990-EZ, or 990-PF) (2019)
Page 3
Name of organization
THE FOUNDATION FOR AIDS RESEARCH
  		Employer identification number

13-3163817
Part II
Noncash Property (see instructions). Use duplicate copies of Part II if additional space is needed.
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
Schedule B (Form 990, 990-EZ, or 990-PF) (2019)
Schedule B (Form 990, 990-EZ, or 990-PF) (2019)
Page 4
Name of organization
THE FOUNDATION FOR AIDS RESEARCH
  		Employer identification number

13-3163817
Part III
Exclusively religious, charitable, etc., contributions to organizations described in section 501(c)(7), (8), or (10) that total more than $1,000 for the year from any one contributor. Complete columns (a) through (e) and the following line entry. For organizations completing Part III, enter the total of exclusively religious, charitable, etc., contributions of $1,000 or less for the year. (Enter this information once. See instructions.) Arrow Bullet$  
Use duplicate copies of Part III if additional space is needed.
(a)
No. from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a)
No. from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a)
No. from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a)
No. from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
Schedule B (Form 990, 990-EZ, or 990-PF) (2019)

Additional Data


Software ID:  
Software Version:  
SCHEDULE C
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service
Political Campaign and Lobbying Activities

For Organizations Exempt From Income Tax Under section 501(c) and section 527

SchCMd Bullet Complete if the organization is described below. SchCMd Bullet Attach to Form 990 or Form 990-EZ.
SchCMd BulletGo to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2019
Open to Public
Inspection
If the organization answered "Yes" on Form 990, Part IV, Line 3, or Form 990-EZ, Part V, line 46 (Political Campaign Activities), then
Round Bullet Section 501(c)(3) organizations: Complete Parts I-A and B. Do not complete Part I-C.
Round Bullet Section 501(c) (other than section 501(c)(3)) organizations: Complete Parts I-A and C below. Do not complete Part I-B.
Round Bullet Section 527 organizations: Complete Part I-A only.
If the organization answered "Yes" on Form 990, Part IV, Line 4, or Form 990-EZ, Part VI, line 47 (Lobbying Activities), then
Round Bullet Section 501(c)(3) organizations that have filed Form 5768 (election under section 501(h)): Complete Part II-A. Do not complete Part II-B.
Round Bullet Section 501(c)(3) organizations that have NOT filed Form 5768 (election under section 501(h)): Complete Part II-B. Do not complete Part II-A.
If the organization answered "Yes" on Form 990, Part IV, Line 5 (Proxy Tax) (see separate instructions) or Form 990-EZ, Part V, line 35c (Proxy Tax) (see separate instructions), then
Round Bullet Section 501(c)(4), (5), or (6) organizations: Complete Part III.
Name of the organization
THE FOUNDATION FOR AIDS RESEARCH
 
Employer identification number

13-3163817
Part I-A
Complete if the organization is exempt under section 501(c) or is a section 527 organization.

1
Provide a description of the organization’s direct and indirect political campaign activities in Part IV (see instructions for definition of “political campaign activities")

2
Political campaign activity expenditures (see instructions) ....................................................................SchCMd Bullet
$  
3
Volunteer hours for political campaign activities (see instructions) ..................................................................
 

Part I-B
Complete if the organization is exempt under section 501(c)(3).
1
Enter the amount of any excise tax incurred by the organization under section 4955 ................................SchCMd Bullet
$  
2
Enter the amount of any excise tax incurred by organization managers under section 4955 .......................SchCMd Bullet
$  
3
If the organization incurred a section 4955 tax, did it file Form 4720 for this year? .........................................
4a
Was a correction made? ......................................................................................................................
b
If "Yes," describe in Part IV.
Part I-C
Complete if the organization is exempt under section 501(c), except section 501(c)(3).
1
Enter the amount directly expended by the filing organization for section 527 exempt function activities ..... SchCMd Bullet
$  
2
Enter the amount of the filing organization's funds contributed to other organizations for section 527 exempt function activities ............................................................................................................................SchCMd Bullet

$  
3
Total exempt function expenditures. Add lines 1 and 2. Enter here and on Form 1120-POL, line 17b...........SchCMd Bullet

$  
4
Did the filing organization file Form 1120-POL for this year? ...................................................................
5
Enter the names, addresses and employer identification number (EIN) of all section 527 political organizations to which the filing
organization made payments. For each organization listed, enter the amount paid from the filing organization’s funds. Also enter the amount of political contributions received that were promptly and directly delivered to a separate political organization, such as a separate segregated fund or a political action committee (PAC). If additional space is needed, provide information in Part IV.
(a) Name (b) Address (c) EIN (d) Amount paid from filing organization's funds. If none, enter -0-. (e) Amount of political contributions received and promptly and directly delivered to a separate political organization. If none, enter -0-.
1
2
3
4
5
6
For Paperwork Reduction Act Notice, see the instructions for Form 990 or 990-EZ.
Cat. No. 50084S
Schedule C (Form 990 or 990-EZ) 2019

Schedule C (Form 990 or 990-EZ) 2019
Page 2
Part II-A
Complete if the organization is exempt under section 501(c)(3) and filed Form 5768 (election under section 501(h)).
A Check SchCMd Bulletexpenses, and share of excess lobbying expenditures).
B Check SchCMd Bullet
Limits on Lobbying Expenditures
(The term "expenditures" means amounts paid or incurred.) 		(a) Filing
organization's
totals 		(b) Affiliated group totals
1a Total lobbying expenditures to influence public opinion (grass roots lobbying) ......................    
b Total lobbying expenditures to influence a legislative body (direct lobbying) ........................    
c Total lobbying expenditures (add lines 1a and 1b) ............................................................    
d Other exempt purpose expenditures ...............................................................................    
e Total exempt purpose expenditures (add lines 1c and 1d) ..................................................    
f Lobbying nontaxable amount. Enter the amount from the following table in both
columns.		    
If the amount on line 1e, column (a) or (b) is:The lobbying nontaxable amount is:
Not over $500,00020% of the amount on line 1e.
Over $500,000 but not over $1,000,000$100,000 plus 15% of the excess over $500,000.
Over $1,000,000 but not over $1,500,000$175,000 plus 10% of the excess over $1,000,000.
Over $1,500,000 but not over $17,000,000$225,000 plus 5% of the excess over $1,500,000.
Over $17,000,000$1,000,000.
g Grassroots nontaxable amount (enter 25% of line 1f) .................................................    
h Subtract line 1g from line 1a. If zero or less, enter -0-. ................................................    
i Subtract line 1f from line 1c. If zero or less, enter -0-. ................................................    
j If there is an amount other than zero on either line 1h or line 1i, did the organization file Form 4720 reporting
section 4911 tax for this year? ...................................................................................................................

4-Year Averaging Period Under Section 501(h)
(Some organizations that made a section 501(h) election do not have to complete all of the five
columns below. See the separate instructions for lines 2a through 2f.)
Lobbying Expenditures During 4-Year Averaging Period
Calendar year (or fiscal year
beginning in) 		(a) 2016 (b) 2017 (c) 2018 (d) 2019 (e) Total
2a Lobbying nontaxable amount          
b Lobbying ceiling amount
(150% of line 2a, column(e)) 		 
c Total lobbying expenditures          
d Grassroots nontaxable amount          
e Grassroots ceiling amount
(150% of line 2d, column (e))		  
f Grassroots lobbying expenditures          
Schedule C (Form 990 or 990-EZ) 2019


Schedule C (Form 990 or 990-EZ) 2019
Page 3
Part II-B
Complete if the organization is exempt under section 501(c)(3) and has NOT filed Form 5768 (election under section 501(h)).
For each "Yes" response on lines 1a through 1i below, provide in Part IV a detailed description of the lobbying activity.
(a)
Yes|No
(b)
Amount
1
During the year, did the filing organization attempt to influence foreign, national, state or local legislation, including any attempt to influence public opinion on a legislative matter or referendum, through the use of:
a
Volunteers? ...........................................................................................................
 
No
b
Paid staff or management (include compensation in expenses reported on lines 1c through 1i)? ........
Yes
 
c
Media advertisements? ...................................................................................................
 
No
 
d
Mailings to members, legislators, or the public? .............................................................................
 
No
 
e
Publications, or published or broadcast statements? ...........................................................
 
No
 
f
Grants to other organizations for lobbying purposes? ..........................................................
 
No
 
g
Direct contact with legislators, their staffs, government officials, or a legislative body? .......................
 
No
 
h
Rallies, demonstrations, seminars, conventions, speeches, lectures, or any similar means? ..................
 
No
 
i
Other activities? ...................................................................................................................
Yes
 
402,465
j
Total. Add lines 1c through 1i ....................................................................................................
402,465
2a
Did the activities in line 1 cause the organization to be not described in section 501(c)(3)? .....
 
No
b
If "Yes," enter the amount of any tax incurred under section 4912 ...........................................
 
c
If "Yes," enter the amount of any tax incurred by organization managers under section 4912 ...................
 
d
If the filing organization incurred a section 4912 tax, did it file Form 4720 for this year? ........................
 
No
Part III-A
Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6).
Yes
No
1
Were substantially all (90% or more) dues received nondeductible by members? ...............................................
1
 
 
2
Did the organization make only in-house lobbying expenditures of $2,000 or less? ............................................
2
 
 
3
Did the organization agree to carry over lobbying and political expenditures from the prior year? .................................
3
 
 
Part III-B
Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6) and if either (a) BOTH Part III-A, lines 1 and 2, are answered "No" OR (b) Part III-A, line 3, is answered “Yes."
1
Dues, assessments and similar amounts from members ......................................................................
1
 
2
Section 162(e) nondeductible lobbying and political expenditures (do not include amounts of political expenses for which the section 527(f) tax was paid).
a
Current year .............................................................................................................................
2a
 
b
Carryover from last year ............................................................................................................
2b
 
c
Total ...........................................................................................................................................
2c
 
3
Aggregate amount reported in section 6033(e)(1)(A) notices of nondeductible section 162(e) dues .
3
 
4
If notices were sent and the amount on line 2c exceeds the amount on line 3, what portion of the excess does the organization agree to carryover to the reasonable estimate of nondeductible lobbying and political expenditure next year? ......................................................................................................................
4
 
5
Taxable amount of lobbying and political expenditures (see instructions) .........................................
5
 
Part IV
Supplemental Information
Provide the descriptions required for Part l-A, line 1; Part l-B, line 4; Part l-C, line 5; Part II-A (affiliated group list); Part II-A, lines 1 and 2 (see instructions), and Part ll-B, line 1. Also, complete this part for any additional information.
Return Reference Explanation
LOBBYING EXPENSES PART II-B THE FOUNDATION FOR AIDS RESEARCH DEVELOPED AN ACTION AGENDA TO END AIDS THAT IDENTIFIED CRITICAL DECISIONS THAT NEED TO BE MADE TO ADVANCE EVIDENCE BASED AIDS POLICIES. WE CREATED A VARIETY OF ISSUE BRIEFS ON TOPICS SUCH AS THE POTENTIAL IMPACT OF VARIOUS BUDGET SCENARIOS ON GLOBAL HEALTH SERVICES, AND POLICY PRIORITIES TO ADDRESS THE HIV EPIDEMIC AMONG GAY MEN IN THE US. THESE ISSUE BRIEFS WERE SHARED WITH CAPITOL HILL STAFF AND MEMBERS OF THE ADMINISTRATION. AMFAR MET REGULARLY WITH STAFF TO MEMBERS OF CONGRESS AND WITH ADMINISTRATION STAFF, AND WE PROVIDED INPUT TO THE ADMINISTRATION ON DEVELOPMENT OF THE PEPFAR BLUEPRINT FOR AN AIDS FREE GENERATION. AMFAR SPONSORED SEVERAL BRIEFINGS ON CAPITOL HILL ON AIDS POLICY AND RESEARCH ISSUES. AMFAR USES THESE BRIEFINGS AS AN EDUCATIONAL TOOL. The Foundation engaged an independent consultant to engage in lobbying activities on its behalf. Fees paid to this consultant totaled $104,808 in the fiscal year ending September 30, 2018.
Schedule C (Form 990 or 990EZ) 2019


Additional Data


Software ID:  
Software Version:  

SCHEDULE D
(Form 990)
Department of the Treasury
Internal Revenue Service
Supplemental Financial Statements
SchDMd Bullet Complete if the organization answered "Yes," on Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b.
SchDMd Bullet Attach to Form 990.
SchDMd Bullet Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2019
Open to Public Inspection
Name of the organization
THE FOUNDATION FOR AIDS RESEARCH
 
Employer identification number

13-3163817
Part I
Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" on Form 990, Part IV, line 6.
(a) Donor advised funds (b) Funds and other accounts
1 Total number at end of year .........    
2 Aggregate value of contributions to (during year)    
3 Aggregate value of grants from (during year)    
4 Aggregate value at end of year ........    
5
Did the organization inform all donors and donor advisors in writing that the assets held in donor advised funds are the organization’s property, subject to the organization’s exclusive legal control? ............
6
Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................
Part II
Conservation Easements.
Complete if the organization answered "Yes" on Form 990, Part IV, line 7.
1
Purpose(s) of conservation easements held by the organization (check all that apply).
2
Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.
Held at the End of the Year
a Total number of conservation easements ...................... 2a  
b Total acreage restricted by conservation easements .................... 2b  
c Number of conservation easements on a certified historic structure included in (a) ..... 2c  
d Number of conservation easements included in (c) acquired after 7/25/06, and not on a historic structure listed in the National Register ... 2d  
3
Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during the
tax year SchDMd Bullet  
4
Number of states where property subject to conservation easement is located SchDMd Bullet  
5
Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and enforcement of the conservation easements it holds? ............
6
Staff and volunteer hours devoted to monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet  
7
Amount of expenses incurred in monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet $  
8
Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .............................
9
In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" on Form 990, Part IV, line 8.
1a
If the organization elected, as permitted under FASB ASC 958, not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.
b
If the organization elected, as permitted under FASB ASC 958, to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:
(i)
Revenue included on Form 990, Part VIII, line 1 .........................SchDMd Bullet $  
(ii)
Assets included in Form 990, Part X ...............................SchDMd Bullet $ 474,123
2
If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under FASB ASC 958 relating to these items:
a
Revenue included on Form 990, Part VIII, line 1 ..........................SchDMd Bullet $  
b
Assets included in Form 990, Part X ...............................SchDMd Bullet $  
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 52283D
Schedule D (Form 990) 2019

Schedule D (Form 990) 2019
Page 2
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)
3
Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):
a
d
b
e
Donated Items, Inventory etc.
c
4
Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.
5
During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?...
Part IV
Escrow and Custodial Arrangements. Complete if the organization answered "Yes" on Form 990, Part IV, line 9, or reported an amount on Form 990, Part X, line 21.
1a
Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................
b If "Yes," explain the arrangement in Part XIII and complete the following table: Amount
c Beginning balance ............................. 1c  
d Additions during the year ............................ 1d  
e Distributions during the year .......................... 1e  
f Ending balance ................................ 1f  
2a
Did the organization include an amount on Form 990, Part X, line 21, for escrow or custodial account liability? ...
b
If "Yes," explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII ....
Part V
Endowment Funds.
Complete if the organization answered "Yes" on Form 990, Part IV, line 10.
(a) Current year (b) Prior year (c) Two years back (d) Three years back (e) Four years back
1a Beginning of year balance .... 593,133 541,231 493,036 490,979 443,886
b Contributions ... 4,100 5,950 7,293 7,998 6,543
c Net investment earnings, gains, and losses 86,877 45,952 40,902 -5,941 40,550
d Grants or scholarships ...          
e Other expenditures for facilities
and programs ... 		         
f Administrative expenses ....          
g End of year balance ...... 684,110 593,133 541,231 493,036 490,979
2
Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:
a
Board designated or quasi-endowment SchDMd Bullet  
b
Permanent endowment SchDMd Bullet54.460 %
c
Term endowment SchDMd Bullet45.540 %
The percentages on lines 2a, 2b, and 2c should equal 100%.
3a
Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes
No
(i) Unrelated organizations .................
3a(i)
 
No
(ii) Related organizations .................
3a(ii)
 
No
b
If "Yes" on 3a(ii), are the related organizations listed as required on Schedule R? .........
3b
 
 
4
Describe in Part XIII the intended uses of the organization's endowment funds.
Part VI
Land, Buildings, and Equipment.
Complete if the organization answered "Yes" on Form 990, Part IV, line 11a. See Form 990, Part X, line 10.
Description of property (a) Cost or other basis
(investment) 		(b) Cost or other basis (other) (c) Accumulated depreciation (d) Book value
1a Land .....      
b Buildings ....        
c Leasehold improvements   2,542,490 145,208 2,397,282
d Equipment ....   304,826 266,627 38,199
e Other .....   4,995,170 4,509,117 486,053
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).)..SchDMdBullet 2,921,534
Schedule D (Form 990) 2019

Schedule D (Form 990) 2019
Page 3
Part VII
Investments—Other Securities.
Complete if the organization answered "Yes" on Form 990, Part IV, line 11b. See Form 990, Part X, line 12.
(a) Description of security or category
(including name of security)		 (b) Book value (c) Method of valuation:
Cost or end-of-year market value
(1) Financial derivatives.........    
(2) Closely-held equity interests........    
(3)Other
(B)
(C)
(D)
(E)
(F)
(G)
(H)
(I)
Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)Small Bullet  
Part VIII
Investments—Program Related. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11c. See Form 990, Part X, line 13.
(a) Description of investment (b) Book value (c) Method of valuation:
Cost or end-of-year market value
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)Small Bullet  
Part IX
Other Assets.
Complete if the organization answered 'Yes' on Form 990, Part IV, line 11d. See Form 990, Part X, line 15.
(a) Description (b) Book value
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........Small Bullet  
Part X
Other Liabilities.
Complete if the organization answered 'Yes' on Form 990, Part IV, line 11e or 11f. See Form 990, Part X, line 25.
1.(a) Description of liability (b) Book value
(1) Federal income taxes 0
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)Small Bullet 1,965,068
2. Liability for uncertain tax positions. In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII
Schedule D (Form 990) 2019

Schedule D (Form 990) 2019
Page 4
Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return. Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1 Total revenue, gains, and other support per audited financial statements ....... 1 31,971,417
2 Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a Net unrealized gains (losses) on investments .... 2a -450,746
b Donated services and use of facilities ......... 2b 115,591
c Recoveries of prior year grants ........... 2c  
d Other (Describe in Part XIII.) ............ 2d -1,504
e Add lines 2a through 2d ..................... 2e -336,659
3 Subtract line 2e from line 1.................. 3 32,308,076
4 Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b . 4a  
b Other (Describe in Part XIII.) ........... 4b  
c Add lines 4a and 4b.................... 4c  
5 Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ...... 5 32,308,076
Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return. Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1 Total expenses and losses per audited financial statements ........... 1 39,150,984
2 Amounts included on line 1 but not on Form 990, Part IX, line 25:
a Donated services and use of facilities ......... 2a 115,591
b Prior year adjustments ............ 2b  
c Other losses ................ 2c  
d Other (Describe in Part XIII.) ............ 2d -1,504
e Add lines 2a through 2d.................... 2e 114,087
3 Subtract line 2e from line 1................... 3 39,036,897
4 Amounts included on Form 990, Part IX, line 25, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b .. 4a  
b Other (Describe in Part XIII.) ............ 4b  
c Add lines 4a and 4b..................... 4c  
5 Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ...... 5 39,036,897
Part XIII
Supplemental Information
Provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b; Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.
Return Reference Explanation
ENDOWMENTS PART V, LINE 4 AMFAR'S ENDOWMENT FUND IS INTENDED TO FUND THE VARIOUS GENERAL RESEARCH PROGRAMS THE ORGANIZATION SPONSORS. Reconciliation of Revenue & Expenses Part XI & Part XII, Line 2d Loss/Gain on Disposal of Fixed Assets $-1,504
FIN 48 - INCOME TAXES AMFAR FOLLOWS GUIDANCE THAT CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING ISSUES RELATING TO FINANCIAL STATEMENT RECOGNITION AND GUIDANCE ON MEASUREMENT. THIS GUIDANCE PROVIDES THAT THE TAX EFFECTS FROM AN UNCERTAIN TAX POSITION CAN ONLY BE RECOGNIZED IN THE FINANCIAL STATEMENTS IF THE POSITION IS "MORE-LIKELY-THAN-NOT" TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. THE ASSESSMENT OF THE TAX POSITION IS BASED SOLELY ON THE TECHNICAL MERITS OF THE POSITION, WITHOUT REGARD TO THE LIKELIHOOD THAT THE TAX POSITION MAY BE CHALLENGED. AMFAR IS EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3), THOUGH IT IS SUBJECT TO TAX ON INCOME UNRELATED TO ITS EXEMPT PURPOSE, UNLESS THAT INCOME IS OTHERWISE EXCLUDED BY THE CODE. AMFAR HAS PROCESSES PRESENTLY IN PLACE TO ENSURE THE MAINTENANCE OF ITS TAX-EXEMPT STATUS; TO IDENTIFY AND REPORT UNRELATED INCOME; TO DETERMINE ITS FILING AND TAX OBLIGATIONS IN JURISDICTIONS FOR WHICH IT WAS NEXUS; AND TO IDENTIFY AND EVALUATE OTHER MATTERS THAT MAY BE CONSIDERED TAX POSITIONS. AMFAR HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS.
COLLECTIONS OF ART, HISTORICAL TREASURES, OR OTHER SIMILAR ASSETS PART III, LINE 4 AMFAR HOLDS VARIOUS ITEMS OF JEWELRY, PHOTOGRAPHS AND OTHER ITEMS OF ARTISTIC VALUE THAT HAVE BEEN DONATED TO THE ORGANIZATION FOR SALE AT SPECIAL EVENTS. THE ORGANIZATION HAS MAINTAINED THESE ITEMS IN INVENTORY FOR A FEW YEARS AND IS IN THE PROCESS OF SELLING THEM.
Schedule D (Form 990) 2019


Additional Data


Software ID:  
Software Version:  




SCHEDULE F(Form 990)
Department of the Treasury
Internal Revenue Service
Statement of Activities Outside the United States
Right pointing arrow large image Complete if the organization answered "Yes" to Form 990, Part IV, line 14b, 15, or 16.Right pointing arrow large image Attach to Form 990.Right pointing arrow large image Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2019
Open to Public Inspection
Name of the organization
THE FOUNDATION FOR AIDS RESEARCH
 
Employer identification number

13-3163817
Part I
General Information on Activities Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 14b.
1
For grantmakers. Does the organization maintain records to substantiate the amount of its grants and
other assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used
to award the grants or assistance? . . . . . . . . . . . . . . . . . . . . . . . . .
2
For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of its grants and other assistance outside the United States.
3
Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)
(a) Region (b) Number of offices in the region (c) Number of employees, agents, and independent contractors in the region (d) Activities conducted in region (by type) (such as, fundraising, program services, investments, grants to recipients located in the region) (e) If activity listed in (d) is a program service, describe specific type of
service(s) in the region		 (f) Total expenditures
for and investments
in the region
East Asia and the Pacific     Grantmaking n/a 2,543,870
Europe (Including Iceland and Greenland)     Grantmaking N/A 1,646,178
North America     Grantmaking N/A 103,578
South America     Grantmaking N/A 144,717
South Asia     Grantmaking N/A 93,219
Sub-Saharan Africa     Grantmaking N/A 63,965
East Asia and the Pacific 1 16 Program Services THERAPEUTICS,TRAINING 1,827,595
East Asia and the Pacific     Fundraising N/A 1,853,009
Europe (Including Iceland and Greenland)     Fundraising N/A 7,537,495
South America     Fundraising N/A 518,164
           
           
           
           
           
           
           
3a Sub-total .... 1 16 16,331,790
b Total from continuation sheets to Part I ...      
c Totals (add lines 3a and 3b) 1 16 16,331,790
For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2019
Schedule F (Form 990) 2019
Page 2
Part II
Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.
1 (a) Name of organization (b) IRS code section
and EIN (if applicable)		 (c) Region (d) Purpose of
grant 		(e) Amount of
cash grant 		(f) Manner of
cash
disbursement 		(g) Amount
of noncash
assistance 		(h) Description
of noncash
assistance 		(i) Method of
valuation
(book, FMV,
appraisal, other)
East Asia/Pacific BASIC RESEARCH 499,920 wire transfe 0    
East Asia/Pacific BASIC RESEARCH 74,986 wire transfe 0    
East Asia/Pacific GMT INITIATIVE 184,615 wire transfe 0    
East Asia/Pacific TREAT ASIA 5,254 wire transfe 0    
East Asia/Pacific TREAT ASIA 6,445 wire transfe 0    
East Asia/Pacific TREAT ASIA 11,906 wire transfe 0    
East Asia/Pacific TREAT ASIA 9,304 wire transfe 0    
East Asia/Pacific TREAT ASIA 17,273 wire transfe 0    
East Asia/Pacific TREAT ASIA 62,499 wire transfe 0    
East Asia/Pacific TREAT ASIA 6,250 wire transfe 0    
East Asia/Pacific TREAT ASIA 9,126 wire transfe 0    
East Asia/Pacific TREAT ASIA 19,996 wire transfe 0    
East Asia/Pacific TREAT ASIA 17,650 wire transfe 0    
East Asia/Pacific TREAT ASIA 14,600 wire transfe 0    
East Asia/Pacific TREAT ASIA 9,454 wire transfe 0    
East Asia/Pacific TREAT ASIA 21,224 wire transfe 0    
East Asia/Pacific TREAT ASIA 16,800 wire transfe 0    
East Asia/Pacific TREAT ASIA 21,328 wire transfe 0    
East Asia/Pacific TREAT ASIA 22,724 wire transfe 0    
East Asia/Pacific TREAT ASIA 22,464 wire transfe 0    
East Asia/Pacific TREAT ASIA 21,414 wire transfe 0    
East Asia/Pacific TREAT ASIA 23,630 wire transfe 0    
East Asia/Pacific TREAT ASIA 21,614 wire transfe 0    
East Asia/Pacific TREAT ASIA 21,446 wire transfe 0    
East Asia/Pacific TREAT ASIA 14,050 wire transfe 0    
East Asia/Pacific TREAT ASIA 23,200 wire transfe 0    
East Asia/Pacific TREAT ASIA 20,994 wire transfe 0    
East Asia/Pacific TREAT ASIA 21,256 wire transfe 0    
East Asia/Pacific TREAT ASIA 61,320 wire transfe 0    
East Asia/Pacific TREAT ASIA 69,357 wire transfe 0    
East Asia/Pacific TREAT ASIA 7,500 wire transfe 0    
East Asia/Pacific TREAT ASIA 6,825 wire transfe 0    
East Asia/Pacific TREAT ASIA 6,225 wire transfe 0    
East Asia/Pacific TREAT ASIA 6,600 wire transfe 0    
East Asia/Pacific TREAT ASIA 7,500 wire transfe 0    
East Asia/Pacific TREAT ASIA 7,500 wire transfe 0    
East Asia/Pacific TREAT ASIA 7,500 wire transfe 0    
East Asia/Pacific TREAT ASIA 7,500 wire transfe 0    
East Asia/Pacific TREAT ASIA 7,500 wire transfe 0    
East Asia/Pacific TREAT ASIA 284,731 wire transfe 0    
East Asia/Pacific TREAT ASIA 184,408 wire transfe 0    
East Asia/Pacific TREAT ASIA 68,602 wire transfe 0    
East Asia/Pacific TREAT ASIA 7,500 wire transfe 0    
East Asia/Pacific TREAT ASIA 15,000 wire transfe 0    
East Asia/Pacific TREAT ASIA 15,000 wire transfe 0    
East Asia/Pacific TREAT ASIA 15,000 wire transfe 0    
East Asia/Pacific TREAT ASIA 15,000 wire transfe 0    
East Asia/Pacific TREAT ASIA 25,000 wire transfe 0    
East Asia/Pacific TREAT ASIA 20,000 wire transfe 0    
East Asia/Pacific TREAT ASIA 10,046 wire transfe 0    
East Asia/Pacific TREAT ASIA 10,958 wire transfe 0    
East Asia/Pacific TREAT ASIA 11,351 wire transfe 0    
East Asia/Pacific TREAT ASIA 6,167 wire transfe 0    
East Asia/Pacific TREAT ASIA 7,690 wire transfe 0    
East Asia/Pacific TREAT ASIA 13,770 wire transfe 0    
East Asia/Pacific TREAT ASIA 110,962 wire transfe 0    
East Asia/Pacific TREAT ASIA 15,082 wire transfe 0    
East Asia/Pacific TREAT ASIA 11,658 wire transfe 0    
East Asia/Pacific TREAT ASIA 9,480 wire transfe 0    
East Asia/Pacific TREAT ASIA 20,740 wire transfe 0    
East Asia/Pacific TREAT ASIA 13,272 wire transfe 0    
East Asia/Pacific TREAT ASIA 7,939 wire transfe 0    
East Asia/Pacific TREAT ASIA 86,459 wire transfe 0    
East Asia/Pacific TREAT ASIA 15,194 wire transfe 0    
East Asia/Pacific TREAT ASIA 6,641 wire transfe 0    
East Asia/Pacific TREAT ASIA 18,750 wire transfe 0    
East Asia/Pacific TREAT ASIA 5,625 wire transfe 0    
East Asia/Pacific TREAT ASIA 5,625 wire transfe 0    
East Asia/Pacific TREAT ASIA 5,625 wire transfe 0    
East Asia/Pacific TREAT ASIA 5,625 wire transfe 0    
East Asia/Pacific TREAT ASIA 5,625 wire transfe 0    
East Asia/Pacific TREAT ASIA 15,000 wire transfe 0    
Europe BASIC RESEARCH 75,000 wire transfe 0    
Europe BASIC RESEARCH 289,933 wire transfe 0    
Europe BASIC RESEARCH 270,025 wire transfe 0    
Europe BASIC RESEARCH 6,667 wire transfe 0    
Europe RESEARCH 129,113 wire transfe 0    
Europe RESEARCH 680,440 wire transfe 0    
Europe RESEARCH 195,000 wire transfe 0    
North America (excl USA) BASIC RESEARCH 33,334 wire transfe 0    
North America (excl USA) BASIC RESEARCH 75,000 wire transfe 0    
South America BASIC RESEARCH 15,000 wire transfe 0    
South America GMT INITIATIVE 150,288 wire transfe 0    
South Asia PUBLIC POLICY 24,989 wire transfe 0    
South Asia TREAT ASIA 7,500 wire transfe 0    
South Asia TREAT ASIA 15,776 wire transfe 0    
South Asia TREAT ASIA 11,250 wire transfe 0    
South Asia TREAT ASIA 15,000 wire transfe 0    
South Asia TREAT ASIA 8,704 wire transfe 0    
Sub-Saharan Africa TREAT ASIA 63,965 WIRE TRANSFE 0    
2 Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .......MediumBullet
90
3 Enter total number of other organizations or entities .......................MediumBullet
 
Schedule F (Form 990) 2019
Schedule F (Form 990) 2019Page 3
Part III
Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 16.
Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance (b) Region (c) Number of recipients (d) Amount of
cash grant 		(e) Manner of cash
disbursement 		(f) Amount of
noncash
assistance 		(g) Description
of noncash
assistance 		(h) Method of
valuation
(book, FMV,
appraisal, other)
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
Schedule F (Form 990) 2019
Schedule F (Form 990) 2019
Page 4
Part IV
Foreign Forms
1 Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 Did the organization have an interest in a foreign trust during the tax year? If "Yes," the organization may be required to separately file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A; don't file with Form 990). . . . . . . . . . . . . . . . . . . . . . . .
3 Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471). . . . . . . . . . . . . . . . . . . . . . . . . . . .
4 Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If “Yes,” the organization may be required to file Form 8621, Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621) .
5 Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships (see Instructions for Form 8865). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6 Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to separately file Form 5713, International Boycott Report (see Instructions for Form 5713; don't file with Form 990).. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Schedule F (Form 990) 2019
Schedule F (Form 990) 2019
Page 5
Part V
Supplemental Information
Provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information. See instructions.
ReturnReference Explanation
FOREIGN ACTIVITIES PART I, LINE 2 INTERNATIONAL ORGANIZATIONS ARE RECOMMENDED FOR FUNDING BASED UPON THE RESULTS OF COMMUNITY-BASED PEER REVIEW AND/OR PROGRAM STAFF ASSESSMENT OF PROPOSAL MERIT AND ORGANIZATION CAPACITY TO UNDERTAKE PROPOSED PROJECTS THAT ARE CHARITABLE IN PURPOSE. PRE-AWARD DUE-DILIGENCE FOR NEW INTERNATIONAL GRANTEES INCLUDES REVIEW OF ORGANIZATION DOCUMENTS AND REGISTRATIONS TO VERIFY THAT THE ORGANIZATION OPERATES FOR A CHARITABLE PURPOSE AND THAT BASIC CAPACITY FOR PROJECT OVERSIGHT AND GOVERNANCE HAS BEEN ESTABLISHED. ALL INTERNATIONAL GRANTEES ARE REQUIRED TO REPORT SEMI-ANNUALLY ON PROJECT PROGRESS AND EXPENDITURES; CONTINUED REPORTING IS REQUIRED UNTIL SUCH TIME AS GRANT FUNDS ARE EXPENDED IN FULL. REPORTS ARE REVIEWED BY ADMINISTRATIVE AND PROGRAM STAFF. ADDITIONAL OVERSIGHT IS PROVIDED AS NECESSARY BY MEANS OF ONGOING, INFORMAL CONTACT WITH SITES REGARDING PROGRESS AND TECHNICAL ISSUES AND SITE VISITS WHERE FEASIBLE. INTERNATIONAL RESEARCH GRANT RECIPIENTS SUBMIT AN INTERIM AND A FINAL PROGRESS REPORTING ADDITION TO EXPENDITURES REPORTS DUE FOLLOWING THE ENDS OF THE 2ND, 3RD AND FINAL QUARTERS OF THE PERFORMANCE PERIOD.
FOREIGN ACTIVITIES PART I, LINE 3, COLUMN D THE FOUNDATION FOR AIDS RESEARCH CONDUCTS MANY OF ITS GRANT-MAKING PROGRAM SERVICES (SEE PART III OF FORM 990) IN U.S. AND FOREIGN JURISDICTIONS. IN COLUMN D, THE ORGANIZATION HAS REPORTED THE BASIC PROGRAM THESE GRANTS SUPPORT; PLEASE REFER TO PART III FOR MORE INFORMATION ABOUT THESE PROGRAMS/INITIATIVES.
FOREIGN ACTIVITIES - STATUS OF GRANTEES THE FOUNDATION FOR AIDS RESEARCH SUPPORTS MANY NON-U.S. ORGANIZATIONS IN THE FIGHT AGAINST AIDS AND HIV-RELATED DISEASES. FOR PURPOSES OF SCHEDULE F, PART II, LINE 2 - ALL 90 CHARITIES SUPPORTED ARE PRESUMED TO BE THE EQUIVALENT OF U.S. CHARITIES.
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
Schedule F (Form 990) 2019
Additional Data


Software ID:  
Software Version:  



SCHEDULE G (Form 990 or 990-EZ)
Department of the Treasury
Internal Revenue Service
Supplemental Information Regarding
Fundraising or Gaming Activities
Complete if the organization answered "Yes" on Form 990, Part IV, lines 17, 18, or 19, or if the organization entered more than $15,000 on Form 990-EZ, line 6a. right arrowAttach to Form 990 or Form 990-EZ.
right arrowGo to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2019
Open to Public Inspection
Name of the organization
THE FOUNDATION FOR AIDS RESEARCH
 
Employer identification number

13-3163817
Part I
Fundraising Activities.Complete if the organization answered "Yes" on Form 990, Part IV, line 17.
Form 990-EZ filers are not required to complete this part.
1
Indicate whether the organization raised funds through any of the following activities. Check all that apply.
a e
b f
c g
d
2a
Did the organization have a written or oral agreement with any individual (including officers, directors, trustees
or key employees listed in Form 990, Part VII) or entity in connection with professional fundraising services?
b
If "Yes," list the 10 highest paid individuals or entities (fundraisers) pursuant to agreements under which the fundraiser is
to be compensated at least $5,000 by the organization.


(i) Name and address of individual
or entity (fundraiser) 		(ii) Activity (iii) Did fundraiser have custody or control of contributions? (iv) Gross receipts
from activity 		(v) Amount paid to
(or retained by)
fundraiser listed in
col. (i) 		(vi) Amount paid to
(or retained by)
organization
Yes No
aab productions INC events production   No 24,583,369 682,268 23,901,102
EIDOLON COMM INC direct mail   No 1,934,251 286,181 1,648,070
Donor Services Group LLC Tele marketing   No 0 1,829 -1,829
Josh Woods Production events Production   No 4,164,907 345,000 3,819,907
             
             
             
             
             
             
Total . . . . . . . . . . . . . . . . . . . . right arrow 30,682,527 1,315,278 29,367,250
3
List all states in which the organization is registered or licensed to solicit contributions or has been notified it is exempt from registration or licensing.
AL, AK, AR, CA, CO, CT, DC, FL, GA, HI, IL, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WV, WI
For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.
Cat. No. 50083H
Schedule G (Form 990 or 990-EZ) 2019
Schedule G (Form 990 or 990-EZ) 2019
Page 2
Part II
Fundraising Events. Complete if the organization answered "Yes" on Form 990, Part IV, line 18, or reported more than $15,000 of fundraising event contributions and gross income on Form 990-EZ, lines 1 and 6b. List events with gross receipts greater than $5,000.









VerticalRevenue
(a) Event #1

Cannes
(event type) 		(b) Event #2

Dallas
(event type) 		(c) Other events

24
(total number) 		(d) Total events
(add col. (a) through col. (c))

1
Gross receipts . . . . .
12,592,424
3,879,548
16,669,851
33,141,823

2
Less: Contributions . . . .
12,169,924
3,677,858
15,250,501
31,098,283
3 Gross income (line 1 minus
line 2) . . . . . .
422,500
201,690
1,419,350
2,043,540



VerticalDirectExpenses
4 Cash prizes . . . . .        
5 Noncash prizes . . . .        
6 Rent/facility costs . . . . 1,313,249 277,433 1,031,298 2,621,980
7 Food and beverages . . . 407,894 213,512 926,491 1,547,897
8 Entertainment . . . . 1,816,828 18,019 1,844,078 3,678,925
9 Other direct expenses . . . 2,908,726 545,286 3,038,196 6,492,208
10 Direct expense summary. Add lines 4 through 9 in column (d) . . . . . . . . . . right arrow 14,341,010
11 Net income summary. Subtract line 10 from line 3, column (d). . . . . . . . . . right arrow -12,297,470
Part III
Gaming. Complete if the organization answered "Yes" on Form 990, Part IV, line 19, or reported more than $15,000 on Form 990-EZ, line 6a.
VerticalRevenue
(a) Bingo (b) Pull tabs/Instant
bingo/progressive bingo 		(c) Other gaming (d) Total gaming (add col.(a) through col.(c))

1
Gross revenue . . . . .
 
 
 
 
VerticalDirectExpenses

2
Cash prizes . . . . .
 
 
 
 

3
Noncash prizes . . . .
 
 
 
 

4
Rent/facility costs . . . .
 
 
 
 

5
Other direct expenses . . .
 
 
 
 


6

Volunteer labor . . . .
%
%
%


7
Direct expense summary. Add lines 2 through 5 in column (d) . . . . . . . . . . right arrow
 

8
Net gaming income summary. Subtract line 7 from line 1, column (d). . . . . . . . . right arrow
 

9
Enter the state(s) in which the organization conducts gaming activities:
a
Is the organization licensed to conduct gaming activities in each of these states? . . . . . . . .
b
If "No," explain:
 
10a
Were any of the organization's gaming licenses revoked, suspended or terminated during the tax year? . . .
b
If "Yes," explain:
 
Schedule G (Form 990 or 990-EZ) 2019
Schedule G (Form 990 or 990-EZ) 2019
Page 3
11
Does the organization conduct gaming activities with nonmembers? . . . . . . . . . . .
12
Is the organization a grantor, beneficiary or trustee of a trust or a member of a partnership or other entity
formed to administer charitable gaming? . . . . . . . . . . . . . . . . .
13
Indicate the percentage of gaming activity conducted in:
a
The organization's facility . . . . . . . . . . . . . . . . . .
13a
%
b
An outside facility . . . . . . . . . . . . . . . . . . . .
13b
%
14
Enter the name and address of the person who prepares the organization's gaming/special events books and records:
Name right arrow
Address right arrow
15a
Does the organization have a contract with a third party from whom the organization receives gaming
revenue? . . . . . . . . . . . . . . . . . . . . . . . .
b
If "Yes," enter the amount of gaming revenue received by the organization right arrow $   and the
amount of gaming revenue retained by the third party right arrow $   .
c
If "Yes," enter name and address of the third party:
Name right arrow
Address right arrow
16
Gaming manager information:
Name right arrow
Gaming manager compensation right arrow $  
Description of services provided right arrow
 
17
Mandatory distributions:
a
Is the organization required under state law to make charitable distributions from the gaming proceeds to
retain the state gaming license? . . . . . . . . . . . . . . . . . . .
b
Enter the amount of distributions required under state law distributed to other exempt organizations or spent
in the organization's own exempt activities during the tax year right arrow$  
Part IV
Supplemental Information. Provide the explanations required by Part I, line 2b, columns (iii) and (v); and Part III, lines 9, 9b, 10b, 15b, 15c, 16, and 17b, as applicable. Also provide any additional information. See instructions.
Return Reference Explanation
SCHEDULE G, PART I THE FOUNDATION FOR AIDS RESEARCH ACTUALLY PAID OUT $735,053 IN FUNDRAISING EXPENSES FOR THE YEAR ENDING SEPTEMBER 30, 2018. THIS AMOUNT IS REPORTED ON PART IX, LINE 11(E). FOR PURPOSES OF SCHEDULE G, THE FOUNDATION IS REPORTING ALL AMOUNTS PAID TO THE CONSULTANTS LISTED ON PART I, REGARDLESS OF WHETHER SUCH AMOUNTS WERE PURE FUNDRAISING EXPENSES OR EVENT PRODUCTION COSTS. ON SCHEDULE G, THE TOTAL AMOUNT PAID TO THE ORGANIZATIONS LISTED IS $1,315,278. OF THAT $1,315,278, ONLY $735,053 WAS PAID FOR FUNDRAISING SERVICES, THE REMAINING $580,225 WAS PAID FOR EVENT PRODUCTION SERVICES. IN THE INTERESTS OF CLARITY, THE FOUNDATION WOULD ALSO LIKE TO MAKE CLEAR THAT THE COMPENSATION REPORTED AS HAVING BEEN PAID TO THE PROFESSIONAL FUNDRAISERS REPORTED ON SCHEDULE G IS REPORTED ON A FISCAL YEAR BASIS. SOME OF THOSE SAME FUNDRAISERS ARE REPORTED ON THE FOUNDATION'S TOP 5 HIGHEST PAID INDEPENDENT CONTRACTORS LIST (IN SCHEDULE O). IN COMPLIANCE WITH THE INSTRUCTIONS TO THE FORM 990, COMPENSATION REPORTED FOR PART VII (AND LISTED IN SCHEDULE O) IS REPORTED ON A CALENDAR YEAR BASIS. ACCORDINGLY, AMOUNTS ON PART VII AND SCHEDULE G WILL NOT RECONCILE.
Schedule G (Form 990 or 990-EZ) 2019
Additional Data


Software ID:  
Software Version:  

Note: To capture the full content of this document, please select landscape mode (11" x 8.5") when printing.

Schedule I
(Form 990)
Department of the Treasury
Internal Revenue Service
Grants and Other Assistance to Organizations,
Governments and Individuals in the United States
Complete if the organization answered "Yes," on Form 990, Part IV, line 21 or 22.
lBullet Attach to Form 990.
lBullet Go to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2019
Open to Public
Inspection
Name of the organization
THE FOUNDATION FOR AIDS RESEARCH
 
Employer identification number
13-3163817
Part I
General Information on Grants and Assistance
1
Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ........................
2
Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.
Part II
Grants and Other Assistance to Domestic Organizations and Domestic Governments. Complete if the organization answered "Yes" on Form 990, Part IV, line 21, for any recipient
that received more than $5,000. Part II can be duplicated if additional space is needed.
(a) Name and address of organization
or government		 (b) EIN (c) IRC section
(if applicable)		 (d) Amount of cash grant (e) Amount of non-cash
assistance		 (f) Method of valuation
(book, FMV, appraisal,
other)		 (g) Description of
noncash assistance		 (h) Purpose of grant
or assistance
(1) Boston Medical Center
One Boston Medical Ctr PL
Boston,MA02118 		04-3314093 501(c)(3) 6,250 0     BASIC RESEARCH
(2) Regents of the University of California San Franc
3333 California St
San Francisco,CA94143 		94-6036493 501(c)(3) 6,482 0     BASIC RESEARCH
(3) University of Washington
4333 Brooklyn Ave
Seattle,WA981959472 		91-6001537 501(c)(3) 7,500 0     BASIC RESEARCH
(4) Regents of the University of California San Franc
3333 California St
San Francisco,CA94143 		94-6036493 501(c)(3) 17,142 0     BASIC RESEARCH
(5) The Rockefeller University
1230 York Avenue
New York,NY10065 		13-1624158 501(c)(3) 17,856 0     BASIC RESEARCH
(6) The J David Gladstone Institutes
1650 Owens Street
San Francisco,CA94158 		23-7203666 501(c)(3) 31,250 0     BASIC RESEARCH
(7) University of California San Diego
9500 Gilman Drive
San Diego,CA920930679 		95-6006144 501(c)(3) 33,334 0     BASIC RESEARCH
(8) Case Western Reserve University
10900 Euclid Ave 4930
Cleveland,OH44106 		34-1018992 501(c)(3) 33,334 0     BASIC RESEARCH
(9) Case Western Reserve University
10900 Euclid Ave 4930
Cleveland,OH44106 		34-1018992 501(c)(3) 33,334 0     BASIC RESEARCH
(10) Emory University
1599 Clifton Rd
Atlanta,GA303224250 		58-0566256 501(c)(3) 33,334 0     BASIC RESEARCH
(11) Emory University
1599 Clifton Road
Atlanta,GA303224250 		58-0566256 501(c)(3) 33,334 0     BASIC RESEARCH
(12) Johns Hopkins University
733 N Brdwy MRB 117
Baltimore,MD21205 		52-0595110 501(c)(3) 33,334 0     BASIC RESEARCH
(13) State University of New York at Buffalo
520 Le Entrance Ste 211
Amherst,NY14228 		14-1368361 501(c)(3) 33,334 0     BASIC RESEARCH
(14) Foundation for the National Institutes of Health
9650 Rockville Pike
Bethesda,MD208143999 		52-1986675 501(c)(3) 53,332 0     BASIC RESEARCH
(15) Johns Hopkins University
733 N Brdwy MRB 117
Baltimore,MD21205 		52-0595110 501(c)(3) 66,482 0     BASIC RESEARCH
(16) Yale University
266 Whitney Ave
New Haven,CT06511 		06-0646973 501(c)(3) 66,666 0     BASIC RESEARCH
(17) University of Massachusetts Medical School
373 Plantation St
Worcester,MA016052377 		04-3167352 501(c)(3) 66,666 0     BASIC RESEARCH
(18) University of Washington
4333 Brooklyn Ave
Seattle,WA981959472 		91-6001537 501(c)(3) 66,667 0     BASIC RESEARCH
(19) Swarthmore College
500 College Avenue
Swarthmore,PA19081 		23-1352683 501(c)(3) 66,667 0     BASIC RESEARCH
(20) The J David Gladstone Institutes
1650 Owens Street
San Francisco,CA94158 		23-7203666 501(c)(3) 75,000 0     BASIC RESEARCH
(21) Emory University
1599 Clifton Rd
Atlanta,GA303224250 		58-0566256 501(c)(3) 75,000 0     BASIC RESEARCH
(22) The Scripps Research Institute
130 Scripps Way
La Jolla,CA33458 		33-0435954 501(c)(3) 75,000 0     BASIC RESEARCH
(23) The George Washington University
2121 I St NW Ste 601
Washington,DC20052 		53-0196584 501(c)(3) 91,664 0     BASIC RESEARCH
(24) International AIDS Vaccine Initiative
125 Broad St 9th Fl
New York,NY10004 		13-3870223 501(c)(3) 99,682 0     BASIC RESEARCH
(25) Oregon Health and Science University
3181 SW Sam Jackson Park
Portland,OR97239 		93-1176109 501(c)(3) 99,972 0     BASIC RESEARCH
(26) University of Maryland at Baltimore
725 Lombard St S615
Baltimore,MD21201 		52-6002033 501(c)(3) 99,998 0     BASIC RESEARCH
(27) Mayo Clinic College of Medicine
200 First Street SW
Rochester,MN55905 		41-6011702 501(c)(3) 99,999 0     BASIC RESEARCH
(28) University of California San Francisco
3333 California St
San Francisco,CA94143 		94-6036493 501(c)(3) 100,000 0     BASIC RESEARCH
(29) Boston University School of Medicine
650 Albany St EBRC 640
Boston,MA02118 		04-3314093 501(c)(3) 100,000 0     BASIC RESEARCH
(30) Fred Hutchinson Cancer Research Center
1100 Fairview Ave N
Seattle,WA98109 		23-7156071 501(c)(3) 100,000 0     BASIC RESEARCH
(31) Fred Hutchinson Cancer Research Center
1100 Fairview Ave N
Seattle,WA98109 		23-7156071 501(c)(3) 100,000 0     BASIC RESEARCH
(32) University of Washington
4333 Brooklyn Ave
Seattle,WA981959472 		91-6001537 501(c)(3) 299,966 0     BASIC RESEARCH
(33) University of California Los Angeles
11000 Kinross Ave
Los Angeles,CA90095 		95-6006143 501(c)(3) 300,000 0     BASIC RESEARCH
(34) Trustees of the University of Pennsylvania
3451 Walnut St
Philadelphia,PA191046250 		23-1352685 501(c)(3) 300,000 0     BASIC RESEARCH
(35) Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston,MA02215 		04-2103881 501(c)(3) 497,990 0     BASIC RESEARCH
(36) Regents of the University of California San Franc
3333 California St
San Francisco,CA94143 		94-6036493 501(c)(3) 499,956 0     BASIC RESEARCH
(37) Johns Hopkins University
733 N Brdwy MRB 117
Baltimore,MD21205 		52-0595110 501(c)(3) 136,345 0     GMT INITIATIVE
(38) University of Washington
4333 Brooklyn Ave
Seattle,WA981959472 		91-6001537 501(c)(3) 59,169 0     RESEARCH
(39) Johns Hopkins University
733 N Brdway MRB 117
Baltimore,MD21205 		52-0595110 501(c)(3) 165,364 0     RESEARCH
(40) Harvard University
29 Oxford Street
Cambridge,MA02138 		04-2103580 501(c)(3) 207,724 0     RESEARCH
(41) University of California San Francisco
3333 California St
San Francisco,CA94143 		94-6036493 501(c)(3) 3,777,555 0     RESEARCH
(42) Johns Hopkins University
733 N BdRwy MRB 117
Baltimore,MD21205 		52-0595110 501(c)(3) 155,864 0     TREAT ASIA
2
Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................. Bullet Image
42
3
Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image
 
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50055P
Schedule I (Form 990) 2019

Schedule I (Form 990) 2019
Page 2
Part III
Grants and Other Assistance to Domestic Individuals. Complete if the organization answered "Yes" on Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance (b) Number of
recipients		 (c) Amount of
cash grant		 (d) Amount of
noncash assistance		 (e) Method of valuation (book,
FMV, appraisal, other)		 (f) Description of noncash assistance
(1)
(2)
(3)
(4)
(5)
(6)
(7)
Part IV
Supplemental Information. Provide the information required in Part I, line 2; Part III, column (b); and any other additional information.
Return Reference Explanation
GRANTS AND ASSISTANCE PART I, LINE 2 AMFAR PROVIDES GRANTS AND FELLOWSHIPS TO INDEPENDENT NOT-FOR-PROFIT ORGANIZATIONS THROUGH A PEER-REVIEW PROCESS. GRANT APPLICATIONS ARE FIRST REVIEWED BY THE FOUNDATION'S VOLUNTEER SCIENTIFIC ADVISORY COMMITTEE, WHICH COMPRISES RECOGNIZED EXPERTS IN THE MEDICAL, SCIENTIFIC, AND SOCIAL SCIENCES DISCIPLINES RELEVANT TO HIV AND AIDS. THE SCIENTIFIC ADVISORY COMMITTEE THEN SENDS ITS EVALUATIONS TO ONE OF THE THREE COMMITTEES (RESEARCH, GLOBAL INITIATIVES OR PUBLIC POLICY) OF THE FOUNDATION'S PROGRAM BOARD, WHICH SERVES IN AN ADVISORY CAPACITY TO THE BOARD OF TRUSTEES. AFTER A PROGRAM COMMITTEE HAS COMPLETED ITS REVIEW OF THE APPLICATIONS, IT PRESENTS ITS FUNDING RECOMMENDATIONS TO AMFAR'S EXECUTIVE COMMITTEE AND/OR THE FULL BOARD OF TRUSTEES FOR FINAL APPROVAL AND FUNDING AUTHORIZATION. GRANTS AND FELLOWSHIPS ARE PAYABLE OVER A ONE-TO-THREE-YEAR PERIOD, AND ARE REVOCABLE AT AMFAR'S OPTION IF THE RECIPIENT'S PERFORMANCE OR USE OF FUNDS IS NOT CONSISTENT WITH THE TERMS OF THE GRANT OR FELLOWSHIPS. IN CERTAIN CASES, THE ACTUAL AMOUNTS PAID UNDER GRANTS AND FELLOWSHIP AWARDS MAY BE LESS THAN THE ORIGINAL AWARD IF THE RECIPIENT DOES NOT USE THE FULL AMOUNT AWARDED. THEREFORE, A RESERVE FOR UNEXPENDED GRANTS AND FELLOWSHIPS HAS BEEN RECORDED. SUBAWARDS ARE GRANTS AWARDED TO NOT-FOR-PROFIT ORGANIZATIONS TO SUPPORT THE COSTS OF COLLABORATION AND PARTICIPATION IN HIV/AIDS-RELATED RESEARCH PROJECTS FOR WHICH AMFAR HAS SECURED RESTRICTED FUNDS. SUBAWARDS ARE PAYABLE OVER A ONE-YEAR PERIOD, ALTHOUGH ADVANCE PAYMENTS, IN FULL OR IN PART, MAY BE ISSUED FOLLOWING EXECUTION OF THE SUBAWARD AGREEMENT. SUBAWARDS ARE CONTINGENT UPON THE AVAILABILITY OF FUNDS AND ARE REVOCABLE IF THE RECIPIENTS' PERFORMANCE OR USE OF FUNDS IS NOT CONSISTENT WITH THE SUBAWARD TERMS.
Schedule I (Form 990) 2019



Additional Data


Software ID:  
Software Version:  


Schedule J
(Form 990)
Department of the Treasury
Internal Revenue Service
Compensation Information
For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet Complete if the organization answered "Yes" on Form 990, Part IV, line 23.
SchJMediumBullet Attach to Form 990.
SchJMediumBullet Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2019
Open to Public Inspection
Name of the organization
THE FOUNDATION FOR AIDS RESEARCH
 
Employer identification number

13-3163817
Part I
Questions Regarding Compensation
Yes
No
1a
Check the appropiate box(es) if the organization provided any of the following to or for a person listed on Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.
b
If any of the boxes on Line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain .........
1b
 
 
2
Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked on Line 1a? ..
2
 
 
3
Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.
4
During the year, did any person listed on Form 990, Part VII, Section A, line 1a, with respect to the filing organization or a related organization:
a
Receive a severance payment or change-of-control payment? .............
4a
 
No
b
Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........
4b
Yes
 
c
Participate in, or receive payment from, an equity-based compensation arrangement? .........
4c
 
No
If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.
Only 501(c)(3), 501(c)(4), and 501(c)(29) organizations must complete lines 5-9.
5
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:
a
The organization? ....................
5a
 
No
b
Any related organization? .......................
5b
 
No
If "Yes," on line 5a or 5b, describe in Part III.
6
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:
a
The organization? ..................
6a
 
No
b
Any related organization? ......................
6b
 
No
If "Yes," on line 6a or 6b, describe in Part III.
7
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization provide any nonfixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............
7
 
No
8
Were any amounts reported on Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III ..........................
8
 
No
9
If "Yes" on line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................
9
 
 
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50053T
Schedule J (Form 990) 2019

Schedule J (Form 990) 2019
Page 2
Part II
Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.
For each individual whose compensation must be reported on Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.
(A) Name and Title (B) Breakdown of W-2 and/or 1099-MISC compensation (C) Retirement and other deferred compensation (D) Nontaxable
benefits		 (E) Total of columns
(B)(i)-(D) 		(F) Compensation in column (B) reported as deferred on prior Form 990
(i) Base
compensation 		(ii) Bonus & incentive
compensation 		(iii) Other reportable compensation
1Kevin Frost
Chief Executive Officer 		(i)

(ii)		 421,066
-------------
0 		0
-------------
0 		37,529
-------------
0 		36,900
-------------
0 		67,128
-------------
0 		562,623
-------------
0 		0
-------------
0
2Bradley Jensen
Assistant Treasurer, CFO 		(i)

(ii)		 276,038
-------------
0 		0
-------------
0 		0
-------------
0 		18,378
-------------
0 		51,715
-------------
0 		346,131
-------------
0 		0
-------------
0
3Rowena Johnston
ASST SEC, VP, RESEARCH 		(i)

(ii)		 203,095
-------------
0 		0
-------------
0 		0
-------------
0 		14,279
-------------
0 		16,840
-------------
0 		234,214
-------------
0 		0
-------------
0
4Edward Donnelly
Asst Treasurer, Controller 		(i)

(ii)		 163,157
-------------
0 		0
-------------
0 		0
-------------
0 		11,861
-------------
0 		15,430
-------------
0 		190,448
-------------
0 		0
-------------
0
5Eric Muscatell
Vice President of Development 		(i)

(ii)		 218,403
-------------
0 		0
-------------
0 		0
-------------
0 		15,987
-------------
0 		16,840
-------------
0 		251,230
-------------
0 		0
-------------
0
6Annette Sohn
Vice President, TREAT Asia PGM 		(i)

(ii)		 235,334
-------------
0 		0
-------------
0 		0
-------------
0 		16,969
-------------
0 		7,172
-------------
0 		259,475
-------------
0 		0
-------------
0
7AnnMarie Shannahan
Vice President, Public Info. 		(i)

(ii)		 234,029
-------------
0 		0
-------------
0 		0
-------------
0 		16,474
-------------
0 		16,840
-------------
0 		267,343
-------------
0 		0
-------------
0
8Gregorio Millet
Vice President, Public Policy 		(i)

(ii)		 188,800
-------------
0 		0
-------------
0 		0
-------------
0 		13,767
-------------
0 		31,524
-------------
0 		234,091
-------------
0 		0
-------------
0
9Andrew McInness
Director, Publications 		(i)

(ii)		 166,993
-------------
0 		0
-------------
0 		0
-------------
0 		12,016
-------------
0 		51,715
-------------
0 		230,724
-------------
0 		0
-------------
0
10Anthony Ancona
Vice President, Human Resource 		(i)

(ii)		 189,243
-------------
0 		0
-------------
0 		0
-------------
0 		30,144
-------------
0 		17,420
-------------
0 		236,807
-------------
0 		0
-------------
0
11Susan Doster
Chief Technology Officer 		(i)

(ii)		 149,646
-------------
0 		0
-------------
0 		0
-------------
0 		10,967
-------------
0 		39,948
-------------
0 		200,561
-------------
0 		0
-------------
0
12Bennah Serfaty
Sr Director of Communications 		(i)

(ii)		 132,347
-------------
0 		0
-------------
0 		0
-------------
0 		9,551
-------------
0 		51,715
-------------
0 		193,613
-------------
0 		0
-------------
0
13JONATHAN KEY
DIRECTOR, PHILANTHROPY 		(i)

(ii)		 190,220
-------------
0 		0
-------------
0 		0
-------------
0 		13,764
-------------
0 		39,948
-------------
0 		243,932
-------------
0 		0
-------------
0
14John F Logan JD PhD
AssT. Sec., Vp & GEN COUNSEL 		(i)

(ii)		 109,139
-------------
0 		0
-------------
0 		0
-------------
0 		7,637
-------------
0 		6,871
-------------
0 		123,647
-------------
0 		0
-------------
0
Schedule J (Form 990) 2019

Schedule J (Form 990) 2019
Page 3
Part III
Supplemental Information
Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II. Also complete this part for any additional information.
Return Reference Explanation
COMPENSATION PART I, LINE 4 CHIEF EXECUTIVE OFFICER, KEVIN FROST, PARTICIPATED IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN. IN CALENDAR YEAR 2017, AMFAR CONTRIBUTED $35,000 INTO MR. FROST'S NON-QUALIFIED RETIREMENT PLAN. THIS AMOUNT IS NOT REPORTED IN SCHEDULE J, PART II, COLUMN (C) BECAUSE THE CONTRIBUTED AMOUNT WAS DISTRIBUTED TO MR. FROST WITHIN THE SAME CALENDAR YEAR. INCLUDED IN SCHEDULE J COLUMN (B)(III) IS MR. FROST'S 2017 EMPLOYER-FUNDED 457(F) CONTRIBUTION OF $35,000.
Schedule J (Form 990) 2019

Additional Data


Software ID:  
Software Version:  
SCHEDULE M
(Form 990)

Department of the Treasury
Internal Revenue Service
Noncash Contributions
Right pointing arrow large imageComplete if the organizations answered "Yes" on Form 990, Part IV, lines 29 or 30.
Right pointing arrow large image Attach to Form 990.
Right pointing arrow large imageGo to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2019
Open to Public Inspection
Name of the organization
THE FOUNDATION FOR AIDS RESEARCH
 
Employer identification number

13-3163817
Part I
Types of Property
(a)
Check if applicable 		(b)
Number of contributions or items contributed 		(c)
Noncash contribution amounts reported on
Form 990, Part VIII, line 1g 		(d)
Method of determining
noncash contribution amounts
1 Art—Works of art ....        
2 Art—Historical treasures .        
3 Art—Fractional interests ..        
4 Books and publications ..      
5 Clothing and household
goods ....... 		     
6 Cars and other vehicles ..        
7 Boats and planes ....        
8 Intellectual property ...        
9 Securities—Publicly traded . X 9 28,210 sales price
10 Securities—Closely held stock .        
11 Securities—Partnership, LLC,
or trust interests .... 		       
12 Securities—Miscellaneous ..        
13 Qualified conservation
contribution—Historic
structures ..... 		       
14 Qualified conservation
contribution—Other ... 		       
15 Real estate—Residential .        
16 Real estate—Commercial ..        
17 Real estate—Other ...        
18 Collectibles .....        
19 Food inventory ...        
20 Drugs and medical supplies .        
21 Taxidermy ......        
22 Historical artifacts ....        
23 Scientific specimens ..        
24 Archeological artifacts ...        
25 Other Right pointing arrow large image ( Travel Vouchers ) X 47 19,515 sale price
26 Other Right pointing arrow large image ( )
27 Other Right pointing arrow large image ( )
28 Other Right pointing arrow large image ( )
29
Number of Forms 8283 received by the organization during the tax year for contributions
for which the organization completed Form 8283, Part IV, Donee Acknowledgement
29
 
Yes
No
30a
During the year, did the organization receive by contribution any property reported in Part I, lines 1 through 28, that it must hold for at least three years from the date of the initial contribution, and which isn't required to be used for exempt purposes for the entire holding period? ...................
30a
 
No
b
If "Yes," describe the arrangement in Part II.
31
Does the organization have a gift acceptance policy that requires the review of any nonstandard contributions?
31
Yes
 
32a
Does the organization hire or use third parties or related organizations to solicit, process, or sell noncash
contributions? ..........................
32a
 
No
b
If "Yes," describe in Part II.
33
If the organization didn't report an amount in column (c) for a type of property for which column (a) is checked,
describe in Part II.
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 51227J
Schedule M (Form 990) (2019)
Schedule M (Form 990) (2019)
Page 2
Part IISupplemental Information. Provide the information required by Part I, lines 30b, 32b, and 33, and whether the organization is reporting in Part I, column (b), the number of contributions, the number of items received, or a combination of both. Also complete this part for any additional information.
Return Reference Explanation
FORM 990, SCHEDULE M, LINE 31 TO THE EXTENT THAT AMFAR RECEIVES NON-STANDARD CONTRIBUTIONS, THE ORGANIZATION'S POLICY IS TO LIQUIDATE THOSE ITEMS INTO CASH FOR EVENTUAL USE IN SUPPORT OF THE ORGANIZATION'S MISSION.
Schedule M (Form 990) (2019)

Additional Data


Software ID:  
Software Version:  
SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service
Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or 990-EZ or to provide any additional information.
MediumBullet Attach to Form 990 or 990-EZ.
MediumBullet Go to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2019
Open to Public
Inspection
Name of the organization
THE FOUNDATION FOR AIDS RESEARCH
 
Employer identification number

13-3163817
Return Reference Explanation
PROGRAM SERVICE ACCOMPLISHMENTS (1) LINE 4A: RESEARCH: AMFAR SUPPORTS RESEARCH PROJECTS THAT EXPLORE NOVEL APPROACHES TO SCIENTIFICALLY SOUND BUT UNTESTED HYPOTHESES IN ALL AREAS OF RESEARCH ON HIV/AIDS, FUNDING GOAL-ORIENTED STUDIES THAT OFTEN LACK THE PRELIMINARY DATA REQUIRED FOR SUPPORT FROM TRADITIONAL GRANT MAKERS. THE FOUNDATION PLAYS A VITAL ROLE IN HIV/AIDS RESEARCH, IDENTIFYING CRITICAL GAPS IN KNOWLEDGE AND PROVIDING ESSENTIAL SEED MONEY THAT ENABLES GRANTEES AND FELLOWS TO TEST THE MERITS OF NEW CONCEPTS OR TECHNOLOGIES THAT SUBSEQUENTLY CAN BE VALIDATED THROUGH LARGE-SCALE STUDIES, SUCH AS THOSE FUNDED BY THE U.S. NATIONAL INSTITUTES OF HEALTH. AMFAR FELLOWSHIPS ALLOW TALENTED YOUNG RESEARCHERS TO CONDUCT ORIGINAL INVESTIGATIONS UNDER THE GUIDANCE OF EXPERIENCED SCIENTISTS, HELPING TO ENSURE THE LONG-TERM VITALITY OF AIDS RESEARCH. NEW GRANTS AND FELLOWSHIPS GRANTS AND FELLOWSHIPS ARE AWARDED THROUGH A RIGOROUS PROCESS OF PEER REVIEW BY A TEAM OF INDEPENDENT HIV/AIDS EXPERTS DRAWN LARGELY FROM THE VOLUNTEER SCIENTISTS ON AMFARS SCIENTIFIC ADVISORY COMMITTEE. GUIDED BY ITS SCIENTIFIC ADVISORS AND WITH THE APPROVAL OF ITS BOARD OF TRUSTEES, AMFAR PURSUES A STRATEGIC RESEARCH PLAN THAT FOCUSES ON THE PURSUIT OF A CURE FOR HIV. COUNTDOWN TO A CURE FOR AIDS IN 2015, AMFAR ANNOUNCED A $100 MILLION INVESTMENT STRATEGY TO SUPPORT ITS COUNTDOWN TO A CURE FOR AIDS INITIATIVE, WHICH IS AIMED AT DEVELOPING THE SCIENTIFIC BASIS FOR A CURE BY THE END OF 2020. THE STRATEGY REPRESENTS AN UNPRECEDENTED EXPANSION OF AMFARS GRANT MAKING AND IS DESIGNED TO PROVIDE SUPPORT TO ANY SCIENTIST OR TEAM OF INVESTIGATORS FOR ANY RESEARCH IDEA WITH THE POTENTIAL TO ADVANCE THE SEARCH FOR A CURE, AT ANY STAGE OF ITS DEVELOPMENT. IT IS STRUCTURED TO PROVIDE SUSTAINED SUPPORT FOR A WIDE RANGE OF STUDIES THAT ADVANCE BOTH EMERGING AND ESTABLISHED IDEAS. THE STRATEGY COMPRISES THE FOLLOWING COMPONENTS: - AMFAR INSTITUTE FOR HIV CURE RESEARCH ESTABLISHED IN 2015 WITH A $20 MILLION GRANT OVER FIVE YEARS TO THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE INSTITUTE IS THE CORNERSTONE OF AMFARS CURE RESEARCH. - INNOVATION GRANTS THESE TWO-YEAR AWARDS OF UP TO $200,000 EACH ENABLE RESEARCHERS TO TEST INNOVATIVE IDEAS SUPPORTED BY LIMITED PRELIMINARY DATA. - IMPACT GRANTS THESE GRANTS OF UP TO $2 MILLION EACH OVER FOUR YEARS SUPPORT THE IN-DEPTH DEVELOPMENT OF CONCEPTS ALREADY UNDERPINNED BY PRELIMINARY DATA SHOWING GENUINE POTENTIAL FOR ACHIEVING A CURE. - INVESTMENT GRANTS AIMED AT RECRUITING THE EXPERIENCE AND EXPERTISE OF SCIENTISTS FROM OUTSIDE THE FIELD OF HIV, THESE $1 MILLION GRANTS ARE AWARDED OVER A FOUR-YEAR PERIOD. GRANTEES MAY HAVE EXPERTISE IN FIELDS SUCH AS CANCER, NEUROSCIENCE, OR INFLAMMATORY DISEASE THAT CAN DIRECTLY INFORM EFFORTS TO CURE HIV. - ARCHE LAUNCHED IN 2010, THE AMFAR RESEARCH CONSORTIUM ON HIV ERADICATION, OR ARCHE, SUPPORTS COLLABORATIVE TEAMS OF SCIENTISTS IN THE U.S. AND AROUND THE WORLD WORKING ON A RANGE OF HIV CURE STRATEGIES. - OPPORTUNITY FUND THIS FUNDING MECHANISM ENABLES AMFAR TO RESPOND QUICKLY TO EMERGING AND UNFORESEEN RESEARCH OPPORTUNITIES. SINCE LAUNCHING THE COUNTDOWN IN 2014, WE HAVE AWARDED 73 COUNTDOWN GRANTS TOTALING MORE THAN $47 MILLION TO SUPPORT RESEARCH CONDUCTED BY 274 SCIENTISTS WORKING AT 92 INSTITUTIONS IN 16 COUNTRIES. INVESTMENT GRANTS IN FEBRUARY 2018, AMFAR ANNOUNCED A PAIR OF RESEARCH GRANTS THAT RENEW ITS SUPPORT FOR INNOVATIVE APPROACHES TO HIV CURE RESEARCH. TOTALING NEARLY $1 MILLION, THE INVESTMENT GRANTS ARE ALLOWING TWO COLLABORATIVE TEAMS OF HIV RESEARCHERS AND BIOENGINEERS TO CONTINUE PROJECTS INITIATED WITH AMFAR FUNDING AWARDED IN FEBRUARY 2017 INTO A SECOND PHASE. IN THE FIRST PHASE OF THEIR STUDY, ONE PAIR OF RESEARCHERS-DRS. HUI ZHANG AND WEIMING YANG OF JOHNS HOPKINS UNIVERSITY IN BALTIMORE-USED MASS SPECTROMETRY TO IDENTIFY MOLECULES ON THE SURFACE OF CELLS THAT DIFFERENTIATE LATENT RESERVOIRS FROM UNINFECTED CELLS. IN PHASE II, THEY ARE DETERMINING WHETHER THESE NEWLY IDENTIFIED PROTEINS ARE ABLE TO DISTINGUISH THE RESERVOIR IN PATIENT SAMPLES. IN PHASE I OF THEIR PROJECT, THE OTHER PAIR-DRS. KIM WOODROW AND KEITH JEROME OF THE UNIVERSITY OF WASHINGTON IN SEATTLE-FORMULATED NEW DRUG COMBINATIONS LOADED ONTO NANOPARTICLES (HIGHLY MALLEABLE CARRIERS THAT ARE A THOUSAND TIMES SMALLER THAN A CELL) TARGETING THE LATENT HIV RESERVOIR. THE NANOPARTICLES PREFERENTIALLY DELIVERED LATENCY REVERSING AGENTS TO CD4 T CELLS, WHICH REAWAKENED THE RESERVOIR, A PREREQUISITE FOR IMMUNE DIRECTED KILLING OF THE CELL IN A "SHOCK AND KILL" APPROACH TO CURING HIV. IN PHASE II, THE RESEARCHERS ARE TESTING THE LOADED NANOPARTICLES AND MEASURING THEIR EFFECTS ON THE RESERVOIR IN A PRECLINICAL STUDY. IMPACT GRANTS IN SEPTEMBER 2018, AMFAR AWARDED GRANTS TOTALING $828,000 TO ADVANCE TWO CRITICAL AREAS OF HIV CURE RESEARCH. FIVE GRANTS WILL ARE SUPPORTING A RANGE OF EFFORTS TO UNDERSTAND THE MECHANISMS AND PREDICTORS OF POST-TREATMENT CONTROL, WHEREBY A SMALL NUMBER OF INDIVIDUALS ARE ABLE TO CONTROL THEIR HIV AFTER STOPPING TREATMENT. THREE ADDITIONAL GRANTEES ARE STUDYING HIV-POSITIVE POPULATIONS IN LOW-AND MIDDLE-INCOME COUNTRIES TO LOOK FOR DIFFERENCES IN HOW THE PERSISTENT VIRAL RESERVOIR-THE PRINCIPAL BARRIER TO A CURE-FORMS AND CHANGES OVER TIME. IN A COHORT OF POST-TREATMENT CONTROLLERS FROM ONE OF THE LARGEST HIV CLINICAL TRIAL NETWORKS IN THE WORLD, DR. JONATHAN LI OF BRIGHAM AND WOMEN'S HOSPITAL IN BOSTON IS USING NEXT-GENERATION GENOMIC SEQUENCING TO INVESTIGATE WHETHER CHARACTERISTICS OF THE VIRUS OR IMMUNOLOGIC RESPONSES CAN PREDICT POST-TREATMENT CONTROL. ANOTHER GRANTEE, DR. GODWIN NCHINDA, A RESEARCHER IN YAOUNDE, CAMEROON, HAS IDENTIFIED A COHORT OF WOMEN WHO RECEIVED ANTIRETROVIRAL THERAPY (ART) DURING PREGNANCY AND CONTINUE TO CONTROL THEIR VIRUS DESPITE DISCONTINUING TREATMENT AFTER GIVING BIRTH. HE IS STUDYING THIS GROUP TO DETERMINE THE CAUSES OF THEIR VIRAL CONTROL. THE MAJORITY OF WHAT IS KNOWN ABOUT HIV COMES FROM RESEARCH DONE IN HIGH-INCOME COUNTRIES, WHERE HIV SUBTYPE B PREDOMINATES. HOWEVER, SUBTYPE B ACCOUNTS FOR JUST 12% OF GLOBAL HIV INFECTIONS. DR. EDWARD KANKAKA OF THE RAKAI HEALTH SCIENCES PROGRAM IN KAMPALA, UGANDA, HAS SHOWN THAT NON-B HIV-POSITIVE UGANDANS HAD A SMALLER RESERVOIR OF PERSISTENT VIRUS COMPARED TO PEOPLE INFECTED WITH SUBTYPE B. DR. KANKAKA IS EXPANDING THESE STUDIES TO DETERMINE WHETHER FORMATION AND MAINTENANCE OF THE RESERVOIR DIFFER IN THESE POPULATIONS. IN DURBAN, SOUTH AFRICA, DR. ALEX SIGAL IS EXAMINING THE INFLUENCE OF TUBERCULOSIS-A COMMON CO-INFECTION IN LOW- AND MIDDLE-INCOME COUNTRIES-ON THE HIV RESERVOIR. HE IS EXPLORING WHETHER THE IMMUNE RESPONSE TO TB ITSELF ALTERS HIV REACTIVATION-A KEY COMPONENT OF THE "SHOCK AND KILL" APPROACH TO CURING HIV. THE REMAINING GRANTEES ARE DR. MOHAMED ABDEL-MOHSEN OF THE WISTAR INSTITUTE, PHILADELPHIA, PA; DR. JOHN FRATER OF OXFORD UNIVERSITY, UK; DR. REENA RAJASURIAR OF THE UNIVERSITY OF MALAYA, KUALA LUMPUR, MALAYSIA; AND DR. RUI WANG OF HARVARD PILGRIM HEALTHCARE INSTITUTE, WELLESLEY, MA. ARCHE (AMFAR RESEARCH CONSORTIUM ON HIV ERADICATION) IN SEPTEMBER 2018, AMFAR AWARDED $800,000 IN NEW FUNDING TO SIX TEAMS OF RESEARCHERS DEVELOPING AN AMBITIOUS GENE THERAPY-BASED APPROACH TO CURING HIV. THE AWARD LAUNCHES A CRITICAL NEW PHASE IN A STUDY INITIATED IN 2017. IN A THREE-PRONGED ATTACK ON THE HIV RESERVOIR, THE RESEARCHERS WILL EMPLOY BROADLY NEUTRALIZING ANTIBODIES, CAR STEM CELLS-CELLS GENETICALLY REPROGRAMMED TO RECOGNIZE AND ATTACK DISEASE CELLS-AND MOLECULAR SCISSORS TARGETING THE VIRUS. THE GRANT WAS SUPPORTED IN PART BY THE BILL AND MELINDA GATES FOUNDATION. THE INVESTIGATORS ARE: DR. HILDEGARD BUNING OF HANNOVER MEDICAL SCHOOL, GERMANY; DR. KEITH JEROME OF THE UNIVERSITY OF WASHINGTON, SEATTLE; DR. HANS-PETER KIEM OF FRED HUTCHINSON CANCER RESEARCH CENTER, SEATTLE; DR. SCOTT KITCHEN OF UCLA; DR. YASUHIRO TAKEUCHI OF UNIVERSITY COLLEGE LONDON; DR. DREW WEISSMAN OF UNIVERSITY OF PENNSYLVANIA IN PHILADELPHIA; AND DR. RICHARD WYATT OF THE SCRIPPS RESEARCH INSTITUTE IN LA JOLLA, CA. MATHILDE KRIM FELLOWSHIPS IN OCTOBER 2017, AMFAR ANNOUNCED THE RECIPIENTS OF THE 2017 MATHILDE KRIM FELLOWSHIPS IN BASIC BIOMEDICAL RESEARCH: DANIELA MONACO, PH.D., AT EMORY UNIVERSITY IN ATLANTA, GA; GABRIEL OZOROWSKI, PH.D., AT THE SCRIPPS RESEARCH INSTITUTE IN SAN DIEGO, CA; AND JONATHAN RICHARD, PH.D., AT THE UNIVERSIT DE MONTREAL, CENTRE DE RECHERCHE DU CHUM IN MONTREAL, CANADA. THE 2018 KRIM FELLOW, DR. YEN-TING LAI OF THE VACCINE RESEARCH CENTER/NATIONAL INSTITUTES OF HEALTH IN BETHESDA, MD, WAS ANNOUNCED IN SEPTEMBER 2018. THE KRIM FELLOWSHIPS SUPPORT BRIGHT YOUNG SCIENTISTS ADVANCING INNOVATIVE SOLUTIONS TO HIV/AIDS. EACH FELLOW IS AWARDED APPROXIMATELY $150,000 OVER TWO YEARS.
PROGRAM SERVICE ACCOMPLISHMENTS (1) CONT. PUBLISHED RESEARCH RESEARCH STUDIES MAKE THE GREATEST IMPACT ON THE HIV FIELD AND ON THE BROADER SCIENTIFIC COMMUNITY WHEN THEY ARE PUBLISHED IN SCIENTIFIC JOURNALS. IN FY2018, A RECORD 80 SCIENTIFIC PUBLICATIONS RESULTED FROM AMFAR-FUNDED RESEARCH. EXAMPLES INCLUDE: LEARNING HOW ANTIBODIES CAN CURE HIV KILLING HIV RESERVOIR CELLS WOULD POTENTIALLY ERADICATE HIV FROM THE BODY. IN THREE JOURNAL ARTICLES PUBLISHED IN DECEMBER 2017, AMFAR-FUNDED SCIENTISTS DISCUSSED RECENT ADVANCES IN UNDERSTANDING HOW IMMUNE SYSTEM CELLS USE ANTIBODIES TO KILL HIV-INFECTED CELLS VIA ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC). ADCC IS AN IMMUNE RESPONSE IN WHICH ANTIBODIES ACT AS HOMING DEVICES TO RECRUIT IMMUNE CELLS THAT TARGET AND KILL INFECTED CELLS. IN A STUDY PUBLISHED IN THE JOURNAL RETROVIROLOGY, DRS. AMY CHUNG OF THE UNIVERSITY OF MELBOURNE, AUSTRALIA, AND GALIT ALTER OF THE RAGON INSTITUTE OF MGH, MIT, AND HARVARD UNIVERSITY, WROTE ABOUT A PLATFORM OF TECHNIQUES CALLED SYSTEMS SEROLOGY, WHICH THEY DEVELOPED TO EXPLORE THE FUNCTIONALITY OF ANTIBODIES. DR. CHUNG IS ALSO STUDYING THE MECHANISMS OF INTERACTION BETWEEN VACCINES THAT PRODUCE IGA, A TYPE OF ANTIBODY PRESENT ONLY IN MUCOSAL TISSUES, AND IGG, AN ANTIBODY PRESENT IN THE BLOOD, TO PROVIDE PARTIAL PROTECTION AGAINST HIV. WRITING IN THE JOURNAL EBIOMEDICINE, SHE COMMENTS ON A STUDY CARRIED OUT BY RESEARCHERS AT THE UNIVERSITY OF BUENOS AIRES IN ARGENTINA THAT SUPPORTS HER OBSERVATIONS THAT THE RATIO OF IGG TO IGA CORRELATES WITH THE KILLING ACTION OF ANTIBODIES. AND IN A THIRD STUDY PUBLISHED IN THE JOURNAL VIROLOGY, DR. ANDRES FINZI OF THE CENTRE DE RECHERCHE DU CHUM IN MONTREAL REPORTS ON THE SUSCEPTIBILITY OF THE VIRAL PROTEIN ENV-PRESENT ON THE SURFACE OF ACTIVELY INFECTED CELLS-TO ANTIBODIES. NEW RESEARCH POINTS TO THE POWERFUL EFFECT OF ESTROGEN ON THE HIV RESERVOIR A STUDY LED BY AMFAR-FUNDED SCIENTIST DR. JOHNATHAN KARN OF CASE WESTERN RESERVE UNIVERSITY, PUBLISHED IN THE AUGUST 2018 ISSUE OF THE PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, REVEALS THAT ESTROGEN HAS A SIGNIFICANT EFFECT ON THE PERSISTENT HIV RESERVOIR. FOLLOWING A COHORT OF 26 MEN AND 26 WOMEN, THE RESEARCHERS FOUND THAT WOMEN HAVE A SMALLER "INDUCIBLE" RESERVOIR THAN MEN. IN OTHER WORDS, WHILE THE TOTAL SIZE OF THE RESERVOIR APPEARS TO BE THE SAME FOR BOTH SEXES, WOMEN HAVE A SMALLER AMOUNT OF RESERVOIR VIRUS THAT CAN BE COAXED OUT OF HIDING BY SO-CALLED LATENCY-REVERSING AGENTS. THE FINDING HAS IMPORTANT IMPLICATIONS FOR CURE RESEARCH, SPECIFICALLY THE "SHOCK AND KILL" STRATEGY, WHICH AIMS TO SHOCK HIV OUT OF THE RESERVOIR SO THAT IT CAN BE KILLED BY THE IMMUNE SYSTEM OR SOME OTHER KILLING AGENT. THE STUDY RAISES THE QUESTION OF WHETHER THIS STRATEGY WOULD BE LESS EFFECTIVE IN WOMEN, GIVEN THEIR SMALLER INDUCIBLE RESERVOIR, AND CALLS FOR FURTHER INVESTIGATIONS INTO SEX DIFFERENCES IN LATENCY REVERSAL AND HIV PERSISTENCE. HIV CURE SUMMIT A WIDE RANGE OF PERSPECTIVES-FROM CLINICIANS, BIOMEDICAL RESEARCHERS AND SOCIAL SCIENTISTS TO PATIENTS AND COMMUNITY LEADERS-WERE PRESENTED ON NOVEMBER 28 AT AMFAR'S 2017 WORLD AIDS DAY HIV CURE SUMMIT AT THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (UCSF), HOME TO THE AMFAR INSTITUTE FOR HIV CURE RESEARCH. SCIENTIST AND PHYSICIAN PARTICIPANTS INCLUDED DIRECTOR OF THE AMFAR INSTITUTE DR. PAUL VOLBERDING; INSTITUTE BOARD MEMBERS DRS. STEVEN DEEKS, WARNER GREENE, SATISH PILLAI, PETER HUNT, AND NADIA ROAN; DR. JUDITH AUERBACH OF UCSF; AND AMFAR VICE PRESIDENT OF RESEARCH DR. ROWENA JOHNSTON. COMMUNITY PANELISTS INCLUDED TREATMENT ACTIVISTS AND AMFAR INSTITUTE COMMUNITY ADVISORY BOARD MEMBERS LYNDA DEE, JEFF TAYLOR, LOREN JONES AND ROB NEWELLS. CLARK HAWLEY AND LUIS CANALES SHARED THEIR PERSONAL EXPERIENCES OF PARTICIPATING IN HIV CURE RESEARCH. THE SUMMIT WAS ORGANIZED AROUND A SERIES OF THREE PANEL DISCUSSIONS. THE FIRST TWO, MODERATED BY DR. VOLBERDING, FOCUSED ON SOME OF THE POTENTIALLY CURATIVE AGENTS AND STRATEGIES THAT ARE CURRENTLY BEING DEVELOPED AND TESTED. THE FINAL PANEL, LED BY DR. AUERBACH, SERVED AS A DEBATE OVER THE RELATIVE MERITS OF CURE, I.E., TOTAL ERADICATION OF THE VIRUS, VERSUS POST-TREATMENT CONTROL. HIV RESEARCH SUMMIT IN BRAZIL AMFAR HOSTED ITS SECOND ANNUAL HIV RESEARCH SUMMIT AT THE UNIVERSITY OF SAO PAULO, BRAZIL, ON APRIL 10, 2018. THE CONFERENCE, WHICH DREW MORE THAN 150 COMMUNITY MEMBERS, MEDICAL STUDENTS, HEALTHCARE PROFESSIONALS, AND REPRESENTATIVES FROM SAO PAULO-BASED NONGOVERNMENTAL ORGANIZATIONS, WAS HELD IN CONJUNCTION WITH THE ADVANCED COURSE ON HIV PATHOGENESIS AT THE UNIVERSITYS SCHOOL OF MEDICINE. SPEAKERS INCLUDED DR. ROWENA JOHNSTON, AMFAR VICE PRESIDENT AND DIRECTOR OF RESEARCH; DR. STEVEN DEEKS, PROFESSOR OF MEDICINE, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO; DR. BRAD JONES, ASSISTANT PROFESSOR, THE GEORGE WASHINGTON UNIVERSITY; AND DR. LISHOMWA NDHLOVU, ASSOCIATE PROFESSOR, JOHN A. BURNS SCHOOL OF MEDICINE, UNIVERSITY OF HAWAII. THINK TANKS CONSISTENT WITH AMFARS COMMITMENT TO INVESTIGATE EVERY AVENUE THAT MAY LEAD TO A CURE, THE FOUNDATION REGULARLY HOSTS THINK TANKS THAT BRING TOGETHER LEADING INVESTIGATORS IN VARIOUS FIELDS. IN OCTOBER 2017, AMFAR HOSTED A THINK TANK IN ITS NEW YORK CITY OFFICE WITH ITS ARCHE GENE THERAPY GRANTEES AND SOME EXPERTS ON NON-HUMAN PRIMATE RESEARCH. THE THINK TANK DISCUSSED THE ARCHE PROJECTS, IDENTIFIED OPPORTUNITIES FOR COLLABORATION, AND CLARIFIED AMFARS GOALS AND PHILOSOPHY FOR THE FUTURE OF THIS RESEARCH. IN JANUARY 2018, AMFAR DIRECTOR OF RESEARCH DR. ROWENA JOHNSTON AND PROGRAM CONSULTANT DR. JEFFREY LAURENCE TRAVELED TO BERLIN FOR AN ICISTEM THINK TANK. ICISTEM, CREATED AND FUNDED BY AMFAR THROUGH ITS COUNTDOWN TO A CURE FOR AIDS INITIATIVE, IS A CONSORTIUM OF EUROPEAN RESEARCHERS THAT HAS BEEN WORKING TO REPLICATE THE CASE OF "THE BERLIN PATIENT. (THE "LONDON PATIENT," REPORTED IN MARCH 2019 BY ICISTEM RESEARCHER DR. RAVI GUPTA, WAS THE FIRST OF THE GROUPS PATIENTS TO GO INTO HIV REMISSION.) AT THE END OF APRIL 2018, DRS. JOHNSTON AND LAURENCE HELD ANOTHER THINK TANK IN AMFARS NEW YORK CITY OFFICE TO PROVIDE UPDATES ON RESEARCH PROGRESS SO FAR AND TO DECIDE HOW BEST TO CONTINUE EFFORTS TOWARDS BUILDING A GENE THERAPY CURE FOR HIV. PROGRAM SERVICE ACCOMPLISHMENTS (2) LINE 4B: TREAT ASIA: AMFARS TREAT ASIA (THERAPEUTICS RESEARCH, EDUCATION, AND AIDS TRAINING IN ASIA) PROGRAM IS A NETWORK OF HOSPITALS, CLINICS, AND RESEARCH INSTITUTIONS WORKING WITH CIVIL SOCIETY TO ENSURE THE SAFE AND EFFECTIVE DELIVERY OF TREATMENTS FOR HIV AND ITS CO-INFECTIONS TO ADULTS AND CHILDREN ACROSS THE ASIA-PACIFIC THROUGH RESEARCH, EDUCATION, AND ADVOCACY OF EVIDENCE-BASED HIV-RELATED POLICIES. THE TREAT ASIA NETWORK ENCOMPASSES 21 ADULT AND 20 PEDIATRIC SITES THROUGHOUT THE REGION, WHICH COLLABORATE ON A VARIETY OF PROJECTS. TREAT ASIA SCIENTISTS PRODUCED 20 PUBLICATIONS IN PEER-REVIEWED MEDICAL JOURNALS IN FY2018. INTERNATIONAL AIDS DATABASE SINCE 2006, TREAT ASIA HAS MANAGED THE ASIA-PACIFIC SECTION OF THE INTERNATIONAL EPIDEMIOLOGIC DATABASES TO EVALUATE AIDS (IEDEA), A GLOBAL COLLABORATION ESTABLISHED BY THE U.S. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES. IN FY2018 IEDEA FUNDED MANY TREAT ASIA STUDIES, INCLUDING (ALONG WITH VIIV HEALTHCARE) THE THIRD YEAR OF STAY (STUDY OF TRANSITIONING ASIAN YOUTH), WHICH IS DOCUMENTING THE EXPERIENCE OF HIV-INFECTED YOUNG ADULTS WHO ARE TRANSITIONING FROM PEDIATRIC TO ADULT CARE. ANOTHER MAJOR IEDEA-FUNDED STUDY WAS THE SECOND YEAR OF THE INITIATIVE CALLED GRADUATE: A GLOBAL FRAMEWORK OF DATA COLLECTION USED FOR ADOLESCENT HIV TRANSITION EVALUATION. LED BY TREAT ASIA DIRECTOR DR. ANNETTE SOHN AND DR. MARY-ANN DAVIES OF THE UNIVERSITY OF CAPE TOWN, SOUTH AFRICA, GRADUATE, WHICH IS BEING CONDUCTED IN IN MALAWI, SOUTH AFRICA, AND THAILAND, AIMS TO IMPROVE HOW CLINICAL AND PROGRAM DATA ON ADOLESCENTS LIVING WITH HIV ARE ORGANIZED AND STUDIED IN RESOURCE-LIMITED SETTINGS. TREAT ASIA HIV OBSERVATIONAL DATABASE (TAHOD) IN 2002, TREAT ASIA PIONEERED THE REGIONS FIRST ADULT OBSERVATIONAL DATABASE FOR HIV/AIDS, WHICH NOW INCLUDES ANONYMOUS DATA FROM NEARLY 10,000 PATIENTS AT 21 CLINICAL SITES IN 12 COUNTRIES. THE INFORMATION GATHERED IN THE DATABASE INFORMS THE DEVELOPMENT OF MORE EFFECTIVE RESEARCH AND TREATMENT PROGRAMS AND HELPS DEFINE TREATMENT STANDARDS SPECIFIC TO HIV/AIDS IN ASIA. TREAT ASIA PEDIATRIC HIV OBSERVATIONAL DATABASE (TAPHOD) THE TREAT ASIA PEDIATRIC HIV OBSERVATIONAL DATABASE (TAPHOD) IS A REGIONAL PEDIATRIC HIV STUDY SET UP BY TREAT ASIA IN 2006. IT WAS MODELED AFTER THE ADULT DATABASE AND INCLUDES DATA FROM MORE THAN 6,400 CHILDREN AND ADOLESCENTS AT 18 CLINICAL SITES IN CAMBODIA, INDIA, INDONESIA, MALAYSIA, THAILAND, AND VIETNAM.
PROGRAM SERVICE ACCOMPLISHMENTS (2) CONT. ASSESSING FAILING SECOND-LINE HIV TREATMENT REGIMENS: THE TASER-2 STUDY THE TREAT ASIA STUDY TO EVALUATE RESISTANCE 2 (TASER-2) WAS INITIATED IN 2016 TO IMPROVE ASSESSMENT OF VIRAL FAILURE AND ASSOCIATED HIV DRUG RESISTANCE IN HIV-INFECTED ADULTS ON SECOND-LINE ART. THE STUDY IS FUNDED BY VIIV HEALTHCARE AND THE US NATIONAL INSTITUTES OF HEALTH THROUGH THE IEDEA GLOBAL COHORT CONSORTIUM. OVER 2,400 PARTICIPANTS HAVE BEEN ENROLLED ACROSS 12 PARTICIPATING SITES IN CAMBODIA, HONG KONG SAR, INDIA, INDONESIA, JAPAN, MALAYSIA, THE PHILIPPINES, SINGAPORE, SOUTH KOREA, AND VIETNAM. THE STUDY WILL PROVIDE DETAILED ANALYSIS OF THE PREVALENCE OF VIROLOGIC FAILURE, ASSOCIATED FACTORS, AND HIV DRUG RESISTANCE MUTATIONS. THIS INFORMATION WILL HELP TO BETTER PREDICT THE NEED FOR THIRD-LINE ART REGIMENS IN THE REGION, AS WELL AS TO FACILITATE ADVOCACY EFFORTS FOR INCLUSION OF THIRD-LINE OPTIONS IN NATIONAL TREATMENT GUIDELINES AND EXPANSION OF ROUTINE VIRAL LOAD TESTING CAPACITIES IN THE REGION. TAHOD LOW-INTENSITY TRANSFER (TAHOD-LITE) LAUNCHED IN 2015, TAHOD LOW-INTENSITY TRANSFER (TAHOD-LITE) CONTAINS DATA FROM OVER 37,000 HIV-POSITIVE PATIENTS ACROSS 10 TREAT ASIA NETWORK SITES. AS AN EXTENSION OF TAHOD, TAHOD-LITE AIMS TO INCREASE THE SCOPE OF ADULT DATA COLLECTION BY GATHERING A SUBSET OF CORE VARIABLES FROM THE ENTIRE COHORT OF HIV-INFECTED PATIENTS WHO HAVE SOUGHT CARE AT SELECTED TAHOD SITES. EVALUATING DEPRESSION AND ANXIETY IN THAI ADOLESCENTS WITH HIV AS PART OF TREAT ASIAS INITIATIVE TO ADDRESS THE MENTAL HEALTH CONCERNS OF ADOLESCENTS LIVING WITH HIV IN ASIA, A STUDY FUNDED THROUGH THE US NATIONAL INSTITUTES OF HEALTH IEDEA COLLABORATION IS EVALUATING THE PREVALENCE AND CLINICAL COURSE OF DEPRESSION AND ANXIETY IN THAI ADOLESCENTS WITH HIV. LED BY DR. TAVITIYA SUDJARITRUK OF CHIANG MAI UNIVERSITY IN CHIANG MAI, THAILAND, THE STUDY, WHICH BEGAN IN EARLY 2018, IS COMPARING DEPRESSION AND ANXIETY IN 150 ADOLESCENTS LIVING WITH HIV AND 150 MATCHED CONTROLS WITHOUT HIV. ADDRESSING ADULT MENTAL HEALTH IN JANUARY 2018, TREAT ASIA ORGANIZED A THINK TANK IN BANGKOK ON MENTAL HEALTH ISSUES IN ADULTS LIVING WITH HIV IN ASIA. LIKE CHILDREN AND ADOLESCENTS, ADULTS LIVING WITH HIV HAVE A HIGHER PREVALENCE OF ANXIETY AND DEPRESSION COMPARED WITH THEIR UNINFECTED PEERS, AND THESE ISSUES HAVE BEEN INADEQUATELY STUDIED AND TREATED. THE THINK TANK BROUGHT TOGETHER RESEARCHERS, CLINICIANS, AND PSYCHOLOGISTS FROM ACROSS ASIA AND FROM COLUMBIA UNIVERSITY IN NEW YORK CITY. PARTICIPANTS HIGHLIGHTED SOME CENTRAL ISSUES, AS WELL AS STRENGTHS, IN THEIR COUNTRIES APPROACHES AND RESOURCES FOR ASSESSING AND TREATING DEPRESSION IN ADULTS WITH HIV. THEY PROCEEDED TO CONSIDER RESEARCH, POLICY, AND CAPACITY DEVELOPMENT ACTIVITIES THAT MIGHT HELP ADDRESS SOME OF THE GAPS IN MENTAL HEALTH MANAGEMENT IN HIV CARE SETTINGS IN THE REGION. EMPOWERING YOUTH ADVOCATES THE SECOND CLASS OF TREAT ASIA'S YOUTH ACATA-ASIA COMMUNITY FOR AIDS TREATMENT AND ADVOCACY-CONTINUED ITS TWO-YEAR LEADERSHIP TRAINING PROGRAM IN FY2018. LAUNCHED IN 2015 WITH SUPPORT FROM VIIV HEALTHCARES POSITIVE ACTION FOR ADOLESCENTS PROGRAM, THE YOUTH ACATA PROGRAM AIMS TO EDUCATE PARTICIPANTS ABOUT HIV AND ANTIRETROVIRAL THERAPY AND CONNECT THEM TO OTHER HIV-POSITIVE YOUTH IN THE REGION. YOUTH ACATA MEMBERS HAVE BEGUN PARTICIPATING IN GLOBAL YOUTH PROGRAMS, INCLUDING SPARK17 AND THE INTERNATIONAL AIDS SOCIETYS ADOLESCENT TREATMENT COALITION. THE CURRENT GROUP INCLUDES YOUNG PEOPLE FROM MALAYSIA, INDIA, INDONESIA, THE PHILIPPINES, AND TAIWAN. HELPING ADOLESCENTS TRANSITION TO ADULT CARE AS PART OF ITS ONGOING EFFORTS TO IMPROVE THE PROCESS OF ADOLESCENT TRANSITION TO ADULT HIV CARE, TREAT ASIA AND REGIONAL PARTNERS CONDUCTED TRAININGS IN CAMBODIA, INDONESIA, MALAYSIA, THAILAND, AND VIETNAM FOR CLINICIANS WHO WORK WITH HIV-POSITIVE CHILDREN AND ADOLESCENTS TO HELP THEM BETTER PREPARE FOR THE MOVE TO ADULT HIV CARE. THE DAY-LONG SESSIONS FOCUSED ON CLINICAL CHALLENGES IN LONG-TERM HIV CARE AND TREATMENT, COMMUNICATION AND MANAGEMENT STRATEGIES TO IMPROVE RETENTION IN HIV CARE, AND ADOLESCENT HIV TRANSITION CARE MODELS. ADVOCATING FOR HIV AND CO-INFECTION TREATMENT ACCESS IN OCTOBER 2017, AMFARS PUBLIC POLICY OFFICE AND TREAT ASIA ORGANIZED A CONSULTATION IN BANGKOK WITH EXPERTS FROM LOCAL, NATIONAL, REGIONAL, AND INTERNATIONAL ORGANIZATIONS IN 11 COUNTRIES IN ASIA, EUROPE, AFRICA, AND NORTH AMERICA. THEY MET TO DISCUSS "ESSENTIAL STANDARDS" FOR VOLUNTARY LICENSES-ARRANGEMENTS WHEREBY A PATENT HOLDER ALLOWS OTHERS TO MANUFACTURE, IMPORT, AND/OR DISTRIBUTE ITS PATENTED DRUG-IN ORDER TO ENSURE GENUINE ACCESS. IN OCTOBER 2017, TREAT ASIA AND THE INTERNATIONAL ASSOCIATION COALITION PLUS BEGAN A NEW PARTNERSHIP TO IMPROVE HEPATITIS C (HCV) DIAGNOSIS AND TREATMENT ACCESS IN ASIA THROUGH THE UNITAID-FUNDED "HIV/HCV DRUG AFFORDABILITY PROJECT." THE PARTNERSHIPS GOAL IS TO BUILD LOCAL MOVEMENTS TOWARDS IMPLEMENTING NATIONAL TREATMENT PROGRAMS. A KEY STRATEGY HAS BEEN TO ENGAGE AND PARTNER WITH LOCAL CIVIL SOCIETY ORGANIZATIONS AND POLICY MAKERS TO ADVANCE ACCESS TOGETHER. IN NOVEMBER AND DECEMBER 2017, TREAT ASIA ORGANIZED TWO TRAININGS ON HEPATITIS B AND C AND THE IMPORTANCE OF ADDRESSING THESE DISEASES IN THE CONTEXT OF HIV CO-INFECTION. THE FIRST TRAINING, FOR COMMUNITY MEMBERS AND TREATMENT ADVOCATES FROM EIGHT COUNTRIES, AIMED TO SIMPLIFY WORLD HEALTH ORGANIZATION (WHO) HEPATITIS B AND C SCREENING AND TREATMENT GUIDELINES. THE SECOND FOCUSED ON SUPPORTING IMPLEMENTATION OF THE WHO GUIDELINES AT THE NATIONAL LEVEL, AND FAMILIARIZING CLINICIANS WITH THE GUIDELINES. IN COLLABORATION WITH THE WORLD HEALTH ORGANIZATION (WHO) SOUTH EAST ASIA REGIONAL OFFICE (SEARO) AND WESTERN PACIFIC REGIONAL OFFICE (WPRO), TREAT ASIA ORGANIZED A ROUNDTABLE DISCUSSION IN BANGKOK IN SEPTEMBER 2018 TITLED "ENHANCING ACCESS TO NEWER HIV AND HEPATITIS C MEDICINES." MANAGERS FROM INTELLECTUAL PROPERTY OFFICES, NATIONAL REGULATORY BODIES, AND HIV PROGRAMS IN NINE ASIAN COUNTRIES ATTENDED, ALONG WITH REPRESENTATIVES FROM THE CLINTON HEALTH ACCESS INITIATIVE, MEDICINES PATENT POOL, DRUGS FOR NEGLECTED DISEASES INITIATIVE, UNAIDS, AND THE WHO. INTRODUCING PREP TO THE PHILIPPINES IN FY 2018, PROJECT PREPPY, A TWO-YEAR PILOT PROJECT BEING CONDUCTED AT TWO CLINICS IN MANILA, THE PHILIPPINES, COMPLETED ENROLLMENT AND COMMENCED EVALUATING COMMUNITY-BASED, PEER-DRIVEN DELIVERY OF ANTIRETROVIRAL PRE-EXPOSURE PROPHYLAXIS (PREP). PROJECT PREPPY IS AN EFFORT TO CURB THE RAPID SPREAD IN RECENT YEARS OF HIV AMONG MSM AND TRANSGENDER INDIVIDUALS IN THE PHILIPPINES. AMFAR IS AMONG SEVERAL ORGANIZATIONS INVOLVED IN THE STUDY, A MULTIAGENCY COLLABORATION WITH EXPERTS FROM GOVERNMENT, ACADEMIA, AND MULTILATERAL AND NONGOVERNMENTAL ORGANIZATIONS. BASED ON EXPERIENCES FROM THE FIRST YEAR OF THE PROJECT, THE PHILIPPINES IS MOVING FORWARD TO AN EXPANSION OF PREP SERVICES IN OTHER AREAS OF THE COUNTRY. PUBLICATIONS IN FY2018, TREAT ASIA CREATED THE SECOND AND THIRD IN A SERIES OF INFOGRAPHICS TITLED WHY HAS ASIA FALLEN BEHIND ON HIV/AIDS TO ILLUSTRATE THE STAGNATION IN HIV PROGRAM COVERAGE IN THE ASIA-PACIFIC. THE STAGNATION IS A REMINDER TO GOVERNMENTS, CIVIL SOCIETY, AND DONORS THAT MUCH MORE NEEDS TO BE DONE TO BRING HIV/AIDS UNDER CONTROL IN THE REGION. IN NOVEMBER 2017, IT PUBLISHED STIGMA FUELING ASIAN HIV/AIDS EPIDEMICS, AND IN JUNE 2018, IT RELEASED FUNDING GAPS COULD PUT ASIA FURTHER BEHIND ON HIV/AIDS. IN JANUARY 2018, IN COLLABORATION WITH YOUNG PEOPLE LIVING WITH HIV, SOCIAL WORKERS, AND PEDIATRICIANS IN THE ASIA-PACIFIC REGION, TREAT ASIA DEVELOPED TOOLS TO HELP PROVIDERS MANAGE THE TRANSITION OF ADOLESCENTS FROM PEDIATRIC TO ADULT HIV CLINICS. THEY INCLUDE A FLIPCHART FOR USE DURING PROVIDER-PATIENT DISCUSSIONS-AVAILABLE IN ENGLISH, BAHASA INDONESIA, KHMER, MALAY, THAI, AND VIETNAMESE-AND PROVIDE INFORMATION ON DIFFERENCES BETWEEN PEDIATRIC AND ADULT HIV CLINICS, WHEN THE CARE TRANSITION SHOULD BE MADE, WHAT YOUNG PEOPLE SHOULD EXPECT AT AN ADULT HIV CLINIC, AND HIV TREATMENT AND PREVENTION. PRODUCTION WAS SUPPORTED BY THE CHILDREN AND YOUTH PROGRAM OF THE THAI RED CROSS AIDS RESEARCH CENTRE, AND VIIV HEALTHCARES POSITIVE ACTION FOR ADOLESCENTS PROGRAM. IN JUNE 2018, TREAT ASIA PRODUCED A POLICY BRIEF TITLED HEPATITIS C: POLICY RECOMMENDATIONS FOR ADDRESSING A GROWING EPIDEMIC. THE REPORT URGES NATIONAL GOVERNMENTS TO IMPROVE ACCESS TO CARE AND TREATMENT BY ESTABLISHING NATIONAL SURVEILLANCE SYSTEMS AND PROGRAMS FOR VIRAL HEPATITIS, INTEGRATING HIV AND HARM REDUCTION PROGRAMS WITH HEPATITIS C PROGRAMS, BUILDING SKILLS OF NON-SPECIALIST PROVIDERS TO FACILITATE EXPANSION OF HEPATITIS C TREATMENT, AND APPROVING FAST-TRACK REGISTRATION OF DIRECT-ACTING ANTIVIRAL MEDICATIONS THAT ARE EFFECTIVE AGAINST ALL GENOTYPES OF HEPATITIS C.
PROGRAM SERVICE ACCOMPLISHMENTS (3) CONT. IN ADDITION, TREAT ASIA CONTINUED TO PUBLISH LAY-LANGUAGE ARTICLES ON HIV/AIDS RESEARCH, POLICY, AND COMMUNITY ISSUES FACING THE ASIA-PACIFIC AS A WHOLE. THE ARTICLES AND EDUCATIONAL PIECES APPEAR IN THE TREAT ASIA REPORT, A BIMONTHLY E-NEWSLETTER, AND ON TREAT ASIAS WEBSITE, WWW.TREATASIA.ORG. 17TH ANNUAL NETWORK MEETING THE 2017 TREAT ASIA ANNUAL NETWORK MEETING WAS HELD IN OCTOBER 2017 IN BALI, INDONESIA, WHERE AROUND 100 ADULT AND PEDIATRIC INVESTIGATORS, TREAT ASIA STAFF, AND PROGRAM PARTNERS GATHERED TO REVIEW THE NETWORKS HIV RESEARCH ACCOMPLISHMENTS, COLLECTIVELY PLAN FOR FUTURE INITIATIVES, AND CONSIDER CONTINUED CHALLENGES TO REGIONAL HIV RESEARCH AND RESPONSES. HIGHLIGHTS OF THE 17TH ANNUAL NETWORK MEETING INCLUDED: - PERSPECTIVES ON MOVING FROM CONTROLLING TO ENDING THE HIV EPIDEMICS OF THE ASIA-PACIFIC REGION FROM DR. PRAPHAN PHANUPHAK, DIRECTOR OF THE THAI RED CROSS AIDS RESEARCH CENTRE (TRC-ARC), DRAWING ON HIS MORE THAN THIRTY YEARS OF EXPERIENCE LEADING NATIONAL AND REGIONAL RESEARCH AND RESPONSE EFFORTS. - A DEBATE ON WHETHER HIV SELF-TESTING SHOULD BE AVAILABLE TO ALL ADULTS IN THE REGION, WITH DR. ROSSANA DITANGCO OF THE RESEARCH INSTITUTE FOR TROPICAL MEDICINE, PHILIPPINES, ARGUING IN FAVOR, AND DR. MAN-PO LEE OF QUEEN ELIZABETH HOSPITAL, HONG KONG SAR, CHINA, ARGUING AGAINST. - A PRESENTATION OF THE LATEST RESEARCH ON HIV, AGING, AND MENTAL HEALTH BY DR. REENA RAJASURIAR OF THE UNIVERSITY OF MALAYA, MALAYSIA. - A POLICY PERSPECTIVE ON HOW DATA AND TECHNOLOGY ARE BEING USED TO OPTIMIZE THE IMPACT OF GLOBAL HIV PROGRAMS AND CHARACTERIZE THE SCOPE OF THE OPIOID EPIDEMIC IN THE U.S. BY BRIAN HONERMANN, FROM AMFARS PUBLIC POLICY OFFICE IN WASHINGTON, D.C. OTHER CONFERENCES TREAT ASIA STAFF AND NETWORK INVESTIGATORS ATTENDED AND PRESENTED AT SEVERAL REGIONAL AND INTERNATIONAL CONFERENCES ON HIV-RELATED ISSUES. EXAMPLES INCLUDE: AIDS 2018 IN JULY, TREAT ASIA, PARTNER INVESTIGATORS, AND AFFILIATES PLAYED A PROMINENT ROLE AT THE 22ND INTERNATIONAL AIDS CONFERENCE IN AMSTERDAM, THE NETHERLANDS, LEADING AND PRESENTING AT NUMEROUS PLENARIES, SYMPOSIA, AND OTHER SESSIONS. DR. ANNETTE SOHN, DIRECTOR OF TREAT ASIA, CO-CHAIRED A SYMPOSIUM TITLED "COMING OF AGE WITH HIV: A TESTIMONY OF OUR SUCCESS AND A MEASURE OF OUR READINESS FOR THE FUTURE," AT WHICH DR. THANYAWEE PUTHANAKIT OF CHULALONGKORN UNIVERSITY IN BANGKOK, THAILAND, ALSO SPOKE. DR. WIN MIN HAN OF HIV-NAT, BANGKOK; DR. IVAN MARBANIANG OF BJ GOVERNMENT MEDICAL COLLEGE AND JOHNS HOPKINS UNIVERSITY COLLABORATION IN PUNE, INDIA; AND TARANDEEP ANAND OF ADAM'S LOVE, THAILAND, PRESENTED POSTERS AT THE CONFERENCE. AT THE 10TH INTERNATIONAL WORKSHOP ON HIV PEDIATRICS, WHICH TOOK PLACE IMMEDIATELY BEFORE AIDS 2018, DR. TAVITIYA SUDJARITRUK OF CHIANG MAI UNIVERSITY IN CHIANG MAI, THAILAND; DR. THIDA SINGTOROJ OF TREAT ASIA; AND DR. SUPATTRA RUNGMAITREE OF MAHIDOL UNIVERSITY IN BANGKOK; REPORTED FINDINGS OF A VARIETY OF TREAT ASIA-FUNDED STUDIES ON ASIAN ADOLESCENTS LIVING WITH HIV. ALSO DURING AIDS 2018, DR. SIRINYA TEERAANANCHAI OF THE HIV NETHERLANDS AUSTRALIA THAILAND RESEARCH COLLABORATION (HIV-NAT) BECAME THE FOURTH TREAT ASIA INVESTIGATOR TO RECEIVE A PRESTIGIOUS COLLABORATIVE INITIATIVE FOR PAEDIATRIC HIV EDUCATION AND RESEARCH (CIPHER) GRANT TO STUDY AND DESCRIBE LINKAGE FROM HIV DIAGNOSIS ALONG THE TREATMENT CASCADE IN YOUTH LIVING WITH HIV. APACC TREAT ASIA WAS ALSO WELL REPRESENTED AT THE THIRD ASIA PACIFIC AIDS & CO-INFECTIONS CONFERENCE (APACC) IN JUNE 2018 IN HONG KONG. APACC IS A REGIONAL-LEVEL HIV RESEARCH CONFERENCE THAT PROVIDES OPPORTUNITIES FOR LOCAL CLINICIANS, STUDENTS, AND RESEARCHERS TO SUBMIT ABSTRACTS FOR PRESENTATION. DR. SOHN CO-CHAIRED THE CONFERENCE AND TREAT ASIA RESEARCH DIRECTOR DR. JEREMY ROSS CO-CHAIRED A SESSION ON KEY POPULATION-LED SERVICES. PROGRAM SERVICE ACCOMPLISHMENTS (3) LINE 4C: PUBLIC INFORMATION: AMFAR SEEKS TO TRANSLATE AND DISSEMINATE INFORMATION ON IMPORTANT HIV-RELATED RESEARCH, TREATMENT, PREVENTION, AND POLICY ISSUES FOR DIVERSE AUDIENCES AND TO INCREASE AWARENESS AND KNOWLEDGE OF THE PANDEMIC. AMFAR PUBLISHES A WIDE RANGE OF EDUCATIONAL MATERIALS, MAINTAINS AN INFORMATIVE WEBSITE, AND ENGAGES RESPECTED PUBLIC FIGURES, HIV/AIDS SCIENTISTS, AND POLICYMAKERS IN COMMUNICATING THE NEED FOR CONTINUED RESEARCH TO DEVELOP NEW METHODS OF PREVENTION, TREATMENT, AND, ULTIMATELY, A CURE FOR HIV. EDUCATIONAL MATERIALS AMFAR PRODUCES A RANGE OF PERIODICALS IN BOTH PRINT AND ELECTRONIC FORMATS, INCLUDING ITS NEWSLETTER INNOVATIONS, PUBLISHED TWICE A YEAR AND DISTRIBUTED TO ABOUT 40,000 PEOPLE; THE TREAT ASIA REPORT, AN EMAIL NEWSLETTER DISTRIBUTED SIX TIMES A YEAR TO MORE THAN 4,000 READERS IN THE INTERNATIONAL HEALTH COMMUNITY; AND A MONTHLY E-MAIL NEWSLETTER DISTRIBUTED TO NEARLY 70,000 PEOPLE. THE FOUNDATIONS WEBSITES-WWW.AMFAR.ORG AND WWW.CURECOUNTDOWN.ORG-FEATURE NEWS, INTERVIEWS, AND ORIGINAL ARTICLES COVERING HIV RESEARCH, POLICY, THE GLOBAL EPIDEMIC, AND AMFAR PROGRAMS AND ACTIVITIES. THE WEBSITES ATTRACT A COMBINED AVERAGE OF 45,000 VISITORS PER MONTH. AMFAR ALSO CREATES AND DISTRIBUTES REPORTS, PRESS RELEASES, AND UPDATES ON MAJOR HIV/AIDS ISSUES AND CONDUCTS PUBLIC SERVICE ADVERTISING CAMPAIGNS THAT HAVE BEEN INSTRUMENTAL IN EDUCATING POLICYMAKERS, HEALTHCARE PROFESSIONALS, PEOPLE LIVING WITH HIV/AIDS, AND THE PUBLIC. EPIC VOICES IN FY2018, AMFAR ADDED EIGHT NEW EPIC VOICES TO THE ORIGINAL FOUR POSTED ON CURECOUNTDOWN.ORG. LAUNCHED IN 2017, EPIC VOICES IS AN ONLINE VIDEO SERIES THAT AIMS TO REENERGIZE THE RESPONSE TO HIV AMONG MILLENNIAL AND LGBTQ COMMUNITIES. THE GOALS OF THE CAMPAIGN ARE TO RENEW AWARENESS OF THE PERSISTENT THREAT OF HIV, UNDERSCORE THE URGENT NEED TO ADVANCE HIV RESEARCH, AND SUPPORT AMFARS LEADERSHIP IN THE SEARCH FOR A CURE. ALONG WITH ACTIVISTS AND PEOPLE LIVING WITH HIV, IT FEATURES LEADING RESEARCHERS AND PUBLIC HEALTH PROFESSIONALS. SOCIAL MEDIA AMFAR HAS VIGOROUSLY EXPANDED ITS PRESENCE IN THE SOCIAL MEDIA ARENA, REACHING LARGE NUMBERS OF PEOPLE, INCLUDING A YOUNGER DEMOGRAPHIC THAT IS OFTEN LESS EDUCATED ABOUT HIV AND THE AIDS EPIDEMIC. THE FOUNDATION REGULARLY ADDS CONTENT TO ITS FACEBOOK PAGE, LIVE TWEETS FROM EVENTS, AND POSTS IMAGES ON INSTAGRAM FROM FUNDRAISING AND PROGRAM EVENTS. AMFAR HAS 73,000 LIKES ON FACEBOOK, 43,000 TWITTER FOLLOWERS, AND MORE THAN 155,000 INSTAGRAM FOLLOWERS. MEDIA OUTREACH IN FY2018, AMFAR CONTINUED TO WORK CLOSELY WITH THE MEDIA TO RAISE THE PROFILE OF HIV/AIDS, BOTH DOMESTICALLY AND INTERNATIONALLY, AND TO HELP ENSURE THE ACCURACY OF HIV-RELATED PRESS COVERAGE. ARTICLES AND REPORTS INVOLVING AMFAR-MANY OF WHICH INCLUDED INTERVIEWS WITH STAFF-WERE CARRIED IN NUMEROUS MEDIA OUTLETS, INCLUDING THE LANCET, THE NEW YORK TIMES, THE WASHINGTON POST, THE CHICAGO TRIBUNE, BAY AREA REPORTER, THE ASSOCIATED PRESS, NPR, U.S. NEWS & WORLD REPORT, TIME, THE HILL, DAILY MAIL, CNBC, WABC-TV, CNN, CBS NEWS, NBC NEWS, POLITICO, MEDIA PLANET, BUZZFEED, VOX, KAISER HEALTH NEWS, MODERN HEALTHCARE, HEALTHDAY NEWS, MEDPAGE TODAY, HARPERS BAZAAR, RAI, VOGUE, W MAGAZINE, WWD, POZ, A&U MAGAZINE, INTERNATIONAL BUSINESS TIMES, PAPER, HUFFPOST, AND PEOPLE. CELEBRITY SUPPORT AMFARS PUBLIC AWARENESS EFFORTS ARE GREATLY ENHANCED BY THE COMMITTED SUPPORT OF PUBLIC FIGURES WHO LEND THEIR VOICES AND DONATE THEIR TIME, TALENTS, AND RESOURCES TO HELP SUSTAIN THE FOUNDATIONS MISSION. SUPPORT OF AMFAR BY PROMINENT PUBLIC FIGURES BEGAN WITH THE LATE DAME ELIZABETH TAYLOR, AMFARS FOUNDING INTERNATIONAL CHAIRMAN, AND OTHERS HAVE FOLLOWED IN HER FOOTSTEPS. HEIDI KLUM WAS FEATURED IN AMFARS PUBLIC SERVICE AWARENESS CAMPAIGN ABOUT SAFE SEX, WHICH RESULTED IN COVERAGE FROM BUZZFEED, THEM., CBS NEWS, RAPPLER, NEWNOWNEXT, AND DAILY MAIL. OTHER CELEBRITY SUPPORTERS INCLUDED AMFAR AMBASSADORS MILLA JOVOVICH, MICHELLE YEOH, CHEYENNE JACKSON, AND LIZA MINNELLI, EDWARD ENNINFUL, ZARA LARSSON, JULIAN PERRETTA, ANGELA MISSONI, DEAN AND DAN CATEN, KATE HUDSON, LINDA EVANGELISTA, DONATELLA VERSACE, KATY PERRY, SIENNA MILLER, KAROLINA KURKOVA, BENICIO DEL TORO, STING, GRACE JONES, ELLIE GOULDING, JASON DERULO, NEYMAR JR., SEU JORGE, JEAN-PAUL GAULTIER, KATE MOSS, VIK MUNIZ, KYLIE MINOGUE, TOVE LO, KAWS, CATHY LEE, LEE DANIELS, STEFANO TONCHI, HALSEY, TARAJI P. HENSON, ALAN CUMMING, WHOOPI GOLDBERG, IMAN, SCARLETT JOHANSSON, QUEEN LATIFAH, LAURA LINNEY, JULIA ROBERTS, TOM HANKS, JAMES CORDEN, FERGIE, CHARLIZE THERON, ADRIEN BRODY, JESSICA CHASTAIN, MATT BOMER, GWYNETH PALTROW, DIANA ROSS, CHIARA FERRAGNI, DIANE KRUGER, KATIE HOLMES, UMA THURMAN, ZOE SALDANA, TOBEY MAGUIRE, DAME HELEN MIRREN, LEA MICHELE, MICHELLE RODRIGUEZ, WILL SMITH, NICOLE KIDMAN, NAOMI CAMPBELL, JON HAMM, EVA LONGORIA, NICKI MINAJ, ANDREA BOCELLI, CHRIS TUCKER, JENNIFER GARNER, VICTORIA JUSTICE, AND CARINE ROITFELD.
PROGRAM SERVICE ACCOMPLISHMENTS (5) LINE 4D: PUBLIC POLICY: INFORMED BY THOROUGH RESEARCH AND ANALYSIS, AMFAR IS A HIGHLY RESPECTED ADVOCATE OF RATIONAL AND COMPASSIONATE HIV/AIDS-RELATED PUBLIC POLICY. THE FOUNDATION IS ENGAGED IN EFFORTS TO SECURE NECESSARY INCREASES IN FUNDING FOR HIV/AIDS RESEARCH; IMPLEMENT THE U.S. NATIONAL HIV/AIDS STRATEGY; EXPAND ACCESS TO CARE AND TREATMENT; ADVOCATE FOR CONTINUED ROBUST U.S. SUPPORT FOR INTERNATIONAL HIV/AIDS PROGRAMS; AND PROTECT THE CIVIL RIGHTS OF ALL PEOPLE AFFECTED BY HIV/AIDS. ENDING THE DOMESTIC HIV EPIDEMIC IN JULY 2018, AMFAR PUBLISHED A SERIES OF REPORTS TO FACILITATE THE ANALYSIS AND POLICY DECISIONS NEEDED TO ADVANCE THE DIFFICULT PROCESS OF DEVELOPING AND DEPLOYING LONG-ACTING HIV TREATMENT AND PREVENTION PRODUCTS CURRENTLY IN THE PIPELINE. LONG-ACTING HIV TREATMENT AND PREVENTION ARE COMING: PREPARING FOR POTENTIAL GAME CHANGERS DESCRIBES THE CRITICAL ISSUES (E.G., FDA REVIEW AND APPROVAL, PAYER COVERAGE, AND ACCESS DECISIONS) THAT MUST BE NAVIGATED BY POLICY MAKERS TO MAKE POTENTIALLY GAME-CHANGING NEW PRODUCTS AVAILABLE FOR PEOPLE LIVING WITH HIV OR VULNERABLE TO INFECTION. HIV AND THE OPIOID EPIDEMIC IN JANUARY 2018, AMFAR PUBLISHED AN ANALYSIS ONLINE IN HEALTH AFFAIRS DETAILING THE AVAILABILITY OF MEDICATION-ASSISTED TREATMENT (MAT) NATIONALLY FOR OPIOID USE DISORDER. WHERE MULTIPLE MODES OF MEDICATION-ASSISTED TREATMENT ARE AVAILABLE ASSESSES ACCESS TO MAT, SPECIFICALLY WHERE DRUG TREATMENT FACILITIES OFFER SEVERAL OF THE THREE CURRENTLY AVAILABLE DRUGS. THESE OPTIONS MAY BE IMPORTANT FOR PATIENTS WITH DIFFERENT TREATMENT NEEDS. THE AUTHORS REPORT THAT IN THE HEART OF APPALACHIA, A REGION HEAVILY AFFECTED BY THE OPIOID EPIDEMIC, KENTUCKY AND TENNESSEE HAVE NO FACILITIES THAT PROVIDE ALL THREE FORMS OF MAT AND ACCEPT MEDICAID. IN MARCH 2018, AMFAR PUBLISHED GETTING TO SERVICES: FAR, FAR AWAY, AN INFOGRAPHIC REVEALING THAT NEARLY 30% OF AMERICANS (95.7 MILLION PEOPLE) LIVE MORE THAN TEN MILES FROM A FACILITY PROVIDING MAT, AND NEARLY 80% (260.9 MILLION PEOPLE) LIVE MORE THAN TEN MILES FROM A SYRINGE SERVICES PROGRAM. SINCE UPTAKE OF TREATMENT FOR SUBSTANCE USE DISORDER AND HARM REDUCTION SERVICES AT SYRINGE SERVICES PROGRAMS CAN REDUCE THE RISK OF ACQUIRING HIV AND HEPATITIS C (HCV) THROUGH THE SHARING OF NEEDLES, ACCESS TO SERVICES IS CRITICALLY IMPORTANT. IN APRIL 2018, AMFAR PUBLISHED A REPORT THAT OUTLINES A COMPREHENSIVE LEGISLATIVE AGENDA TO ADDRESS THE INTERCONNECTED PUBLIC HEALTH THREATS OF OPIOID USE ALONG WITH INFECTIOUS DISEASES SUCH AS HIV AND HCV. TOWARD AN EFFECTIVE STRATEGY TO COMBAT HIV, HEPATITIS C AND THE OPIOID EPIDEMIC: RECOMMENDATIONS FOR POLICY MAKERS PROPOSES A MULTIFACETED STRATEGY THAT INCREASES ACCESS TO TREATMENT, REDUCES THE RISK OF HIV AND HCV ACQUISITION, AND LOWERS THE RISK OF FATAL DRUG OVERDOSES. AMFAR ALSO PUBLISHED AN ANALYSIS ONLINE IN THE AMERICAN JOURNAL OF PUBLIC HEALTH ASSESSING THE IMPACT OF MEDICAID EXPANSION ON THE OPIOID EPIDEMIC. MEDICAID CURRENTLY PROVIDES COVERAGE FOR FOUR IN TEN NON-ELDERLY AMERICANS WITH OPIOID USE DISORDER. WHILE OPIOID PRESCRIBING IN THE MEDICAID POPULATION HAS INCREASED IN RECENT YEARS, THE STUDY FOUND NO STATISTICAL DIFFERENCE IN PRESCRIPTION RATES BETWEEN STATES THAT EXPANDED MEDICAID AND STATES THAT DID NOT, AND THAT AN EXPANSION IN COVERAGE INCREASED ACCESS TO ADDICTION TREATMENT. GLOBAL HEALTH IN MARCH 2018, AMFAR PUBLISHED LIVES ON THE LINE: THE HUMAN IMPACT OF PROPOSED CUTS TO GLOBAL HIV FUNDING, AN INFOGRAPHIC SHOWING THE HUMAN COSTS THAT WOULD RESULT FROM THE TRUMP ADMINISTRATIONS PROPOSED FY2019 BUDGET, INCLUDING $800 MILLION IN PROPOSED CUTS TO THE U.S. PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR), A 17% DECREASE. SUCH A SUBSTANTIAL DECREASE COULD CAUSE MORE THAN 1 MILLION HIV TREATMENT DISRUPTIONS FOR BOTH CHILDREN AND ADULTS, NEW HIV INFECTIONS, AND HUNDREDS OF THOUSANDS OF PREVENTABLE AIDS-RELATED DEATHS. IN JULY 2018, AMFAR VICE PRESIDENT AND DIRECTOR OF PUBLIC POLICY GREG MILLETT COAUTHORED A LANCET REPORT WARNING THAT UNAIDS TARGETS TO END THE HIV EPIDEMIC BY 2030 CAN ONLY BE MET WITH STRONGER COMBINED HEALTH SERVICE INTEGRATION AND BY INCORPORATING HIV INTO GLOBAL HEALTH POLICY. THIS REPORT ON THE "DANGEROUS COMPLACENCY" THREATENING THE GLOBAL HIV RESPONSE COINCIDED WITH A UNAIDS REPORT WARNING OF NEW HIV INFECTIONS INCREASING IN SOME 50 COUNTRIES, AIDS-RELATED DEATHS NOT FALLING FAST ENOUGH, AND INSUFFICIENT RESOURCES TO SUSTAIN PROGRESS. IN JULY 2018, AMFAR ALSO PUBLISHED AN UPDATED ISSUE BRIEF OUTLINING SERIOUS POTENTIAL IMPACTS OF THE MEXICO CITY POLICY (MCP) ON GLOBAL AIDS FUNDING. MCP HAS HISTORICALLY PROHIBITED U.S. FAMILY PLANNING FUNDING FOR NON-U.S. NONGOVERNMENTAL ORGANIZATIONS PERFORMING OR PROMOTING ABORTION. PRESIDENT REAGAN INTRODUCED THE MEASURE IN 1984 AND IT HAS GONE BACK AND FORTH EVER SINCE. AFTER BEING REPEALED BY PRESIDENT OBAMA, THE POLICY HAS BEEN REVIVED AND EXPANDED BY THE TRUMP ADMINISTRATION. AMFAR FUNDED A STUDY WITH JOHNS HOPKINS UNIVERSITY, GAY SOCIAL NETWORK HORNET, MSM-GF, AND EMORY UNIVERSITY TO COMPARE THE NUMBER OF GAY AND BISEXUAL MEN USING HORNET OR FACEBOOK IN VARIOUS COUNTRIES TO UNAIDS POPULATION SIZE ESTIMATES FOR GAY AND BISEXUAL MEN. IN JULY 2018, AMFAR PUBLISHED WHEN SIZE MATTERS: HOW SOCIAL MEDIA CAN HELP DETERMINE KEY POPULATION SIZE, AN INFOGRAPHIC SHOWING THAT DATA FROM THE STUDY HAD ALREADY BEEN USED TO TRIPLE THE OFFICIAL POPULATION SIZE OF MEN WHO HAVE SEX WITH MEN (MSM) IN TANZANIA. MORE ACCURATE ESTIMATES HELP PEPFAR AND THE GLOBAL FUND SET HIV PREVENTION TARGETS AND BUDGETS THAT ARE SUFFICIENT FOR THE NEEDS OF THESE KEY POPULATIONS. CROI 2018 AMFARS PUBLIC POLICY OFFICE PARTICIPATED IN THE CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS (CROI) IN BOSTON IN MARCH. AMFAR POLICY ASSOCIATE ALANA SHARP PRESENTED THE POSTER, "220 VULNERABLE COUNTIES: ONE YEAR LATER," PROVIDING NEW ANALYSIS OF COUNTY-LEVEL ACCESS TO DRUG TREATMENT AND SYRINGE SERVICES FACILITIES NATIONALLY. THE STUDY HIGHLIGHTED SOME PROGRESS IN INCREASING ACCESS TO SERVICES IN VULNERABLE COUNTIES, AND AREAS OF ONGOING CONCERN: COUNTIES THAT ARE VULNERABLE TO HIV AND/OR HEPATITIS C OUTBREAKS HAVE HISTORICALLY HAD LESS ACCESS TO TREATMENT AND HARM REDUCTION SERVICES THAN THE REST OF THE COUNTRY, AND NATIONALLY, ACCESS TO SYRINGE SERVICES REMAINS VERY LOW, WITH LONG AVERAGE DISTANCES TO THESE FACILITIES. IAS 2018 AMFARS PUBLIC POLICY OFFICE PARTICIPATED IN THE 22ND INTERNATIONAL AIDS CONFERENCE (AIDS 2018) IN AMSTERDAM IN JULY. THE OFFICE CO-SPONSORED A SATELLITE SESSION, WITH PLANNED PARENTHOOD GLOBAL AND THE CENTER FOR HEALTH AND GENDER EQUITY, TITLED "THE TRUMP EFFECT: HOW THE U.S. IS JEOPARDIZING THE GLOBAL AIDS RESPONSE." AMFAR ALSO PARTICIPATED IN THE WORKSHOP, "UNDERSTANDING THE GLOBAL GAG RULE: A PRACTICAL WORKSHOP FOR HOW TO SUSTAIN GLOBAL HEALTH PROGRESS AMIDST THE NEW U.S. POLICY ENVIRONMENT." THESE SEMINARS FOCUSED ON THE NUANCES OF POLICY TO HELP IMPLEMENTERS BETTER UNDERSTAND THE POLICY AND EDUCATE ABOUT POTENTIAL HARMS AND HARM REDUCTION STRATEGIES. AMFAR VICE PRESIDENT AND DIRECTOR OF PUBLIC POLICY GREG MILLETT MODERATED "AIDS 2018 LIVE!" A FACEBOOK LIVE SESSION ON HIV FUNDING. AMFAR POLICY ASSOCIATE JENNIFER SHERWOOD PRESENTED A POSTER TITLED "MAPPING THE IMPACT OF THE EXPANDED MEXICO CITY POLICY FOR HIV/FAMILY PLANNING SERVICE INTEGRATION IN PEPFAR-SUPPORTED COUNTRIES: A RISK INDEX.HER COLLEAGUE, POLICY ASSOCIATE ALANA SHARP, PRESENTED THE POSTER: "APPLYING THE GLOBAL FUND ALLOCATION FORMULA-ARE THE DATA DRIVING ALLOCATIONS" IN THE NEWS THROUGHOUT THE YEAR, GREG MILLETT WAS WIDELY QUOTED IN STORIES ON THE OPIOID EPIDEMIC, WHICH OFTEN INCLUDED THE AMFAR OPIOID AND HEALTH INDICATORS DATABASE. MEDIA HIGHLIGHTS INCLUDED BUZZFEED, VOX, REUTERS, AND KAISER HEALTH NEWS. IN OCTOBER 2017, PRESIDENT TRUMP DECLARED THE OPIOID CRISIS A PUBLIC HEALTH EMERGENCY, AND AMFARS PUBLIC POLICY OFFICE WAS INTERVIEWED BY THE MEDIA TO DISCUSS THE IMPACT OF THE OPIOID EPIDEMIC INCLUDING ITS CONNECTION TO DOMESTIC HIV OUTBREAKS. MEDIA HIGHLIGHTS INCLUDED KEY STORIES IN POLITICO AND AN INTERVIEW WITH DR. SUSAN BLUMENTHAL, AMFAR SENIOR POLICY AND MEDICAL ADVISOR, FOR A WASHINGTON POST PODCAST, "CAPE UP." IN OBSERVANCE OF WORLD AIDS DAY IN DECEMBER 2017, AMFAR CEO KEVIN ROBERT FROST WROTE AN OP-ED FOR MEDIAPLANET ON THE DANGERS OF COMPLACENCY AS WELL AS EVOLVING CHALLENGES IN ENDING HIV.
POLICIES FORM 990, PART VI, SECTION B LINE 11 - THE FORM 990 WAS PREPARED BY A NATIONALLY RENOWNED ACCOUNTING FIRM IN CONJUNCTION WITH THE ORGANIZATION'S FINANCIAL DEPARTMENT. A COPY OF THE DRAFT FORM 990 WAS CIRCULATED TO THE FULL BOARD OF TRUSTEES FOR DISCUSSION AND COMMENT. EACH BOARD MEMBER WAS PROVIDED AMPLE OPPORTUNITY TO COMMENT ON THE INFORMATION CONTAINED IN THE 990 PRIOR TO ITS FILING WITH THE INTERNAL REVENUE SERVICE. LINE 12 - EACH OFFICER, DIRECTOR, TRUSTEE AND KEY EMPLOYEE OF AMFAR ("FOUNDATION") IS REQUIRED TO ANNUALLY DISCLOSE ANY CONFLICTS OF INTEREST THAT ARISE BY VIRTUE OF EMPLOYMENT, BOARD SERVICE, OR POSITION WITH THE FOUNDATION. THE FOUNDATION MONITORS COMPLIANCE WITH ITS CONFLICT OF INTEREST POLICY THROUGH AN ANNUAL QUESTIONNAIRE/DISCLOSURE STATEMENT THAT IS DISTRIBUTED TO THESE INDIVIDUALS. POTENTIAL CONFLICTS ARE INVESTIGATED IMMEDIATELY. LINE 15 - AMFAR ("FOUNDATION FOR AIDS RESEARCH") UNDERTAKES A THOROUGH PROCESS TO ENSURE THAT THE COMPENSATION IT PAYS TO ITS TOP MANAGEMENT OFFICIAL AND ALL OF ITS OFFICERS AND KEY EMPLOYEES IS REASONABLE GIVEN THE MARKET IN WHICH THE FOUNDATION OPERATES. AN INDEPENDENT CONSULTING FIRM QUALIFIED IN THE AREA OF NONPROFIT COMPENSATION PREPARES AN ANALYSIS OF MARKET COMPENSATION RANGES BY JOB FUNCTION AND PRESENTS IT TO THE COMPENSATION COMMITTEE OF THE BOARD. ON THE BASIS OF THIS INFORMATION, STAFF COMPENSATION IS DETERMINED ACCORDING TO SALARY RANGES APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD, IN CONSULTATION WITH THE CEO AND CFO. CEO COMPENSATION IS REVIEWED AND DETERMINED BY THE COMPENSATION COMMITTEE OF THE BOARD UTILIZING THE INDEPENDENT CONSULTANT ANALYSIS. AMFAR'S last independent compensation study was commissioned in 2017; the Foundation is in the process of undergoing a compensation study currently to ensure that the President & CEO's compensation is reasonable given the market in which the Foundation operates.
DISCLOSURE FORM 990, PART VI, SECTION C LINE 19 - AMFAR MAKES ITS FORM 990 AVAILABLE TO THE PUBLIC BY RETAINING A COPY AT ITS PLACE OF BUSINESS AND ON ITS WEBSITE, WWW.AMFAR.ORG. THE FORM 990 IS LIKEWISE PUBLISHED ON THE INTERNET AT WWW.GUIDESTAR.ORG. THE FOUNDATION'S FINANCIAL STATEMENTS ARE MADE AVAILABLE IN ITS ANNUAL REPORT AND ON ITS WEBSITE. THE FOUNDATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE NOT ORDINARILY MADE AVAILABLE TO THE PUBLIC, BUT, IF REQUESTED, WILL BE PROVIDED AT MANAGEMENT'S DISCRETION.
FUNCTIONAL EXPENSES PART IX, LINES 1 & 3 THE FOUNDATION FOR AIDS RESEARCH REPORTS ITS GRANTS NET OF GRANT RETURNS OR RECOVERIES. PERIODICALLY, GRANTS REMITTED TO CHARITABLE ORGANIZATIONS ARE RETURNED TO AMFAR FOR A VARIETY OF REASONS. ON SCHEDULES F & I, GRANTS ARE REPORTED IRRESPECTIVE OF WHETHER THEY WERE ULTIMATELY RETURNED TO AMFAR SINCE CATEGORIZING THE "RETURNED" AMOUNTS WOULD BE TIME CONSUMING. THEREFORE, AMOUNTS REPORTED ON PART IX, LINE 1 WILL NOT TIE TO TOTAL GRANTS ON SCHEDULE I; AMOUNTS REPORTED ON PART IX, LINE 3 WILL NOT TIE TO TOTAL GRANTS ON SCHEDULE F.
For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.
Cat. No. 51056K
Schedule O (Form 990 or 990-EZ) 2019


Additional Data


Software ID:  
Software Version: